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   RESUME	  	   L'introduction	  des	  technologies	  de	  séquençage	  de	  nouvelle	  génération	  est	  en	  vue	  de	  révolutionner	  la	  médecine	  moderne.	  L'impact	  de	  ces	  nouveaux	  outils	  a	  déjà	  contribué	  à	   la	  découverte	  de	  nouveaux	  gènes	  et	  de	  voies	  cellulaires	   impliqués	  dans	  la	  pathologie	  de	  maladies	  génétiques	  rares	  ou	  communes.	  En	  revanche,	  l'énorme	  quantité	  de	  données	  générées	   par	   ces	   systèmes	   ainsi	   que	   la	   complexité	   des	   analyses	   bioinformatiques	  nécessaires,	  engendre	  un	  goulet	  d'étranglement	  pour	  résoudre	  les	  cas	  les	  plus	  difficiles.	  L'objectif	   de	   cette	   thèse	   a	   été	   d’identifier	   les	   causes	   génétiques	   de	   deux	   maladies	  héréditaires	   utilisant	   ces	   nouvelles	   techniques	   de	   séquençage,	   couplées	   à	   des	  technologies	   d'enrichissement	   de	   gènes.	   Dans	   ce	   cadre,	   nous	   avons	   développé	   notre	  propre	   méthode	   de	   travail	   (pipeline)	  pour	   l’alignement	   des	   fragments	   de	  séquence	   	  (reads).	   Suite	   à	   l'identification	   de	   gènes,	   nous	   avons	   réalisé	   une	   analyse	  fonctionnelle	  pour	  élucider	  leur	  rôle	  dans	  la	  maladie.	  	  	  Dans	  un	  premier	  temps,	  nous	  avons	  étudié	  et	  identifié	  des	  mutations	  impliquées	  dans	  une	  forme	  récessive	  de	  la	  rétinite	  pigmentaire	  qui	  est	  à	  ce	  jour	  la	  dégénérescence	  rétinienne	   héréditaire	   la	   plus	   fréquente.	   En	   particulier,	   nous	   avons	   constaté	   que	   des	  mutations	   faux-­‐sens	  dans	   le	  gène	  FAM161A	  étaient	   la	  cause	  de	   la	   rétinite	  pigmentaire	  préalablement	   associé	   avec	   le	   locus	  RP28.	  De	  plus,	   nous	   avons	  démontré	   que	   ce	   gène	  avait	  des	  fonctions	  au	  niveau	  du	  cil	  du	  photorécepteur,	  complétant	  le	  large	  spectre	  des	  cilliopathies	  rétiniennes	  héréditaires.	  	  Dans	  un	  second	  temps,	  nous	  avons	  exploré	  la	  possibilité	  qu'un	  syndrome,	  relativement	  fréquent	   en	   pédiatrie	   de	   fièvre	   récurrente,	   appelé	   PFAPA	   (acronyme	   de	   fièvre	  périodique	   avec	   adénite	   stomatite,	   pharyngite	   et	   cervical	   aphteuse)	   puisse	   avoir	   une	  origine	   génétique.	   L’étiologie	   de	   cette	   maladie	   n'étant	   pas	   claire,	   nous	   avons	   tenté	  d'identifier	  le	  spectre	  génétique	  de	  patients	  PFAPA.	  Comme	  nous	  n’avons	  pas	  pu	  mettre	  à	   jour	   un	   nouveau	   gène	   unique	   muté	   et	   responsable	   de	   la	   maladie	   chez	   tous	   les	  individus	   dépistés,	   il	   semblerait	   qu’un	   modèle	   génétique	   plus	   complexe	   suggérant	  l'implication	   de	   plusieurs	   gènes	   dans	   la	   pathologie	   ait	   été	   identifié	   chez	   les	   patients	  touchés.	   Ces	   gènes	   seraient	   notamment	   impliqués	   dans	   des	   processus	   liés	   à	  l'inflammation	   ce	   qui	   élargirait	   l’impact	   de	   ces	   études	   à	   d’autres	   maladies	   auto-­‐inflammatoires.	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ABSTRACT	  	  	   Next	  generation	  sequencing	  technologies	  are	   literally	   leading	  to	  a	  revolution	   in	  contemporary	   biology	   and	  medicine.	   The	   impact	   of	   these	   new	   tools	   has	   already	   been	  instrumental	   in	   the	   discovery	   of	   new	   genes	   and	   pathways	   involved	   in	   the	   etiology	   of	  rare	  or	  common	  inherited	  diseases.	  Conversely,	  the	  huge	  amount	  of	  data	  produced,	  and	  the	  complexity	  of	  the	  following	  bioinformatics	  analysis	  remain	  a	  bottleneck	  for	  solving	  the	  most	   challenging	   cases.	  The	  purpose	  of	   this	   thesis	   is	   to	  use	   these	  new	  sequencing	  techniques,	   in	  combination	  with	  DNA	  enrichment	  technologies,	   for	  the	  identification	  of	  the	  genetic	  cause	  of	  two	  hereditary	  diseases.	  In	  this	  framework	  we	  developed	  our	  own	  pipeline	  for	  reads	  mapping.	  Whenever	  possible,	  we	  also	  performed	  a	  deeper	  functional	  analysis	  to	  elucidate	  the	  role	  of	  this	  gene	  in	  the	  context	  of	  the	  disease.	  	   In	   the	   first	   part	   of	   the	   thesis	  we	   investigated	   and	   identified	   the	   genetic	   injury	  involved	   in	   an	   autosomal	   recessive	   form	   of	   retinitis	   pigmentosa,	   the	   most	   common	  inherited	  retinal	  degeneration.	  In	  particular,	  we	  found	  that	  non-­‐sense	  mutations	  in	  the	  gene	  FAM161A	  were	  the	  cause	  of	  retinitis	  pigmentosa	  linked	  to	  the	  previously-­‐mapped	  locus	  RP28.	  Coherently	  with	  our	  workflow,	  we	  studied	  this	  novel	  disease	  gene,	  and	  we	  could	   demonstrate	   that	   it	   had	   functions	   at	   the	   level	   of	   the	   photoreceptor	   connecting	  cilium,	  expanding	  the	  spectrum	  of	  retinal	  inherited	  ciliopathies.	  	  	   In	  the	  second	  part	  we	  explored	  the	  possibility	  that	  a	  relatively	  common	  pediatric	  syndrome	   with	   recurrent	   fever,	   but	   not	   with	   a	   clear	   etiology,	   PFAPA	   syndrome	  (acronym	   for	   Periodic	   Fever	   with	   Aphthous	   stomatitis,	   Pharyngitis	   and	   cervical	  Adenitis),	   could	   have	   a	   genetic	   background.	   We	   performed	   a	   whole	   exome	   genetic	  screening	   of	   11	   PFAPA	   affected	   patients	   to	   identify	   the	   gene(s)	   causing	   the	   disease.	  Although	  we	  did	  not	   identify	   any	   single	   gene	  mutated	  and	   shared	  among	  all	   screened	  individuals,	   a	   more	   complex	   genetic	   pattern	   was	   analyzed,	   implying	   oligogenic	   or	  complex	   inheritance	   of	   the	   trait.	   In	   particular	   the	   contribution	   of	   rare	   variants	   in	  inflammation	   related	   genes	   was	   investigated.	   This	   observation	   could	   also	   explain	   the	  pleiotropic	   spectrum	   of	   phenotypes	   found	   in	   several	   different	   autoinflammatory	  diseases.	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PREFACE	  	  LIVING	  THE	  “NEXT	  GEN”	  	  
“Each	  generation	  goes	  further	  than	  the	  generation	  preceding	  it	  because	  it	  stands	  on	  the	  shoulders	  
of	   that	   generation.	   You	   will	   have	   opportunities	   beyond	   anything	   we've	   ever	   known.”	  -­‐	  Ronald	  Reagan,	  American	  president	  and	  actor,	  1965	   	  In	   1977,	   the	   Nobel	   laureate	   Frederick	   Sanger	   presented	   in	   Proceedings	   of	   the	  
National	  Academy	  of	  Science	  of	  the	  United	  States	  of	  America	  his	  work	  on	  DNA	  sequencing	  technique	  using	  radiolabeled	  “dideoxy”	  nucleotides	  that	  he	  used	  to	  sequence	  a	  long	  DNA	  fragment	  of	  a	  bacteriophage	  genome	  [1].	  The	  subsequent	  development	  of	  this	  basic	  idea	  led	  to	  the	  modern	  “automated	  Sanger	  sequencing”	  with	  capillary	  electrophoresis,	  which	  was	  one	  if	  the	  driving	  factors	  behind	  the	  genetic	  revolution.	  This	  golden	  age	  of	  genetics	  culminated	   with	   the	   complete	   sequencing	   of	   the	   human	   genome,	   in	   2001,	   released	  independently	  by	  two	  different	  groups	  [2,	  3].	  It	  took	  about	  13	  years	  to	  have	  a	  completed	  “draft”	   of	   the	   human	   genome,	   with	   the	   collaboration	   of	   different	   groups	   around	   the	  world.	   The	   knowledge	   acquired	   from	   this	   project	   helped	   researchers	   to	   identify	   the	  genetic	   cause	   of	   several	   different	   inherited	   diseases,	   and	   revealed	   the	   complexity	   and	  the	  high	  number	  of	  variants	  that	  are	  present	  in	  different	  individuals.	  	  A	  second	  revolution	  in	  genetics	  began	  with	  the	   introduction	  of	  next-­‐generation	  sequencing	   (NGS)	   technologies.	   These	   techniques	  were	   initially	   developed	   for	   the	   de-­‐
novo	  sequencing	  of	  unknown	  bacterial	  genomes,	  and	  thus	  almost	  completely	  primer	  free	  [4].	  A	  few	  companies	  recently	  developed	  different	  machines	  for	  NGS,	  which	  mostly	  differ	  on	   the	   template	   preparation	   and	   the	   chemistry	   used	   for	   sequencing.	   The	   first	   NGS	  platform	   released	   on	   the	   market	   was	   the	   454	   Genome	   Sequences	   FLX,	   developed	   by	  Roche	  [5].	  This	  system	  uses	  an	  emulsion-­‐based	  clonal	  PCR	  for	  template	  preparation	  [6]	  and	   a	   modified	   pyrosequencing	   protocol	   for	   sequence	   reading	   (Fig.	   1a).	   It	   is	   very	  efficient	   for	  de-­‐novo	   sequencing	  and	   for	   the	  unrivaled	   length	  of	   reads	   (almost	  600	  bp)	  but	   on	   the	   other	   hand,	   it	   has	   some	   drawbacks,	   mostly	   connected	   to	   mistakes	   in	   the	  interpretation	   of	   the	   homopolymers-­‐containing	   DNA	   sequences	   [7].	   Another	   well-­‐known	  platform	  for	  NGS	  has	  been	  produced	  by	  Life	  Technology	  and	  it	   is	  known	  as	  the	  SOLiD	   system	   [4].	   The	   template	   is	   prepared	   by	   emulsion	   PCR,	  whereas	   the	   chemistry	  used	   for	   sequencing	   consists	   essentially	   in	   sequential	   steps	   of	   ligation	   by	   using	   dye-­‐labeled	  couples	  of	  oligonucleotides	  (Fig.	  1b)	  [8].	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Figure	  1.	  Schematic	  representation	  of	  two	  different	  NGS	  methods.	  	  
a)	   Different	   phases	   for	   Roche	   454	   library	   production	   and	   sequencing	   chemistry	   are	   depicted.	  The	  first	   two	  images	  show	  double	  stranded	  DNA	  sharing	  and	  adapter	   ligation.	  The	  third	  to	   the	  fifth	  images	  square	  show	  the	  special	  in	  situ	  PCR	  system	  called	  “emulsion	  PCR”	  that	  is	  performed	  on	  specific	  beads.	  These	  beads	  are	  then	  collected	  and	  loaded	  onto	  a	  silica	  membrane.	  The	  signal	  for	  a	  specific	  base	   is	  obtained	  by	  a	  pyrosequencing	  reaction.	   In	  this	  case	  the	  addition	  of	  a	  base	  causes	   the	   elongation	   of	   the	   single	   strand	   fragment	   and	   an	   emission	   of	   light.	   A	   CCD	   camera	  registers	   the	   emitted	   light	   and	   the	   software	   converts	   in	   sequence	   reads	   (adapted	   from	  Roche	  website).	  b)	  A	  depiction	  of	  the	  sequencing	  method	  for	  SOLiD	  technology.	  Again	  the	  template	  DNA	  is	   fragmented,	   denaturated,	   and	   ligated	   to	   a	   specific	   linker	   attached	   to	   beads.	   The	   sequencing	  reaction	   is	  mediated	  by	   special	   ligation	   reactions	   in	  which	   specific	   color	  marked	  dinucleotides	  are	  added	  to	  the	  growing	  sequence.	  The	  subsequent	  phase	  is	  called	  “primer	  reset”,	  in	  which	  the	  previous	   primer	   is	   removed	   and	   another	   primer	  with	   a	   base	   less	   respect	   the	   previous	   one	   is	  annealed	  to	  the	  adapter.	  This	  is	  repeated	  six	  times.	  For	  this	  reason	  every	  single	  base	  for	  any	  read	  is	  called	  at	  least	  twice	  giving	  a	  better	  accuracy	  compared	  to	  other	  machines	  (Adapted	  from	  Life	  Technology	  website).	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Among	  the	  advantages	  of	  this	  method	  are	  the	  high	  accuracy	  and	  the	  reduced	  error	  rates,	  making	   the	   sequencing	   process	   slower	   with	   respect	   to	   its	   competitors.	   The	   third	  platform,	  and	  the	  most	  popular	  of	  the	  three,	  is	  Solexa	  Genome	  Analyzer	  by	  Illumina	  Inc.	  It	   has	   the	   best	   ratio	   in	   output	   rate	   and	   running	   time,	   compensated	   by	   a	   lower	  multiplexing	   capability	   [9].	   The	   process	   of	   template	   preparation	   is	   easy,	   and	   requires	  the	   shearing	   of	   DNA	   to	   generate	   shorter	   fragments	   that	   are	   then	   ligated	   to	   specific	  adapters.	   These	   fragments	   are	   then	   immobilized	   on	   a	   silicate	   surface,	   where	   in-­‐situ	  “bridge”	   PCR	   [10]	   is	   performed	   (Fig.	   2).	   This	   reaction	   generates	   clusters	   of	   DNA	  fragments	  on	  the	  silicate	  surface	  that	  are	  then	  denaturated	  as	  single	  stranded	  DNA.	  After	  the	   addition	   of	   fluorescent	   dye	   terminators	   there	   is	   the	   elongation	   step	   of	   one	   single	  base,	   with	   a	   modality	   similar	   to	   classical	   Sanger	   reaction.	   A	   CCD	   camera	   reads	   the	  emitted	  fluorescence	  and	  saves	  a	  picture.	  This	  synthesis/terminator	  step	  is	  repeated	  for	  several	  cycles.	  Software	  then	  analyzes	  images	  and	  converts	  them	  into	  a	  short	  nucleotide	  sequence,	  the	  so-­‐called	  “read”.	  These	   techniques	   have	   been	   intensively	   used	   to	   investigate	   single	   nucleotide	  polymorphisms	   (SNPs)	   diversity	   among	   individuals	   [11]	   or	   in	   cancer	   genetics,	   to	  identify	   genetic	   injuries	   linked	   to	   a	  particular	   type	  of	   cancer	   [12,	  13].	   Indeed,	  NGS	   re-­‐sequencing	   has	   had	   a	  major	   impact	   on	   human	   genetics,	   as	   demonstrated	   by	   the	   large	  number	   of	   novel	   genes	   recently	   associated	   to	   rare	   inherited	   diseases	   [14].	   The	  combination	  of	  targeted	  enrichment	  techniques,	  such	  as	  whole-­‐exome	  capturing	  [15]	  or	  custom	  targeted	  sequencing	  with	  NGS,	  allowed	  researchers	  to	  investigate	  only	  exons	  or	  regions	   of	   interest	   in	   a	   particular	   family,	   making	   the	   identification	   of	   the	   causative	  mutation	  easier	  and	  faster.	  	  In	  this	  dissertation	  I	  have	  made	  extensive	  use	  of	  NGS	  technology	  to	  identify	  the	  causative	   mutations	   for	   two	   different	   and	   non-­‐related	   diseases.	   The	   first,	   and	   major,	  part	  of	  this	  thesis	  focuses	  on	  the	  discovery	  and	  characterization	  of	  a	  new	  gene	  involved	  in	   retinitis	   pigmentosa.	   The	   second	   part	   attempts	   to	   identify	   the	   genetic	   basis	   of	   a	  common	   pediatric	   recurrent	   fever	   known	   as	   Periodic	   Fever	   with	   Aphthous	   stomatis,	  
Pharyngitis	  and	  cervical	  Adenitis	  (PFAPA).	  	  
NEXT	  GENERATION	  SEQUENCING:	  BIOINFORMATICS	  TOOLS	  	  	  
“Computers	  are	  useless.	  They	  can	  only	  give	  you	  answers.”,	  Pablo	  Picasso,	  Spanish	  painter,	  1967	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   NGS	   is	   the	   current	   golden	   standard	   for	  mutational	   screening	   in	   both	   rare	   and	  common	   diseases.	   The	   combination	   of	   exome	   capturing	   with	   NGS	   has	   solved	   several	  difficult	   cases	   of	   rare	   syndromes	   for	  which	   few	   families	  were	   available	   [16].	  We	  have	  discussed	  the	  different	  machines	  and	  techniques	  that	  can	  perform	  NGS,	  but	  we	  have	  not	  discussed	   the	   important	   step	   between	   sequencing	   and	   variant	   identification:	  bioinformatics	  analysis.	  This	  step	  is	  not	  a	  simple	  technical	  issue,	  but	  a	  critical	  part	  of	  the	  sequencing	   process.	   In	   fact,	   due	   to	   the	   large	   amount	   of	   raw	   data	   generated	   by	   the	  sequencing	   techniques,	   a	   correct	   alignment	   to	   the	   reference	   sequence	   and	   a	   perfect	  calling	   of	   all	   variants	   is	   the	   difference	   between	   finding	   and	   not	   finding	   the	   causative	  change.	   Therefore	   it	   is	   not	   surprising	   that	   a	   large	   portion	   of	   recent	   bioinformatics	  research	   has	   focused	   its	   attention	   on	   improving	   or	   generating	   ever	   better	   or	   more	  sophisticated	   systems	   to	   respond	   these	   above-­‐mentioned	   tasks	   [17-­‐19].	   A	   general	  pipeline	  for	  NGS	  has	  consecutive	  steps:	  1)	  base-­‐calling	  with	  quality	  score	  calculation;	  2)	  read-­‐mapping;	  3)	  quality	  recalibration;	  4)	  genotyping	  and	  SNPs	  calling.	  These	  steps	  are	  now	  described	  separately	  with	  the	  most	  common	  software	  used	  for	  these	  analyses.	  	   	  The	   base-­‐calling	   step	   is	   the	   first	   bioinformatic	   analysis	   performed	   on	   the	  original	  output	  generated	  by	  the	  sequencing	  machine.	  The	  software	  analyzes	  the	  output	  and	   converts	   it	   into	   a	   sequence	   of	   DNA.	   Moreover,	   it	   also	   gives	   an	   estimation	   of	   the	  quality	  of	  the	  “calls”,	  a	  technical	  term	  that	  indicate	  the	  base	  “called”	  by	  the	  machine	  in	  a	  given	  position	  by	  analysis	  of	  the	  output.	  This	  is	  called	  per-­‐base	  quality	  score	  calculation.	  Usually	   this	   value	   is	   indicative	   of	   the	   quality	   of	   a	   single	   base	  without	   considering	   the	  surrounding	   ones.	   In	   general	   this	   step	   is	   performed	   directly	   by	   in-­‐house	   software	  produced	   by	   the	   sequencing	   machine	   company,	   although	   several	   different	   specific	  methods	  have	  been	  recently	  developed	  to	  improve	  the	  quality	  of	  the	  calls	  by	  30%	  [20].	  	  	   The	  second	  step	  for	  a	  correct	  call	  is	  the	  alignment.	  In	  this	  step	  the	  large	  number	  of	  sequences	  are	  aligned	  to	  a	  reference	  genome.	  The	  quality	  of	  the	  alignment	  is	  crucial	  for	  the	  identification	  of	  the	  causative	  variant,	  since	  bad	  alignment	  or	  skipping	  of	  a	  real	  insertion/deletion	   (indels)	   of	   some	   bases	   could	   generate	   false	   positive	   or	   negative	  results.	  Another	  important	  element	  to	  take	  in	  account	  for	  a	  good	  alignment	  is	  the	  time	  necessary	  for	  the	  computer	  to	  accomplish	  this	  task.	  A	  good	  aligner	  should	  be	  also	  easily	  accessible	  also	  to	  not	  expert	  bioinformaticians,	  in	  terms	  of	  parameters	  and	  functionality	  set	  up.	  Up	  to	  now	  two	  different	  systems	  have	  been	  used	  for	  alignment	  algorithm.	  One	  is	  based	  on	  the	  “Burrows-­‐Wheeler	  transform”	  (BTW)	  algorithm,	  and	  it	  is	  used	  by	  software	  like	   Bowtie	   [21],	   BWA	   [22],	   and	   SOAP2	   [23].	   This	   algorithm	   is	   based	   on	   data	  compression	   and	   permutation	   to	   simplify	   the	   large	   amount	   of	   data,	   making	   the	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alignment	   fast,	   and	   without	   requiring	   huge	   computer	   memory.	   Although	   the	  permutation	  system	  is	  very	  good	  in	  aligning	  repetitive	  sequences	  is	  not	  so	  accurate	  for	  indels	  and	  gaps,	  and	  is	  less	  sensitive	  compared	  to	  the	  “hashing”-­‐based	  algorithms.	  This	  second	  system	  is	  based	  on	  a	  “hash	  table”,	  and	   is	   ‘state	  of	   the	  art’	   in	  sequence	  aligners.	  Put	  simply,	  the	  software	  creates	  hash	  tables	  of	  the	  reference	  genome	  and	  reorders	  it	  in	  an	  intuitive	  way.	  Reads	  are	  then	  used	  to	  search	  these	  tables	  and	  to	  align	  them	  in	  the	  best	  way.	   It	   requires	   more	   memory	   and	   time,	   but	   this	   strategy	   is	   far	   more	   accurate	   than	  BTW-­‐based	   algorithms.	  Moreover,	   the	  newly	   released	   software	  using	   this	   system	   (e.g.	  MAQ	   [18]	   and	   Novoalign)	   are	   much	   more	   implemented	   and	   fast	   compared	   to	   older	  softwares.	  	   Quality	  score	  recalibration	  is	  the	  third	  step	  and	  it	  is	  necessary	  to	  have	  a	  correct	  variant	  call.	  In	  fact	  the	  per-­‐base	  quality	  score	  is	  not	  overly	  precise	  and	  it	  does	  not	  take	  into	  account	  the	  environment	  where	  the	  called	  base	  is	  present.	  To	  resolve	  this	  issue,	  the	  quality	   score	   is	   recalibrated	   according	   to	   the	   reference	   information	   and	   the	   list	   of	  known	  SNPs.	  Some	  alignment	  software,	  like	  Novoalign,	  perform	  this	  step	  directly	  during	  the	   alignment,	   whereas	   for	   other	   systems	   specific	   tools	   are	   present	   such	   as	   for	   the	  Genome	  Analysis	  Tool	  Kit	  (GATK)	  [24]	  or	  in	  SOAP2	  package.	  	   Genotyping	   and	   variant	   calling	   follow	   the	   previously	   described	   procedures.	  These	   steps	   are	   composed	   of	   two	   different	   parts,	   although	   the	   same	   tool	   usually	  performs	  them	  at	  the	  same	  time.	  Firstly,	  a	  correct	  genotype	  must	  be	  given	  to	  each	  base	  of	   the	  alignment	  such	  as	  homozygous	  (homo)	  or	  heterozygous	  (het).	  Classical	  systems	  usually	  simply	  count	  the	  number	  of	  aligned	  reads	  having	  the	  mismatch	  base	  compared	  to	  the	  reference	  to	  determine	  the	  genotype	  (if	  around	  50%	  reads	  have	  it	  then	  the	  change	  is	  called	  as	  het,	  if	  around	  100%	  it	  is	  called	  as	  homo),	  but	  the	  new	  recent	  algorithms	  take	  into	   account	   other	   different	   options	   to	   make	   less	   mistakes.	   Recent	   systems	   use	   a	  probabilistic	  model	  for	  calculating	  the	  genotype	  based	  on	  quality	  score.	  Moreover,	  they	  also	  consider	  the	  percentage	  of	  errors	  in	  a	  specific	  region,	  and	  they	  correct	  the	  quality	  score	  according	  to	  this	  observation	  [18,	  23].	  For	  example,	  the	  use	  of	  a	  SNPs	  database	  is	  important	  for	  calculating	  the	  minor	  allele	  frequency,	  and	  for	  recalibrating	  the	  genotype	  calling	  according	  the	  observed	  ratio	  of	  het/homo.	  Other	  systems	  take	  in	  account	  known	  linkage	   disequilibrium	   data	   for	   any	   single	   variant	   to	   calculate	   the	   probabilistic	   value.	  Also	  the	  use	  of	  genotype	  information	  based	  on	  large	  sequencing	  experiments	  could	  help	  in	  this	  sense.	  The	  variant	  calling	  is	  then	  based	  on	  the	  genotypes	  and	  it	  gives	  the	  position	  and	  the	  type	  of	  change	  considering	  different	  filtering	  variants.	  This	  step	  generates	  a	  VCF	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file	  (Variant	  Call	  Format,	  the	  standard	  format	  of	  variant	  file)	  that	  has	  to	  be	  deciphered	  and	  annotated	  to	  infer	  essential	  information	  and	  to	  find	  the	  correct	  gene.	  	  This	   bioinformatics	   analysis	   however	   is	   the	   easiest	   part	   in	   the	   identification	   of	   a	  mutation.	  The	  challenging	  part	  starts	   just	  after	   this,	  and	  requires	  smartness,	  obstinacy	  and	  a	  dust	  of	  good	  luck.	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   I.1INTRODUCTION	  	  1.1	  THE	  EYE	  	  “The	  tongue	  can	  hide	  the	  truth,	  never	  the	  eyes.”	  Mikhail	  Bulgakov,	  Russian	  writer	  1891	  The	  organ	   involved	   in	  vision	   is	   the	  eye.	  Despite	   its	   small	   size,	   the	  eye	  contains	  some	  of	  the	  most	  complex	  machinery	  present	  in	  the	  body.	  Anatomically,	  it	  is	  made	  up	  of	  three	  different	  layers,	  each	  having	  a	  specific	  function	  (Fig.	  3a)[25]:	  	  1. The	  fibrous	  tunic,	  which	  is	  comprised	  of	  the	  cornea	  and	  the	  sclera.	  It	  is	  composed	  of	  dense	  connective	   tissue.	   It	  has	  both	  a	  protective	   function	  and	  a	  role	  in	  maintaining	  the	  shape	  of	  the	  eye.	  	  2. The	  vascular	  tunic,	  which	  is	  comprised	  of	  the	  iris,	  the	  ciliary	  bodies	  and	  the	  choroid.	  The	  iris	  defines	  the	  size	  of	  the	  pupil	  and	  the	  ciliary	  bodies	  are	   involved	   in	   controlling	   lens	   shape.	   The	   choroid	   has	   a	   vascular	  function	  and	  provides	  oxygen	  or	  nutrients	  to	  the	  outer	  retina.	  3. The	   nervous	   tunic,	   which	   corresponds	   to	   the	   inner	   sensory	   tissue	  including	  the	  retina.	  Adjacent	   to	   the	   nervous	   tunic	   there	   is	   a	   large	   cavity,	   filled	   with	   a	   gel-­‐like	  substance	   called	  vitreous.	  The	  vitreous	   is	   composed	  of	  99%	  water,	  with	   the	  other	  1%	  consisting	  of	  collagen,	  hyaluronic	  acid	  and	  other	  extracellular	  matrix	  proteins	  [26].	  The	  main	   function	   of	   the	   vitreous	   is	   to	   keep	   the	   shape	   and	   structure	   of	   the	   eye	   that	   is	  required	  to	  have	  the	  correct	  focus	  point.	  	  Protected	   by	   the	   sclera	   and	   blood	   supplied	   by	   the	   choroid	   there	   is	   the	   retina,	  which	   is	   the	  sensitive	  and	  most	   important	   tissue	  of	   the	  eye	  and	  belongs	   to	   the	  central	  nervous	  system.	  During	  development,	  the	  retina	  (about	  0.2	  mm	  thick)	  is	  derived	  from	  an	  out-­‐pocketing	  of	  the	  neural	  tube,	  called	  the	  optic	  vesicle,	  which	  leads	  to	  the	  formation	  of	  the	  optic	   cup.	  The	  external	  part	  of	   the	  optic	   cup	   forms	   the	   retinal	  pigment	  epithelium	  (RPE),	  whereas	  the	  inner	  part	  leads	  to	  the	  formation	  of	  the	  retina	  (Fig.	  3b).	  The	  RPE	  is	  an	   epithelial	   tissue	   directly	   connected	   to	   the	   choroid	   and	   has	   three	   main	   functions:	  Firstly,	   the	   presence	   of	   melanin	   pigment	   in	   RPE	   cells	   is	   necessary	   for	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Figure	  3.	  The	  eye	  and	  the	  retina	  
a)	  A	  schematic	  view	  of	  the	  eye.	  Light	  enters	  through	  the	  pupil	  that	  is	  protected	  by	  a	  crystalline	   tissue	   called	   cornea.	   The	   lens	   concentrates	   light-­‐waves	   at	   the	   level	   of	  macula,	   a	   highly	   pigmented	   part	   of	   the	   eye.	   The	   center	   of	   the	  macula	   is	   called	   the	  fovea	  and	  in	  humans	  it	  contains	  the	  highest	  density	  of	  cones	  and	  corresponds	  to	  the	  point	  of	  best	  visual	  acuity.	  	  The	  optic	  disc	  is	  the	  blind	  point	  of	  the	  eye.	  b)	  Longitudinal	  section	  of	   the	  eye.	   It	   is	  possible	   to	  distinguish	   the	  peculiar	   laminar	  structure	  of	   the	  retinal	   tissue.	   ONL,	   outer	   nuclear	   layer;	   INL,	   inner	   nuclear	   layer;	   RPE,	   retinal	  pigmented	  ephitelium	  (Adapted	  from	  Den	  Hollander	  et	  al.,	  2010).	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the	  absorption	  of	  light	  passing	  over	  the	  retina,	  preventing	  it	  from	  being	  reflected	  off	  of	  the	   back	   of	   the	   eye	   [27];	   secondly,	   it	   has	   an	   important	   trophic	   function,	   since	   it	   is	   in	  direct	  contact	  with	  the	  choroid	  and	  provides	  the	  necessary	  molecules	  for	  photoreceptor	  feeding	  and	  renewal;	  finally,	  it	  has	  a	  direct	  role	  in	  the	  regeneration	  of	  the	  photoreceptor	  outer	   segment	   via	   the	   phagocytosis	   of	   the	   apical	   part	   of	   photoreceptor	   cells	   [28].	  Conversely,	   the	   retina	   is	   an	   ordered	   laminated	   structure	   composed	   of	   neurons	   with	  different	   specialization	   and	   shapes	   (Fig.	   3b).	   The	   cell	   bodies	   and	   the	   nuclei	   of	   these	  neurons	   are	   well	   separated,	   forming	   different	   layers.	   The	   most	   external	   part	   of	   the	  retina,	   in	   direct	   contact	  with	   the	   vitreous,	   is	   composed	   of	   the	   nuclei	   of	   ganglion	   cells.	  These	  cells	  project	  their	  dendrites	   into	  the	  brain	  forming	  the	  optic	  nerve.	  Where	  these	  dendrites	   form	   the	  optic	  nerve	   there	   is	   the	   so-­‐called	   “blind	   spot”	  of	   the	  eye	   (the	  optic	  disc),	  where	  no	  single	  photosensitive	  cell	  is	  present	  [29].	  Ganglion	  cells	  touch	  dendrites	  from	  intermediate	  neurons	  at	  the	  level	  of	  the	  inner	  plexiform	  layer	  (IPL).	  Here	  both	  the	  soma	  of	  amacrine	  cells	  and	  the	  dendrites	  of	  bipolar	  cells,	  which	  have	  their	  nuclei	  in	  the	  inner	  nuclear	  layer	  (INL),	  can	  be	  found.	  Whereas	  bipolar	  cells	  have	  a	  direct	  function	  in	  transmitting	   the	   signal	   from	   the	   photoreceptor	   to	   ganglion	   cells,	   amacrine	   cells	  work	  more	   as	  message	   collectors	   and	   integrate	   the	   signal	   from	   rod-­‐connected	   bipolar	   cells.	  The	   INL	   also	   contains	   the	   cell	   bodies	   of	   horizontal	   cells,	   which	   are	   involved	   in	   the	  modulation	  of	  the	  signals	  from	  photoreceptors	  under	  different	  light	  conditions.	  Bipolar	  and	   horizontal	   cells	   connect	   to	   photoreceptor	   dendrites	   in	   the	   outer	   plexiform	   layer	  (OPL).	   Two	   different	   types	   of	   cells	  make	   up	   the	   photoreceptor	   layer;	   rods	   and	   cones,	  which	  are	  directly	  connected	  with	  the	  RPE	  layer.	  Photoreceptors	  are	  the	  photosensitive	  cells	  in	  the	  retina	  and	  their	  apical	  part	  is	  where	  phototransduction	  reactions	  occur.	  	  1.2	  PHOTORECEPTOR	  CELLS	  AND	  THE	  VISION	  
“What	  we	  call	  the	  beginning	  is	  often	  the	  end.	  And	  to	  make	  an	  end	  is	  to	  make	  a	  beginning.	  The	  end	  is	  
where	  we	  start	  from.”	  -­‐	  T.	  S.	  Eliot,	  English	  poet,	  1888	  Photoreceptors	   are	   particular	   neuronal	   cells	   [30]	   with	   a	   specific	   function:	   to	  capture	   light	   and	   transmit	   the	   signal	   to	   neurons.	   Each	   photoreceptor	   contains	  photopigments,	  composed	  of	  a	  protein	  moiety	  called	  opsin,	  plus	  a	  small	  light-­‐absorbing	  compound	   called	   chromophore.	   Although	   photoreceptor	   cells	   present	   species-­‐specific	  features	  at	   the	  structural	   level,	   the	  photoreaction	  cascade	   is	  well	   conserved,	  excluding	  the	   photopigment	   structure	   [31].	   Originally	   photoreceptors	   evolved	   from	   a	   single	  sensitive	   cell,	   but	   during	   evolution	   they	   diverged	   into	   two	   different	   branches,	  distinguishable	  by	  different	  modifications	  of	   the	  apical	  membrane	   in	  order	   to	   increase	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light	  absorption.	  These	  subtypes	  are	  the	  ciliary	  photoreceptors,	  derived	  from	  a	  modified	  primary	  cilium,	  or	  the	  rhabdomeric	  photoreceptors,	   from	  a	  modification	  of	   the	  surface	  in	  a	  microvillar	  way	  to	  form	  a	  rhabdome	  (Fig.	  4)[32].	  Rhabdomeric	  photoreceptors	  are	  common	   in	  arthropods	  (like	  drosophila)	  and	  mollusks,	  whereas	  ciliary	  photoreceptors	  are	  found	  in	  fish	  and	  vertebrates	  as	  well	  as	  in	  mammals.	  
Figure	  4.	  Photoreceptor	  cells	  originate	  from	  a	  common	  ancestor	  photosensitive	  cell.	  The	   figure	   shows	   the	   differences	   and	   similarities	   between	   ciliated	   and	   rhabdomeric	  photoreceptor.	  Both	  originate	  from	  a	  photosensitive	  progenitor.	  Some	  elements	  of	  the	  cell	  are	  conserved	  in	  both	   types	  of	  photoreceptors.	  The	   IS	  of	   ciliated	  photoreceptors	   correspond	   to	  the	  stalk	  of	  rhabdomeric	  ones	  (green	  area).	  The	  OS	  correspond	  to	  the	  rhabdome	  (indicated	  in	  pink),	   whereas	   the	   red	   part	   corresponds	   to	   the	   zonula	   adherens	   (or	   external	   limiting	  membrane	   in	   mammalian	   photoreceptors)	   that	   delimitate	   the	   apical	   membrane	   with	   the	  basolateral	  membrane.	  It	  is	  possible	  to	  observe	  that	  the	  peculiar	  polarization	  of	  the	  sensitive	  cell	  is	  maintained	  during	  evolution.	  r,	  rhabdome;	  s,	   fly	  stalk;	  ZA,	  zonula	  adherens,	  N,	  nucleus;	  OS,	  outer	  segment;	   cc,	  connecting	  cilium;	   IS,	   inner	   segment;	   ELM,	   external	   limiting	   membrane.	   (Adapted	   from	   Lamb	   et	   al.,	  2009).	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   As	  previously	  mentioned,	  vertebrates	  have	   two	  kinds	  of	   ciliary	  photoreceptors	  called	   rods	   and	   cones,	   respectively	   (Fig.	   5),	   because	   of	   their	   resemblance	   to	   such	  geometric	  shapes.	  In	  brief,	  cones	  are	  involved	  in	  daylight	  and	  color	  vision,	  whereas	  rods	  mediate	  night	  or	  dim-­‐light	  vision.	  This	  functional	  difference	  is	  achieved	  by	  using	  distinct	  opsin	  molecules	  that	  are	  capable	  of	  absorbing	  various	  wavelengths	  of	  light.	  Rods	  contain	  a	   specific	   opsin,	   called	   rhodopsin.	   This	   molecule	   can	   absorb	   a	   broad	   range	   of	  wavelengths,	  and	  has	  a	  great	  sensitivity,	  able	  to	  detect	  one	  single	  photon.	  Rhodopsin	  has	  an	  absorbance	  peak	  at	  510	  nm.	  Conversely	  cones	  contain	  a	  different	  opsin,	  less	  sensitive	  than	  rhodopsin	  in	  photon	  capturing,	  but	  much	  more	  specific	  for	  discrete	  wavelengths.	  In	  humans	   there	   are	   three	  different	   opsins,	   called	   S-­‐,	  M-­‐	   and	  L-­‐opsin,	  with	  peaks	  of	   430,	  530	  and	  570	  nm,	  respectively,	  that	  are	  responsible	  for	  trichromic	  vision	  (red,	  green	  and	  blue	   -­‐RGB).	   In	   the	   cones	   of	   rodents,	   only	   two	   diverse	   opsins	   are	   present,	   S-­‐	   and	   LM-­‐opsin,	  giving	  them	  dichromic	  vision.	  In	  humans	  the	  majority	  of	  cones	  are	  localized	  to	  the	  fovea,	   which	   is	   the	   area	   with	   the	   best	   acuity	   of	   the	   eye.	   In	   the	   fovea,	   each	   cone	   is	  connected	   to	  a	   single	  bipolar	   cell	   and	   to	  a	   single	  ganglion	  cell,	   giving	  great	  benefits	   to	  signal	  transmission	  quality	  and	  acuity.	  Conversely,	  the	  periphery	  of	  the	  eye	  is	  enriched	  in	  rods	  and	  each	  ganglion	  or	  bipolar	  cell	  is	  connected	  to	  more	  than	  one	  photoreceptor.	  Therefore	  rods	  are	  more	  abundant	  than	  cones	  (they	  outnumber	  them	  by	  more	  than	  20	  fold)	  and	  are	  distributed	  all	  over	  the	  retina	  surface	  with	  the	  exception	  of	  in	  the	  central	  fovea	  region	  (fovea	  centralis).	  The	  most	  important	  pathway	  for	  photoreceptor	  biology,	  and	  for	  which	  the	  entire	  cell	  is	  specialized,	   is	   the	   phototrasduction	   cascade.	   It	   begins	   in	   the	   outer	   segment	   of	   the	  photoreceptor	  and	  involves	  opsins.	  Although	  this	  pathway	  is	  similar	  between	  rods	  and	  cones,	  small	  differences	  are	  present	  [31].	  In	  rods,	  when	  a	  single	  photon	  enters	  the	  cell,	  it	  causes	   the	   photoisomerization	   of	   the	   chromophore,	   11-­‐cis-­‐retinal,	   that	   becomes	   all-­‐
trans-­‐retinal	   (Fig.	   6b).	   This	   chemical	   shift	   induces	   a	   conformational	   modification	   in	  rhodopsin	   tridimensional	   structure	   that	   leads	   to	   the	   activation	  of	   a	   specific	  G-­‐protein,	  called	   transducin,	   by	   catalyzing	   the	   exchange	   from	   GDP	   to	   GTP.	   This	   stimulates	   the	  activation	  of	  a	  membrane-­‐bound	  phospodiesterase	  (PDE),	  which	  is	  able	  to	  break	  down	  cGMP	  (specifically,	  it	  is	  the	  γ	  subunit	  of	  the	  PDE	  that	  performs	  hydrolysis).	  In	  darkness	  there	   is	   a	   high	   concentration	   of	   cGMP	   in	   the	   cells	   and	   this	   activates	   the	   cGMP-­‐gated	  cation	   channels	   with	   consequent	   depolarization	   of	   the	   cell	   and	   the	   release	   of	   the	  neurotransmitter	   glutamate.	   This	   is	   called	   the	   “dark	   current”.	   In	   the	   presence	   of	   light	  there	   is	   a	   hyperpolarization	   of	   the	   cells	  with	   the	   subsequent	   blocking	   or	   reduction	   of	  glutamate	   transmission	   to	   bipolar	   cells.	   The	   activation	   of	   rhodopsin	   is	   followed	   by	   a	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recovery	   phase	   in	   which	   photopigment	   is	   regenerated	   and	   the	   transducin	   pathway	  deactivated.	  The	  recovery	  is	  started	  by	  the	  decay	  of	  activated	  rhodopsin	  into	  an	  inactive	  state	   via	   phosphorylation,	   mediated	   by	   the	   Rhodopsin	   Kinase	   (encoded	   by	   the	   gene	  GRK1).	  This	  event	  induces	  the	  binding	  of	  the	  protein	  arrestin	  to	  rhodopsin	  that	  arrests	  its	   activation.	   Transducin	   has	   an	   intrinsic	  GTPase	   activity	   and	   autonomously	   converts	  itself	  from	  the	  active	  GTP	  to	  the	  inactive	  GDP	  state.	  This	  causes	  the	  inactivation	  of	  PDE	  and	   the	   regeneration	   of	   normal	   concentrations	   of	   cGMP	   by	   retinal	   guanylyl-­‐cyclase,	  restoring	  the	  dark	  current.	  A	  very	  important	  step	  for	  the	  regeneration	  of	  photoreceptor	  light-­‐sensitivity	   is	   the	   “visual	   cycle”	   that	   happens	   between	   the	   photoreceptors	   (both	  rods	  and	  cones)	  and	   the	  RPE	  cells,	  or	  between	  cones	  and	  Müller	  cells	   [33]	   (Fig.	  6a).	  A	  Retinol	   dehydrogenase	   converts	   the	   all-­‐trans-­‐retinal	   into	   all-­‐trans-­‐retinol,	   which	  subsequently	  moves	   from	   the	  photoreceptors	   to	   the	  RPE	  or	  Müller	   cells	   via	   the	   inter-­‐
photoreceptor	  retinoid-­‐binding	  protein	   (IRBP).	   In	   these	   cells,	   the	   retinol	   is	   sequestered	  by	  cellular	  retinol-­‐binding	  protein	  (CRBP)	  and	  is	  converted	  in	  11-­‐cis-­‐retinal	  by	  different	  chemical	  reactions	  (in	  the	  RPE	  these	  are	  catalyzed	  by	  some	  important	  enzymes	  such	  as	  
lecithin:	   retinol	   acyl-­‐transferase	   LRAT,	   and	   the	   isomer-­‐hydrolase	   RPE65).	   The	   11-­‐cis-­‐retinal	   is	   then	   transported	   back	   to	   the	   photoreceptor	   cell	   where	   it	   can	   restore	  rhodopsin[34].
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Figure	  5.	  Photoreceptor	  cells.	  The	  structure	  of	  a	  cone	  and	  rod	  cell	  is	  depicted.	  a)	  Magnification	  of	  the	  disc	  rim.	  Rhodopsin	  molecules	  are	  indicated	  in	  red.	  b)	  EM	  image	  of	  a	  disc	  stack.	  c)	  Connecting	  cilium	  and	  calical	  process	  (CC	  and	  CP)	  (from	  www.phys.ufl.edu).	  d)	  Inner	  segment	  of	  a	  rod	  where	  is	  possible	  to	  see	  large	  mitochondria	  (from	  Steinberg	  et	  al.,	  1980).	  e)	  The	  nucleus	  (from	  Kizilyaprack	  et	  al,	  2010).	  f)	  Synaptic	  ribbon	  of	  a	  rod	  (Missotten	  et	  al.,	  1965).	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  1.3	  STRUCTURE	  AND	  BIOLOGY	  OF	  PHOTORECEPTORS	  
“The	  universe	  is	  built	  on	  a	  plan,	  the	  profound	  symmetry	  of	  which	  is	  somehow	  present	  in	  the	  inner	  
structure	  of	  our	  intellect.”	  -­‐	  Paul	  Valeri,	  French	  poet,	  1871.	  The	  evolution	  of	  photoreceptors	  is	  strictly	  connected	  with	  their	  function	  [32].	  In	  particular,	  the	  need	  to	  increase	  surface	  area	  for	  light	  capturing	  in	  ciliary	  photoreceptors	  was	  resolved	  by	  the	  formation	  of	  an	  apical	  compartment	  packed	  with	  several	  membrane	  discs,	  known	  as	  the	  outer	  segment	  (OS).	  There	  are	  four	  distinct	  parts	  in	  photoreceptor	  cells:	   the	   already-­‐mentioned	  OS,	   the	   inner	   segment	   (IS),	   the	   nucleus	   and	   the	   synaptic	  terminus	  (Fig.	  3abcd).	  In	  rods,	  the	  OS	  has	  a	  cylindrical	  shape	  and	  it	  is	  composed	  of	  more	  than	   2000	   highly	   organized,	   flattened,	   membranous	   discs	   tightly-­‐packed	   and	  surrounded	  by	  their	  own	  plasma	  membrane	  (Fig	  5b).	  These	  discs	  are	  perpendicular	  to	  the	   entering	   light,	   maximizing	   photon	   capture	   [35].	   They	   are	   made	   up	   of	   a	   central	  thinner	  part	  called	  the	  “lamellae”	  and	  the	  outer	  part	  of	  the	  disc,	  the	  rim,	  which	  are	  very	  different	   in	   terms	  of	  molecular	  composition	  (Fig.	  5a).	  The	  disc	  rim	   is	  connected	   to	   the	  plasma	  membrane	  of	  the	  OS	  through	  specific	  filaments	  [36].	  New	  discs	  are	  formed	  at	  the	  base	  of	   the	  OS,	  close	   to	   the	  ciliary	  compartment	  and	  they	  move	  progressively	   towards	  the	   apical	   part	   where	   they	   mature	   [37].	   The	   lamellae	   are	   filled	   with	   rhodopsin	  molecules,	  increasing	  the	  probability	  of	  capturing	  light,	  whereas	  no	  rhodopsin	  is	  present	  in	  the	  disc	  rims	  [38].	  	  The	  IS	  can	  be	  considered	  as	  the	  industrial	  area	  of	  the	  photoreceptor.	  This	  is	  the	  portion	  of	   the	  cell	  where	   the	  metabolism,	  biosynthesis	  and	  all	  other	  cellular	  pathways	  occur.	   The	   IS	   is	   extremely	   organized	   in	   terms	   of	   internal	   structure.	   The	   apical	   part	   is	  protruding	   forming	   a	   microvilli	   structure	   that	   surrounds	   the	   base	   of	   the	   OS.	   These	  structures	  resemble	  a	  calyx	  of	  a	  flower,	  and	  for	  this	  reason	  are	  called	  “calycal	  processes”	  (Fig	   5c).	   In	   addition,	   at	   the	   apical	   end,	   the	   IS	   forms	   a	   resistant	   ridge-­‐like	   structure.	  Together	  these	  two	  systems	  work	  as	  physical	  support	  to	  the	  cilium	  [27]	  (Fig.	  5c).	  From	  a	  metabolic	   point	   of	   view,	   all	   the	  molecules,	   including	   rhodopsin,	   are	   assembled	   in	   the	  Golgi	   apparatus,	   located	   close	   to	   the	   nuclear	   part	   of	   the	   IS	   (Fig.	   5d).	   Conversely	   the	  upper	  part,	   called	   “ellipsoid”,	   contains	  many	  mitochondria,	  which	   are	  necessary	   to	   fill	  the	   high-­‐energy	   demands	   of	   the	   photoreceptors	   (Fig.	   5d).	   Moreover,	   the	   IS	   directly	  interacts	  with	  Müller	  glia	  cells	  for	  the	  exchange	  of	  nutrients	  and	  in	  particular	  for	  lactate	  production,	  which	  directly	   enters	   into	   the	  photoreceptor’s	   pyruvate	   cycle	   [39].	   The	   IS	  also	   has	   a	   very	   well	   organized	   microtubule	   network	   (cytoplasmic	   microtubules),	  necessary	   for	   the	   transport	   of	   molecules	   to	   different	   structures	   within	   the	  photoreceptor.	  The	   importance	  of	   this	   intracellular	  activity	   is	   clearly	  demonstrated	  by	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the	   transport	   of	   rhodopsin:	   Rhodopsin-­‐containing	   vesicles	   are	   generated	   in	   the	   Golgi	  and	  moved	  away	  through	  the	  cell.	  In	  greater	  detail,	  with	  the	  interaction	  of	  the	  rhodopsin	  protein	   complex	   [40]	   and	   the	   protein	  ArfGAP	  with	  SH3	  domain	  ankyrin	   repeat	  and	  PH	  
domain	  (ASAP1),	   a	   budding	   vesicle	   is	   formed	   from	   the	   Golgi.	   This	   vesicle	   is	   then	  transported	  though	  the	  microtubules	  network	  to	  the	  apical	  part	  of	  the	  cell	  by	  a	  dynein	  driven	  motor	  [41].	  It	  has	  been	  demonstrated	  that	  the	  suppression	  of	  cytoplasmic	  dynein	  motors	  causes	  the	  accumulation	  of	  post-­‐Golgi	  vesicles	  in	  the	  IS	  [42].	  After	  a	  long	  “walk”	  through	   the	   IS	   this	   shuttle	   can	   finally	   reach	   the	  ciliary	   region,	  which	   it	  has	   to	   cross	   to	  reach	  the	  OS.	  
	  
Figure	  6.	  Phototransduction	  and	  the	  visual	  cycle.	  Schematic	  representation	  of	  a	  photoreceptor	  cell	  with	  two	  of	  the	  most	  important	  pathways:	  the	  visual	  cycle	   (blue	   box)	   and	   the	   phototransduction	   cascade	   (red	   box).	   a)	   The	   visual	   cycle	   to	   restore	   the	  rhodopsin	  molecule.	  There	  are	   two	   different	   cycles,	   one	   that	  occurs	  between	   cone	  and	   rods	  and	  RPE	  cells,	  and	  the	  other	  that	  is	  exclusively	  for	  cones	  and	  Müller	  cells.	  hv,	  photon;	  RAL,	  retinal;	  ROL,	  retinol;	  R-­‐ester,	  retinyl	  ester;	  IRBP,	  interphotoreceptor	  retinoid-­‐binding	  protein;	  CRBP,	  cellular	  retinol-­‐binding	  protein;	  CRALBP,	  cellular	  retinalheyde-­‐binding	  protein;	  RDH,	  retinol	  dehydrogenase;	  REH,	  retinyl	  ester	  hydrolase;	  LRAT,	  lecithin:retinol	  acyl	  transferase;	  ARAT,	  acylCoA:retinol	  acyl	  transferase.	  (adapted	  from	  Muniz	   et	   al.,	   2007)	   	   b)	   The	   phototransduction	   cascade	   happens	   in	   the	   disc	   membrane	   and	  photoreceptor	  OS	  membrane.	  The	  light	  causes	  a	  conformational	  change	  in	  rhodopsin	  (Rh)	  that	  becomes	  active	   (Rh*).	   This	   change	   requires	   the	   G-­‐coupled	   protein	   transducin	   that	   catylizes	   GDP	   to	   GTP.	   The	  alpha	   subunit	   of	   the	   transducin	   activates	   phospodiesterase	   (PDE)	   that	   hydrolyzes	   cGMP	   into	   GMP,	  reducing	   the	   concentration	   of	   cGMP	   in	   the	   cell.	   This	   causes	   the	   closure	   of	   the	   sodium	   channel	   (CNG	  channel)	   and	   hyperpolarization	   of	   the	   membrane.	   Also,	   the	   arrestin	   (Arr)	   and	   recoverin	   pathway,	  important	  for	  inhibiting	  the	  process,	  are	  depicted	  in	  the	  box.	  GRK1,	  G-­‐protein-­‐coupled	  receptor	  kinase	  1;	  CNG,	  cyclic	  nucleotide-­‐gated;	  GCAP,	  guanylatr	   cyclase	  activator	  protein	  (adapted	   from	  Purves	  et	   al.,	  2001).	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  1.	  4	  THE	  PHOTORECEPTOR	  CONNECTING	  CILIUM	  
“Only	  Connect!”	  -­‐	  E.M	  Forster,	  English	  writer,	  1910	  The	  cilium	  is	  the	  backbone	  of	  the	  photoreceptor	  and	  it	  has	  several	  fundamental	  functions	  for	  photoreceptor	  biology	  (Fig.	  7a).	  It	  can	  be	  considered	  as	  a	  modified	  primary	  cilium,	  an	  organelle	  found	  in	  almost	  all	  post-­‐mitotic	  vertebrate	  cells.	  The	  primary	  cilium	  has	   a	   structure	   similar	   to	   the	  motile	   cilia	   or	  bacterial	   flagella.	  Although	   some	  primary	  cilia	   have	   conserved	   their	   motile	   functions,	   the	   majority	   of	   mammalian	   cilia	   are	  immotile	  and	  have	  evolved	  mostly	  as	  sensory	  organelles	  [43].	  Three	  different	  parts	  form	  the	   photoreceptor	   connecting	   cilium:	   the	   basal	   body	   (BB),	   the	   connecting	   cilium	   (CC)	  and	  the	  axoneme	  (Fig.	  7bc).	  The	  axoneme	  is	  the	  OS	  part	  of	  the	  cilium.	  It	  is	  composed	  of	  microtubule	   doublets	   arranged	   in	   a	   classical	   9+0	   circular	   composition	   and	   forms	   the	  backbone	   of	   the	   whole	   OS.	   In	   the	   very	   apical	   part,	   however,	   the	   axoneme	   has	   a	   9+0	  singlet	  microtubule	   structure.	   The	   CC	   corresponds	   to	   the	   transition	   zone	   of	   a	   cellular	  primary	   cilium.	   It	   is	   composed	   of	   a	   9+0	   microtubule	   doublet	   and	   it	   works	   as	   a	   thin	  bridge	  between	  the	  IS	  and	  the	  OS	  (this	  is	  the	  reason	  why	  it	  is	  called	  connecting	  cilium).	  In	   the	   part	   of	   the	   CC	   close	   to	   the	   IS	   there	   is	   a	   fibrous	   structure	   that	   cross-­‐links	   each	  microtubule	   doublet.	   This	   structure	   is	   called	   a	   ciliary	   necklace	   and	   forms	   a	   pocket	  around	  the	  CC,	  working	  as	  a	  molecular	  diffusion	  barrier	  [44].	  At	  the	  base	  of	  the	  CC	  there	  is	   the	   basal	   body.	   This	   structure	   originates	   from	   the	   “mother”	   centriole,	   which	   is	   the	  oldest	   centriole	  derived	   from	  mitosis.	  A	   specific	   cloud	  of	  proteins	   surrounding	   the	  BB	  called	   “appendage”	   distinguishes	   this	   structure	   from	   the	   normal	   cellular	   centrioles.	  These	  proteins	  are	   involved	   in	   ciliogenesis	   [45].	   In	  addition	   to	   this,	   the	  photoreceptor	  BB	  is	  connected	  to	  a	  protein	  called	  rootletin	  that	  forms	  a	  specific	  track	  (called	  a	  rootlet)	  to	   the	   synaptic	   terminus	   and	   it	   has	   the	   important	   function	   of	   anchoring	   the	  photoreceptor’s	  ER	  [46].	  	  The	  cilium	  has	  a	  central	  function	  both	  in	  the	  development	  of	  the	  cell	  and	  in	  the	  mature	  cell.	   In	  development,	   it	  directly	  drives	  the	  formation	  of	  the	  OS,	  with	  the	  raising	  cilium	   protruding	   from	   the	   basal	   body	   and	   continuing	   to	   grow	   until	   it	   reaches	   the	  correct	   size.	   Around	   postnatal	   day	   8-­‐10,	   the	   developing	   OS	   is	   filled	   with	   disc-­‐like	  membranes	   that	   are	  not	  yet	  organized	   into	  a	   regular	   shape	   [47].	  These	  discs	  are	   then	  rearranged	  perpendicularly	  to	  the	  ciliary	  backbone	  to	  form	  the	  discs	  stacks,	  typical	  of	  a	  mature	   photoreceptor.	   The	   rearrangement	   is	   directly	   mediated	   by	   the	   axoneme	  microtubules,	  which	  work	  as	  anchoring	  points	  for	  disc	  alignment.	  The	  final	  phase	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Figure	  7.	  Photoreceptor	  connecting	  cilium	  A	   schematic	   view	   of	   the	   photoreceptor	   and	   of	   the	   CC	   area.	   a)	   Representation	   of	   the	  photoreceptor.	   The	   cilium	   contain	   an	   IS	   compartment	   that	   corresponds	   roughly	   to	   the	   BB	  (purple),	   the	   transition	   zone	   between	   the	   IS	   and	   OS	   (orange),	   with	   the	   OS	   part	   called	   the	  axoneme	   (green).	   b)	   Magnification	   of	   the	   black	   box	   area.	   It	   is	   possible	   to	   distinguish	   the	  pericentrosomal	   proteins	   (PCM)	   that	   form	  a	   cloud	   around	   the	   BB;	   the	   periciliary	   complex	  or	  ciliary	   pocket	   (PCC/CP)	   in	   between	   the	   transition	   zone;	   calycal	   process	   and	   the	   rootlet	  connected	  to	  the	  BB.	  c)	  3D	  reconstruction	  of	  (b).	  (from	  Rachel	  et	  al,	  2012).	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  of	   development,	   starting	   after	   day	   10,	   corresponds	   to	   the	   elongation	   of	   the	   axoneme	  and	   of	   the	   OS	   to	   their	   mature	   lengths.	   A	   protein	   called	   RP1	   drives	   the	   axoneme	  elongation	  and	  the	  correct	  stacking	  of	  outgrowing	  discs	  [48].	  This	  molecule	  is	  essential	  for	  cilium	  biology,	  as	  demonstrated	  by	  the	  fact	  that	  mutations	  in	  this	  gene	  cause	  retinitis	  pigmentosa	  [49].	  It	  has	  been	  clearly	  shown	  that	  RP1	  is	  a	  microtubule-­‐associated	  protein	  (MAP),	  enhancing	  the	  addition	  of	  tubulin	  subunits	  to	  the	  growing	  cilium	  [50],	  and	  when	  mutated	  causes	  uncontrolled	  growth	  of	   the	  cilium.	  During	  development,	  newly	   formed	  discs	   are	   constantly	   produced	   at	   the	   ciliary	   region,	   while	   RPE	   cells	   phagocytose	   the	  apical	   part	   of	   the	   photoreceptor	   and	   the	   oldest	   and	   most	   distal	   discs.	   It	   has	   been	  observed,	  in	  addition	  to	  cilium	  structure,	  that	  the	  formation	  of	  functional	  stacked	  discs	  depends	   also	   on	   the	   presence	   of	   integer	   opsin	  molecules.	   In	   fact,	   although	   knock-­‐out	  mice	   for	   the	  rhodopsin	  gene	  show	  a	  normal	   formation	  of	   the	  primitive	  cilium,	   they	  do	  not	  develop	  a	  complete	  OS	  [51].	  Moreover,	  mutations	  of	  the	  signal	  motive	  present	  at	  the	  C-­‐terminal	  of	  the	  rhodopsin	  gene	  in	  humans	  cause	  severe	  retinal	  degeneration	  [52].	  	  	  	   The	   formation	   of	   stacked	   discs	   also	   takes	   place	   in	   mature	   photoreceptors	  throughout	  life,	  since	  light	  has	  a	  damaging	  effect	  on	  the	  OS	  and	  the	  cell	  needs	  a	  continual	  renewal	  of	  its	  proteins	  and	  membranes.	  This	  function	  is	  also	  accomplished	  by	  the	  cilium.	  However,	   since	   the	  OS	  and	   the	   cilium	  do	  not	  have	  any	  biosynthetic	  machinery,	   all	   the	  proteins	  and	  molecules	  necessary	  for	  phototransduction,	  ciliogenesis	  and	  disc	  formation	  are	   produced	   in	   the	   IS	   and	   transported	   to	   the	   OS	   through	   the	   cilium.	   This	   process	   is	  known	   as	   IntraFlagellar	   Transport	   (IFT)	   and	   it	   was	   first	   discovered	   in	   unicellular	  organisms	  [53],	  although	  this	  machinery	  is	  well	  conserved	  among	  different	  species	  [54].	  The	  IFT	  is	  a	  bidirectional	  transport	  of	  IFT	  particles	  along	  the	  cilium	  and	  axoneme	  (Fig.	  8).	  It	  can	  be	  considered	  as	  a	  specialized	  microtubule	  transport	  that	  uses	  specific	  motors	  and	   it	   can	   carry	   multiprotein	   IFT	   particles	   to	   the	   top	   of	   the	   cilium	   and	   back.	   The	  anterograde	  transport	  is	  mediated	  by	  a	  specific	  protein	  called	  kinesin	  II	  (in	  human	  this	  protein	  is	  composed	  of	  two	  subunits	  encoded	  by	  the	  KIF3A,	  and	  KIF3B	  or	  KIF3C	  genes	  [55]	  plus	  a	  non	  motor	  protein	  KAP1).	  Null	  mice	  with	  a	  mutation	  in	  the	  KIF3A	  gene	  have	  retinal	  degeneration,	  with	  poor	  differentiation	  of	  the	  photoreceptor	  OS,	  probably	  due	  to	  the	   accumulation	   of	  OS	   proteins	   in	   the	   IS	   [56].	   Conversely	   retrograde	   transport,	   from	  the	  axoneme	  to	  the	  basal	  body,	  is	  mediated	  by	  another	  motor	  protein	  called	  cytoplasmic	  dynein	  2	  (which	  has	  a	  heavy	  chain,	  encoded	  by	  the	  gene	  DHC1b/2	  in	  mammalian,	  and	  a	  light	  chain	  encoded	  by	  D2LIC	  [57]).	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Figure	  8.	  The	  photoreceptor	  “traffic”	  between	  Golgi	  and	  OS.	  Model	  for	  vesicle	  movement	  and	  IFT	  in	  ciliated	  photoreceptor	  cells.	  The	  vesicles	  containing	  membrane	  proteins	   for	   the	  OS	   formation	   (such	   as	   rhodopsin)	  are	   generated	   at	   the	   Golgi	  and	   transferred	   through	   cytoplasmatic	  microtubules	   at	   the	   peri-­‐cilary	   ridge,	   where	   they	  fuse	   with	   photoreceptor	   membranes.	   There	   they	   go	   through	   the	   basal	   body	   by	   passing	  through	   different	   checkpoints	   and	   are	   sequestered	   by	   IFT	   particles	   that	   directly	   interact	  with	  heterodimeric	   kinesin-­‐II.	  They	   go	   through	   the	   cilium	  until	   they	   reach	   the	  OS	  and	   at	  that	  point	   IFT	  particles	   free	   the	   cargo.	   IFT	  particles	   are	  recycled	  and	   transported	  back	  to	  the	  BB	  thanks	  to	  a	  cytoplasmic	  dynein	  II.	  (Adapted	  from	  Rosenbaum	  et	  al.,	  2002).	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  In	  addition	   to	   these	  motors,	  many	  other	  proteins	  are	  cargo	   for	   the	   IFT.	   In	  general	   the	  IFT	   complex	   can	  be	   fractionated	  by	   sucrose	  density	   gradient	   and	  dissociated	   into	   two	  different	  complexes,	  named	  A	  and	  B	  [54].	  Very	  little	  is	  known	  about	  the	  composition	  of	  these	   complexes,	   although	   proteins	   containing	   mainly	   protein-­‐protein	   interaction	  domains,	   like	   TPR	   repeats	   and	   coiled-­‐coil	   domains,	   are	   their	   major	   constituents.	  Immunofluorescence	   and	   electron	   microscopy	   experiments	   exclusively	   localize	   these	  complexes	  to	  the	  basal	  body,	  probably	  demonstrating	  their	  accumulation	  at	  the	  base	  of	  the	   cilium.	  Although	   this	  protein	   family	   is	  widely	  expressed	   in	  every	   ciliated	  cell,	   only	  one	   subgroup	   has	   been	   identified	   in	   photoreceptors	   and	   their	   depletion	   impairs	  photoreceptor	   development.	   For	   instance,	   IFT88	   disruption	   in	   zebrafish	   leads	   to	   the	  complete	   failure	  of	  primary	  cilium	  formation	  [58].	  Moreover,	  a	  hypomorphic	  mutation	  in	   the	   same	   gene	   causes	   syndromic	   ciliary	   defects	   in	   mice,	   associated	   with	   rapid	  photoreceptor	  degeneration	  [59].	  In	  general,	  the	  disruption	  of	  the	  IFT	  complex	  leads	  to	  the	   accumulation	   of	   opsin	  molecules	   in	   the	   IS,	   which	   has	   a	   strong	   toxic	   effect	   on	   the	  photoreceptor	   cell.	   This	   effect	   could	   either	   be	   due	   to	   the	   impairment	   of	   the	   primary	  cilium	   formation	   or	   via	   the	   direct	   damaging	   of	   the	   IFT	   complex	   for	   opsin	   transport.	  Recently	   it	   has	   been	   shown	   that	   a	   conditional	   knockout	   for	   another	   IFT	   component,	  IFT20,	  causes	  the	  accumulation	  of	  opsin	  and	  rhodopsin	  in	  cones	  and	  rods	  respectively,	  with	  subsequent	  retinal	  degeneration,	  without	  affecting	  the	  OS	  formation	  or	  ciliogenesis	  [60].	  This,	  as	  well	  as	  other	  evidences,	  support	  a	  direct	  implication	  of	  a	  component	  in	  the	  IFT	  machinery	  for	  the	  transport	  of	  phototransduction	  molecules.	  	  Other	  important	  molecular	  complexes	  are	  directly	  or	  indirectly	  linked	  to	  the	  cilium	  and	  to	   the	   IFT	   machinery.	   In	   general,	   mutations	   in	   genes	   that	   make	   up	   a	   part	   of	   these	  complexes	  cause	  widespread	  and	  severe	  diseases,	  for	  which	  retinal	  degeneration	  is	  the	  main	  one	  or	   just	  one	  of	   the	   features.	   Since	   cilium	   function	  or	  development	   is	   severely	  impaired,	   these	   diseases	   are	   generally	   recognized	   as	   ciliopathies.	   One	   example	   is	   the	  Bardet-­‐Biedl	  Syndrome	  (BBS)	  complex.	  Mutations	  in	  genes	  encoding	  proteins	  belonging	  to	   this	   molecular	   complex	   (called	   BBSome)	   cause	   Bardet-­‐Biedl	   syndrome,	   which	   is	  characterized	   by	   hypogonadism,	   obesity,	   polydactyly,	  mental	   disability,	   cystic	   kidneys	  and	  retinal	  degeneration	  [61].	  The	  BBSome	  is	  localized	  at	  the	  base	  of	  the	  cilium,	  and	  has	  a	  fundamental	  function	  in	  vesicle	  trafficking	  to	  the	  cilium	  in	  association	  with	  Rab8	  [62].	  Recently	  a	  new	  and	  direct	  role	  in	  IFT	  trafficking	  and	  the	  turnaround	  of	  IFT	  particles	  has	  been	  clearly	  demonstrated	  for	  some	  of	  BBS	  proteins	  [63].	  Another	  important	  complex	  is	  the	   NephronoPHtisis	   Protein	   complex	   (NPHP)	   that	   is	   composed	   of	   several	   different	  proteins	   (up	   to	   11	   loci	   are	  mapped	   on	   the	   human	   genome	   [64]),	   for	  which	   the	  major	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phenotype	  is	  nephrophtisis,	  the	  most	  common	  cause	  for	  early	  onset	  renal	  failure.	  Often,	  but	  not	  always,	  mutations	  in	  these	  genes	  also	  cause	  an	  associated	  retinal	  degeneration,	  and	   in	   this	   case	   the	   disease	   is	   usually	   called	   Senior-­‐Løcken	   syndrome.	   For	   instance,	  mutations	  in	  NPHP10,	  which	  encodes	  for	  the	  protein	  Serologically	  Defined	  Colon	  Cancer	  
Antigen	  8	  (SDCCAG8)	  causes	  renal-­‐retinal	  ciliopathy	  [65].	  Additionally,	  NPHP1	  (encoding	  for	   nephrocystin)	   knockout	   mice	   show	   problems	   with	   IFT88	   localization	   and	   an	  impairment	   in	   OS	   development	   [66].	   Although	   the	   function	   of	   these	   proteins	   and	   of	  other	  NPHP	  proteins	  has	  not	  yet	  been	  clearly	  elucidated,	  they	  are	  all	  localized	  to	  the	  BB	  or	  CC	  of	  the	  photoreceptor,	  linking	  their	  function	  to	  cilium	  maintenance	  or	  development.	  In	   addition	   to	   the	   renal-­‐retinal	   phenotype,	   mutations	   in	   NHPH	   genes	   can	   be	   also	  connected	   to	   neurological	   defects,	   such	   as	  mental	   retardation	   and	   ataxia.	   In	   this	   case,	  the	  syndrome	  is	  called	   Joubert	  syndrome	  [64].	  Recently,	  mutations	   in	   the	  protein	  Oro-­‐
Facial-­‐Digital	  1	  (OFD1)	  have	  been	  shown	  to	  lead	  to	  a	  X-­‐linked	  form	  of	  Joubert	  syndrome	  [67].	   This	   protein	   controls	   the	   length	   and	   structure	   of	   distal	   centrioles	   and	   it	   is	  important	  in	  recruiting	  IFT88	  to	  the	  centrosome	  [68].	  Another	  important	  NPHP	  gene	  is	  
NPHP6	   that	   encodes	   for	   the	   protein	  CEntrosomal	  Protein	   290	   (CEP290).	  Mutations	   in	  this	  gene	  are	  the	  cause	  of	  different	  ciliopathies	  such	  as	  Joubert	  syndrome,	  Senior-­‐Løken	  syndrome	   [69,	   70],	   Meckel-­‐Grüber	   syndrome	   [71](one	   of	   the	   most	   severe	   form	   of	  syndromic	  ciliopathies)	  and	  BBS	  [72].	  In	  addition,	  it	  has	  been	  clearly	  demonstrated	  that	  hypomorphic	  mutations	   in	   this	   gene	   cause	   a	   severe	   early	   onset	   retinal	   degeneration,	  known	  as	   Leber	   congenital	   amaurosis,	   for	  more	   than	  25%	  of	   patients	   affected	  by	   this	  disease	   [73].	   Similarly,	   a	   naturally	   occurring	   mouse	   mutant	   carrying	   an	   in-­‐frame	  deletion	  in	  CEP290,	  called	  rd16,	  presents	  an	  early-­‐onset	  retinal	  degeneration	  and	  mild	  olfactory	  dysfunction	  without	  any	  other	  ciliopathy	  associated	  phenotype	  [74].	  Although	  the	   function	  of	  CEP290	  has	  not	  been	   completely	   clarified,	   several	   studies	   connect	   this	  protein	   to	   ciliogenesis.	   Specifically,	   CEP290	   knockdown	   causes	   defective	   ciliogenesis	  with	  the	  mislocalization	  of	  Rab8a	  protein	  [75].	  In	  addition	  to	  this	  primary	  effect,	  several	  studies	  demonstrate	  an	  active	  role	  of	  CEP290	  in	  the	  delocalization	  of	  cellular	  inhibitors	  of	  ciliogenesis	  [76,	  77].	  1.5	  RETINITIS	  PIGMENTOSA	  AND	  RELATED	  RETINAL	  DISTROPHIES	  
“The	  only	  thing	  worse	  than	  being	  blind	  is	  having	  sight	  but	  no	  vision.”-­‐	  Helen	  Keller,	  American	  writer	  
and	  political	  activist,	  first	  deaf-­‐blind	  person	  to	  earn	  a	  BA	  degree,	  1900	  circa.	  Retinitis	   pigmentosa	   (RP)	   comprises	   a	   set	   of	   inherited	   retinal	   diseases	  characterized	   by	   the	   progressive	   degeneration	   of	   both	   types	   of	   photoreceptors:	   the	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cones	  and	   the	   rods.	  The	  worldwide	  prevalence	   is	  1	   in	  4000,	  with	  more	   than	  1	  million	  individuals	   affected	   overall	   [78].	   In	   a	   minority	   of	   cases,	   RP	   can	   also	   be	   a	   part	   of	  syndromes	   that	   target	   several	   other	   organs.	   The	   disease	   presents	   highly	   variable	  symptoms.	   Some	   patients	   develop	   symptomatic	   loss	   of	   vision	   in	   childhood,	   whereas	  others	   remain	   totally	   asymptomatic	  until	  mid-­‐adulthood.	  Usually	   the	   initial	   symptoms	  are	  associated	  with	  rod	  photoreceptor	  death	   leading	   to	  difficulties	  with	  dark	  adaption	  and	  night	   blindness.	   The	   disease	   develops	   until	   there	   is	   a	   complete	   loss	   of	   peripheral	  vision,	  tunnel	  vision	  and	  sometimes	  loss	  of	  central	  vision.	  Due	  to	  its	  variable	  phenotype,	  diagnosis	   is	   mostly	   based	   on	   electrophysiological	   and	   imaging	   analysis.	   For	   example,	  fundus	   analysis	   by	   slit-­‐lamp	   examination	   or	   by	   ophthalmoscopy,	   reveals	   a	   typical	  intraretinal	   pigmentation,	   the	   so-­‐called	   bone	   spicule	   deposits,	   due	   to	   the	  migration	   of	  the	   retinal	   pigmented	   epithelium	   into	   the	   neural	   part	   retina	   in	   response	   to	  photoreceptor	   cell	   death	   [79]	   (Fig.	  9a).	  Another	   important	   instrument	   for	  diagnosis	   is	  the	   electroretinogram	   (ERG),	   which	  measures	   the	   electrical	   response	   of	   the	   retina	   to	  flashes	   of	   lights	   with	   an	   electrode	   on	   the	   cornea	   (defined	   as	   a-­‐wave	   and	   b-­‐wave	  amplitude).	  Patients	  with	  RP	  have	  a	  reduction	  in	  the	  electric	  response	  amplitude	  of	  rods	  and	  cones	  and	  a	  delay	  in	  response	  timing,	  both	  in	  scotopic	  and	  photopic	  conditions	  (Fig.	  9c)	  [80].	  	  Another	  non-­‐syndromic	  retinal	  dystrophy,	  closely	  related	  to	  RP,	   is	  called	  Leber	  congenital	  amaurosis	  (LCA),	  taking	  its	  name	  from	  the	  person	  that	  first	  described	  it	  [81].	  This	   form	   of	   retinal	   degeneration	   presents	   different	   clinical	   features,	   including	   early	  severe	  visual	  loss,	  sensory	  nystagmus,	  amaurotic	  pupils	  and	  a	  missing	  ERG	  response.	  It	  is	  more	  rare	  than	  RP	  with	  an	  incidence	  of	  1	  newborn	  in	  every	  30.000,	  but	  accounts	  for	  a	  large	  number	  of	  children	  born	  blind	  [82].	  It	  can	  be	  considered	  as	  one	  of	  the	  most	  severe	  forms	   of	   non	   syndromic	   inherited	   retinal	   blindness,	   and	   it	   is	   usually	   an	   autosomal	  recessive	  condition.	  Mutations	  in	  some	  genes	  involved	  in	  LCA	  have	  also	  been	  associated	  with	   RP,	   demonstrating	   a	   genetic	   overlap	   between	   these	   two	   inherited	   diseases	   of	  retinal	  degeneration	  [83,	  84].	  RP	   can	   be	   present	   as	   one	   symptom	   in	   other	   syndromic	   disease,	   such	   as	   for	  example	  in	  Usher	  syndrome,	  which	  is	  associated	  with	  mild	  to	  severe	  deafness	  and	  is	  the	  major	   cause	   of	   inherited	   deafness-­‐blindness	   in	   children.	   Usher	   syndrome	   is	   a	   rare	  disease	  with	  an	  incidence	  of	  1	  in	  25,000	  newborn	  children	  [85]	  and	  it	  is	  inherited	  as	  an	  autosomal	   recessive	   trait.	   In	   general,	   genes	   mutated	   in	   Usher	   syndrome	   are	   mostly	  connected	  to	  structural	  proteins	  and	  have	  an	  important	  function	  for	  the	  correct	  shaping	  and	  mechanical	   functioning	   of	  mature	   stereocilia	   in	   auditory	   epithelia	   [86].	   However,	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the	   reason	   why	   they	   can	   lead	   to	   RP	   is	   still	   debated.	   In	   fact,	   mouse	   models	   targeting	  proteins	   in	   Usher	   syndrome	   do	   not	   show	   retinal	   degeneration	   or	   abnormalities.	   The	  localization	   of	   Usher	   proteins	   in	   the	   proximity	   of	   the	   CC	   [87,	   88]	   could	   suggest	   a	  functional	  connection	  with	  this	  organelle,	  and	  this	  hypothesis	   is	  also	  reinforced	  by	  the	  observed	   interaction	   of	   several	   Usher	   proteins	   with	   ciliary/BB	   proteins	   [89,	   90].	  Recently	  it	  has	  been	  shown	  that	  USH1	  protein	  complex	  localizes	  to	  the	  calycal	  process	  in	  human	  photoreceptor	  cells	  [91],	  structures	  that	  are	  closely	  linked	  to	  the	  CC	  cilium	  area.	  These	  structures	  are	  very	  well	  developed	  in	  primates,	  but	  not	   in	  rodents.	  A	  role	   in	  the	  formation	  of	  the	  calycal	  processes	  could	  partially	  explain	  the	  missing	  retinal	  phenotype	  in	  the	  mutant	  usher	  mouse	  model	  compared	  to	  the	  observed	  phenotype	  in	  humans.	  From	  a	  genetic	  point	  of	  view,	  RP	  is	  usually	  transmitted	  as	  a	  Mendelian	  trait	  (autosomal	  recessive,	  autosomal	  dominant,	  or	  X-­‐linked),	  although	  in	  a	  small	  portion	  of	  cases	  it	  can	  display	   a	   non-­‐Mendelian	   pattern	   of	   inheritance	   (digenic	   trait,	   di/triallelic	   trait	   or	  maternal	  inheritance)	  [92-­‐94].	  One	  distinguishing	  characteristic	  of	  RP,	  and	  in	  general	  of	  retinal	   dystrophies,	   is	   their	   genetic	   heterogeneity.	   According	   to	   the	  RETNET	  database	  (www.retnet.org)	   16	   different	   genes	   are	   associated	   with	   autosomal	   dominant	   RP	  (adRP),	  3	  to	  X-­‐linked	  RP,	  and	  29	  with	  autosomal	  recessive	  RP	  (arRP)	  and	  7	  genes	  have	  been	  associated	  to	  both	  autosomal	  and	  recessive	  RP.	  Because	  of	  this	  heterogeneity,	  the	  molecular	  diagnosis	  is	  difficult,	  with	  a	  large	  portion	  of	  patients	  worldwide	  for	  which	  the	  causative	   gene	   has	   not	   yet	   been	   identified.	   Genes	   involved	   in	   RP	   and	   in	   retinal	  dystrophies	  are	  mostly	   linked	   to	   three	  major	  processes	  of	   the	  rod	  photoreceptors	  and	  the	   RPE	   (Fig.	   10).	   These	   include:	   the	   retinoid	   cycle,	   which	   takes	   place	   in	   the	   outer	  segment	   of	   the	   photoreceptor	   and	   in	   the	   RPE,	   the	   phototransduction	   cascade	   in	   the	  membranous	   disc	   of	   rod	   photoreceptors,	   and	   the	   ciliary	   transport	   in	   the	   connecting	  cilium,	  involved	  in	  the	  transport	  process	  between	  the	  cytoplasm	  and	  the	  outer	  segment	  of	  the	  photoreceptor	  [95].	  Other	  genes	  are	  involved	  in	  photoreceptor	  development	  and	  regulation	   (like	  NRL	   [96]	   and	   CRX	   [97]),	   or	   are	   ubiquitously	   expressed	   across	   tissues	  (e.g.	  pre-­‐mRNA	  processing	  proteins-­‐PRPs)	  [98-­‐100].	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Figure	  9.	  Retinitis	  pigmentosa,	  ocular	  phenotype.	  Fundus	  image	  and	  ERG	  of	  a	  control	  and	  RP	  patient.	  a)	  Left	  panel,	  normal	  retina	  fundus	  image.	  Right	  panels,	   typical	  defects	  of	  a	  RP	  retina:	  diffuse	  pigmentation;	  pale	  optic	  disc;	   thin	  blood	  vessels	  (from	  Chapple	  et	  al.,	  2001)	  b)	  ERG	  comparison	  between	  a	  control	  and	  a	  RP	  patient.	  It	  is	  possible	  to	  distinguish	  the	  differences	  in	  amplitude	  of	  the	  a-­‐wave	  (a)	  and	  b-­‐wave	  (b)	  both	  for	   	   scotopic	   and	  photopic	   condition	   in	  a	   control	   eye.	  These	  waves	   are	   totally	   abolished	   or	  severely	  reduced	  in	  RP	  retina	  (from	  www.webvision.med.utha.edu).	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Figure	  10.	  Localization	  and	  function	  of	  the	  genes	  mutated	  in	  retinal	  degenerations.	  	  Schematic	   diagram	   of	   a	   rod	   photoreceptor	   and	   its	   major	   biochemical	   pathways.	   Upper	  panel:	  visual	  cycle;	  middle	  panel:	  phototransduction	  cascade;	  lower	  panel:	  ciliary	  transport.	  All	   proteins	   implied	   in	   retinal	   degeneration	   are	   marked	   in	   these	   panels	   or	   on	   the	  photoreceptor	   picture.	   Their	   real	   or	   hypothetical	   localization	   is	   indicated.	   (From	   Den	  Hollander	  et	  al.,	  2010).	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1.6	  AUTOSOMAL	  RECESSIVE	  RP	  AND	  THE	  LOCUS	  RP28	  
“If	  you	  wanted	  to	  dissect	  the	  structure	  of	  living	  cells,	  genetic	  analysis	  was	  an	  extremely	  powerful	  
method,	  so	  my	  interest	  turned	  to	  that”.	  –	  Joshua	  Lederberg,	  American	  molecular	  biologist,	  Nobel	  
Prize	  for	  medicine,	  1958	  The	  most	   common	   form	   of	   RP	   is	   autosomal	   recessive	   caused	   by	  mutations	   in	  several	  different	  genes	  (Figure	  11).	  Despite	  this	  genetic	  heterogeneity,	  a	  few	  of	  them	  are	  responsible	   for	   a	   significant	   number	   of	   cases:	  USH2A	   (1-­‐7%)[101],	   EYS	   (11%)	   [102],	  
ABCA4	   (2-­‐5%)	   [103],	  PDE6A	  (4%)	   [104],	   and	  PDE6B	  (4%)	   [105],	  RPE65	   (2-­‐11%)	   [84],	  while	   others	   are	   rarely	   found	   to	   be	   mutated	   in	   patients	   .	   The	   function	   of	   autosomal	  recessive	   linked	   genes	   (Table	   1)	   is	   mostly	   related	   to	   photoreceptor	   metabolism,	  phototransduction	   cascade,	   signaling,	   trafficking	   of	   intracellular	   proteins,	   ciliary	  function,	  or	  the	  cytoskeleton	  and	  structure	  of	  the	  photoreceptor.	  Although	  most	  of	  these	  genes	  are	  expressed	  only	   in	   the	  retina,	  others,	   like	   IDH3B,	   are	  ubiquitously	  expressed,	  but	  others	  organs	  do	  not	  seem	  to	  be	  affected	  [106].	  	  The	  locus	  RP28	  was	  identified	  in	  1999	  by	  genome-­‐wide	  homozygosity	  mapping	  in	  an	  Indian	  family	  with	  multiple	  consanguineous	  marriages	  [107].	  The	  family	  included	  4	  affected	  members	  with	  arRP.	  A	  locus	  of	  16	  cM	  (14Mb)	  located	  between	  2p11	  and	  2p15	  on	   the	   short	   arm	   of	   chromosome	   2	   and	   with	   a	   maximum	   LOD	   score	   of	   3.38	   was	  identified.	  From	  a	  clinical	  point	  of	  view,	  the	  age	  of	  onset	  of	  the	  affected	  members	  in	  the	  family	  varied	  from	  5	  to	  15	  years,	  and	  fundus	  analysis	  showed	  classical	  RP	  features.	  The	  locus	  was	   then	   confirmed	   and	   refined	   in	   2004	   by	   the	   analysis	   of	   another,	   apparently	  unrelated	  Indian	   family	  by	  microsatellites	  mapping	  of	  known	  RP	   loci	   [108].	  This	   latter	  analysis	   confirmed	   that	   the	   RP28	   locus	   was	   linked	   to	   arRP	   and	   narrowed	   the	   locus	  interval	   to	   a	   region	   of	   about	   1	   cM	   between	   2p14	   and	   2p15.	   The	   clinical	   analysis	   of	  affected	  patients	  revealed	  an	  age	  of	  onset	  between	  8-­‐18	  years,	  with	  classical	  RP	  features.	  Although	   not	   well	   clarified,	   the	   identification	   of	   heterozygous	   SNPs	   in	   the	   suspected	  homozygous	   region	   for	   this	   second	   family	   seems	   to	   suggest	   the	   possibility	   that	   this	  microsatellites	  linkage	  could	  correspond	  to	  a	  false	  positive	  peak.	  	  	  	  
	   36	  
Table	  1.	  Identified	  recessive	  genes	  and	  their	  functions	  
Gene$ Cromosome Function Gene$ Cromosome Function
USH2A 1q41 RGR 10q23.1
PDE6B 4p16 NR2E3 15q23
PDE6A 5q33.1 NRL 14q11.2
RPE65 1p31.2 RP1 8q12.1
CNGA1 4p12 BEST1 11q12.3
CNGB1 16q13 C2ORF71 2p23.2
ABCA4 1p22 EYS 6q12
CRB1 1q31.3 FAM161A 2p15
LRAT 4q32.1 IDH3B 20p13
MERTK 2q13 IMPG2 3q12.3
TULP1 6p21.31 PDE6G 17q25.3
RHO 3q22.1 RBP3 10q11.22
RLBP1 15q26.1 SPATA7 14q31.3
CERKL 2q31.3 TTC8 14q32.11
SAG 2q37.1 ZNF513 2p23.3 Unknown2function82transcription2factor
C8ORF37 8q22.1 PRCD 17q25.1 Unknown2Function




















SAG	  1%	  ABCA4	  5%	  
RLBP1	  1%	   CERKL	  1%	   CNGA1	  2%	   CNGB1	  1%	   MERTK	  1%	  CRB1	  1%	  LRAT	  1%	   NLR	  1%	  NR2E3	  0%	  PDE6A	  4%	  PDE6B	  4%	   PRCD	  0%	  PROM1	  1%	  RPE65	  2%	  RP1	  1%	   RHO	  1%	  RGR	  1%	  TULP1	  1%	  
USH2A	  7%	  
EYS	  12%	  
BEST1	  1%	  IDH3B	  1%	  PDE6G	  1%	  RBP3	  1%	  SPATA7	  1%	  TTC8	  1%	  ZNF513	  1%	  C2ORF71	  1%	  C8ORF37	  1%	  




Figure	  11.	  Frequencies	  of	  genes	  mutated	  in	  non-­‐syndromic	  arRP.	  The	  frequencies	  of	  the	  genes	  were	  derived	  from	  the	  literature.	  Whenever	  mutations	  could	  be	  identified	  only	  in	  one	  or	  few	  cases,	  their	  prevalence	  was	  set	  to	  1%.	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I.2	  PAPER	  	  
ULTRA HIGH THROUGHPUT SEQUENCING EXCLUDES MDH1 AS CANDIDATE 
GENE FOR RP28-LINKED RETINITIS PIGMENTOSA. 	  
Thomas	  Rio	  Frio,1	  Sylwia	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  Christian	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  Silvio	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  Carlo	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  1Department	  of	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  of	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  Switzerland;	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  Institute	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  and	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  Switzerland;	  3Department	  of	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  and	  Genetics,	  Indian	  Institute	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  4Institut	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  Germany	  	  
Abstract	  	  
PURPOSE:	  Mutations	  in	  IDH3B,	  an	  enzyme	  participating	  in	  the	  Krebs	  cycle,	  have	  recently	  been	  found	  to	  cause	  autosomal	  recessive	  retinitis	  pigmentosa	  (arRP).	  The	  MDH1	  gene	  maps	  within	  the	  RP28	  arRP	  linkage	  interval	  and	  encodes	  cytoplasmic	  malate	  dehydrogenase,	  an	  enzyme	  functionally	  related	  to	  IDH3B.	  As	  a	  proof	  of	  concept	  for	  candidate	  gene	  screening	  to	  be	  routinely	  performed	  by	  ultra	  high	  throughput	  sequencing	  (UHTs),	  we	  analyzed	  MDH1	  in	  a	  patient	  from	  each	  of	  the	  two	  families	  described	  so	  far	  to	  show	  linkage	  between	  arRP	  and	  RP28.	  
METHODS:	  With	  genomic	  long-­‐range	  PCR,	  we	  amplified	  all	  introns	  and	  exons	  of	  the	  MDH1	  gene	  (23.4	  kb).	  PCR	  products	  were	  then	  sequenced	  by	  short-­‐read	  UHTs	  with	  no	  further	  processing.	  Computer-­‐based	  mapping	  of	  the	  reads	  and	  mutation	  detection	  were	  performed	  by	  three	  independent	  software	  packages.	  
RESULTS:	  Despite	  the	  intrinsic	  complexity	  of	  human	  genome	  sequences,	  reads	  were	  easily	  mapped	  and	  analyzed,	  and	  all	  algorithms	  used	  provided	  the	  same	  results.	  The	  two	  patients	  were	  homozygous	  for	  all	  DNA	  variants	  identified	  in	  the	  region,	  which	  confirms	  previous	  linkage	  and	  homozygosity	  mapping	  results,	  but	  had	  different	  haplotypes,	  indicating	  genetic	  or	  allelic	  heterogeneity.	  None	  of	  the	  DNA	  changes	  detected	  could	  be	  associated	  with	  the	  disease.	  
CONCLUSIONS:	  The	  MDH1	  gene	  is	  not	  the	  cause	  of	  RP28-­‐linked	  arRP.	  Our	  experimental	  strategy	  shows	  that	  long-­‐range	  genomic	  PCR	  followed	  by	  UHTs	  provides	  an	  excellent	  system	  to	  perform	  a	  thorough	  screening	  of	  candidate	  genes	  for	  hereditary	  retinal	  degeneration.	  	  	  	  	  	  	  	  	  	  	  	  	  
For	  this	  paper	  my	  role	  was	  marginal,	  in	  fact	  I	  just	  performed	  confirmations	  of	  UHT	  data	  by	  
Sanger	  sequencing,	  but	  it	  represented	  my	  first	  contact	  with	  the	  RP28	  family.	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DQG SURJUHVVLYH IRUP RI UHWLQDO GHJHQHUDWLRQ ZLWK DQ
HVWLPDWHG SUHYDOHQFH RI RQH SDWLHQW LQ  SHRSOH >@
$IIHFWHGLQGLYLGXDOVH[SHULHQFHWKHFRQVWDQWDQGXQVWRSSDEOH
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LQFUHDVLQJ ORVV RI VLJKW DQG LQ PDQ\ LQVWDQFHV OHJDO RU
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DQGPXWDWLRQV LQ LWV VHTXHQFH FRXOG EH UHVSRQVLEOH IRU WKH
GLVHDVHLQDPDQQHUVLPLODUWRWKDWRISDWKRJHQLFFKDQJHVLQ
,'+%
$ FRPPRQ DSSURDFK WR WKH PXWDWLRQDO VFUHHQLQJ RI
FDQGLGDWH JHQHV FRQVLVWV RI VHTXHQFLQJ WKHLU H[RQV DQG
LPPHGLDWH LQWURQ ERXQGDULHV +RZHYHU VLQFH SDWKRJHQLF
PXWDWLRQVFDQVRPHWLPHVEHORFDWHGGHHSZLWKLQLQWURQVDV
ZDV UHFHQWO\ VKRZQ IRU UHWLQDO GHJHQHUDWLRQ JHQHV DVZHOO
>@ ZH GHFLGHG WR DQDO\]H WKH IXOO0'+ VHTXHQFH 7R
FLUFXPYHQW SUREOHPV OLQNHG WR VHTXHQFH OHQJWK DQG
FRPSRVLWLRQDQGWRWHVWWKHSRWHQWLDORISDUDOOHOVHTXHQFLQJLQ
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I.3	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NONSENSE MUTATIONS IN FAM161A CAUSE RP28-ASSOCIATED 
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ABSTRACT	  Retinitis	  pigmentosa	  (RP)	  is	  a	  degenerative	  disease	  of	  the	  retina	  leading	  to	  progressive	  loss	  of	  vision	  and,	  in	  many	  instances,	  to	  legal	  blindness	  at	  the	  end	  stage.	  The	  RP28	  locus	  was	  assigned	  in	  1999	  to	  the	  short	  arm	  of	  chromosome	   2	   by	   homozygosity	   mapping	   in	   a	   large	   Indian	   family	   segregating	   autosomal-­‐recessive	   RP	  (arRP).	   Following	   a	   combined	   approach	   of	   chromatin	   immunoprecipitation	   and	   parallel	   sequencing	   of	  genomic	  DNA,	  we	  identified	  a	  gene,	  FAM161A,	  which	  was	  shown	  to	  carry	  a	  homozygous	  nonsense	  mutation	  (p.Arg229X)	   in	   patients	   from	   the	   original	   RP28	   pedigree.	   Another	   homozygous	   FAM161A	   stop	  mutation	  (p.Arg437X)	  was	  detected	  in	  three	  subjects	  from	  a	  cohort	  of	  118	  apparently	  unrelated	  German	  RP	  patients.	  Age	  at	  disease	  onset	  in	  these	  patients	  was	  in	  the	  second	  to	  third	  decade,	  with	  severe	  visual	  handicap	  in	  the	  fifth	  decade	  and	  legal	  blindness	  in	  the	  sixth	  to	  seventh	  decades.	  FAM161A	  is	  a	  phylogenetically	  conserved	  gene,	  expressed	  in	  the	  retina	  at	  relatively	  high	  levels	  and	  encoding	  a	  putative	  76	  kDa	  protein	  of	  unknown	  function.	   In	   the	   mouse	   retina,	   Fam161a	   mRNA	   is	   developmentally	   regulated	   and	   controlled	   by	   the	  transcription	   factor	   Crx,	   as	   demonstrated	   by	   chromatin	   immunoprecipitation	   and	   organotypic	   reporter	  assays	  on	  explanted	  retinas.	  Fam161a	  protein	  localizes	  to	  photoreceptor	  cells	  during	  development,	  and	  in	  adult	   animals	   it	   is	   present	   in	   the	   inner	   segment	   as	   well	   as	   the	   outer	   plexiform	   layer	   of	   the	   retina,	   the	  synaptic	   interface	   between	   photoreceptors	   and	   their	   efferent	   neurons.	   Taken	   together,	   our	   data	   indicate	  that	  null	  mutations	  in	  FAM161A	  are	  responsible	  for	  the	  RP28-­‐associated	  arRP.	  	  	  
In	  this	  paper,	  for	  which	  I	  participated	  equally	  as	  first	  author,	  I	  performed	  the	  gene	  capture	  
of	   the	  whole	  RP28	   locus	  and	   I	   first	  discovered	   the	  nonsense	  mutation	   in	  FAM161A	   in	  an	  
affected	  member	  of	  the	  original	  RP28	  family.	   I	  performed	  the	  RT-­‐PCR	  analysis	  on	  human	  
tissue	  and	  designed	  the	  custom	  antibody.	  The	  immunohistochemistry	  was	  performed	  as	  a	  
collaboration	  between	  myself	  and	  Yvan	  Arsenijevic.	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Figure	  S1.	  Multiple	  Alignments	  of	  FAM161A	  in	  Eight	  Vertebrate	  Species.	  	  Since	   current	   annotations	   of	   FAM161A	   orthologues	   are	   generally	   poor,	   non-­‐human	   entries	  shown	  derive	  from	  the	  conceptual	   translation	  of	  full	  transcripts,	  partial	  cDNA	  clones,	  ESTs,	  or	  "in	  silico	  spliced"	  sequences	  from	  genomic	  DNA,	  all	  available	  from	  public	  databases.	  Conserved	  residues	  are	  blue	  shaded.	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CBR1 cloning into "No basal-dsRed" 
 
















CBR2 cloning into "Rho basal-dsRed" 
 





Figure S2. Sequences and Primers for Cloning of Fam161a CBR1 and CBR2 into "No basal-dsRed" 
and "Rho basal-dsRed" 
Crx consensus motifs are printed in bold and are underlined. 
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Table S1. Non-Annotated DNA Variants Detected Homozygously by Exon Sequence Capturing and 
UHTs for the 188 Genes Present in the RP28 Interval 
 
      






      
      
ENSG00000170264 FAM161A G/A c.685 100 Arg>End 
ENSG00000124383 MPHOSPH10 T/A c.82 89.2 Phe>Ile 
ENSG00000144040 SFXN5 G/A c.364 100 Gly>Ser 
ENSG00000173209 AHSA2 T/A c.393 90.9 Val>Asp 
ENSG00000143971 ETAA1 C/A c.2299 100 Lys>Gln 
ENSG00000173209 AHSA2 G/T c.402 100 Lys>Asn 
ENSG00000169564 PCBP1 G/A c.735 81.9 no (Gln=) 
ENSG00000163170 BOLA3 C/T c.23 100 no (Ala=) 
      
 
Entries are ranked according to the pathogenicity score of the amino acid (aa) residue change, from most 




Table S2. Crx-Driven ChIP-Seq Reads in Murine Retinas 
 
    
Human ENSEMBL ID Human 
Gene 
Symbol 





    
    
ENSG00000170264 FAM161A ENSMUSG00000049811 Fam161a 205
ENSG00000119862 HSPC159 ENSMUSG00000042363 1110067D22Rik 124
ENSG00000170340 B3GNT2 ENSMUSG00000051650 B3gnt2 112
ENSG00000197329 PELI1 ENSMUSG00000020134 Peli1 104
ENSG00000143995 MEIS1 ENSMUSG00000020160 Meis1 77
ENSG00000082898 XPO1 ENSMUSG00000020290 Xpo1 66
ENSG00000186889 TMEM17 ENSMUSG00000049904 Tmem17 40
ENSG00000143951 C2orf86 ENSMUSG00000020319 AV249152 38
ENSG00000115484 CCT4 ENSMUSG00000007739 Cct4 37
ENSG00000115504 EHBP1 ENSMUSG00000042302 Ehbp1 33
ENSG00000173163 COMMD1 ENSMUSG00000051355 Commd1 25
ENSG00000119865 CNRIP1 ENSMUSG00000044629 Cnrip1 25
ENSG00000115946 PNO1 ENSMUSG00000020116 Pno1 21
ENSG00000204923 FBXO48 ENSMUSG00000044966 Fbxo48 19
ENSG00000143971 ETAA1 ENSMUSG00000016984 Etaa1 10
    
 
 
The transcription factor Crx (which is expressed in both rods and cones) is strongly bound to the Fam161a 
genomic region, as reflected by 205 ChIP-seq reads. The number of reads is proportional to the amount of 
Crx-protein precipitated from the region and represents approximately the affinity of Crx to the target DNA. 




Table S3. Haplotypes of Three Apparently Unrelated German Patients with Retinitis Pigmentosa and 
a Homozygous p.Arg437X Mutation 
 
     
SNP ID 
 
Location arRP173 arRP323 M09-0352 
     
     
rs4270331:G>T Exon 1 G/G G/G G/G 
rs11125896:G>A  Intron 1 G/G G/G G/G 
rs11125895:A>G Exon 2 G/G G/G G/G 
rs17513722:A>G Exon 3 A/A A/A A/A 
rs4672457:C>T Exon 3 C/C C/C C/C 
rs35746699:GCA>del 3’ UTR GCA/GCA GCA/GCA GCA/GCA 





Table S4. Rare Sequence Variants of Uncertain Pathogenicity Detected in FAM161 
 
 












     
        
M07-0321 Turkish 2 c.197 C>T heterozygous p.Thr66Ile no 2/366 
M08-0522 German 2 c.228 G>A heterozygous p.Pro76=  0/358 
M09-0413 German 3 c.613 G>C heterozygous p.Asp205His yes 0/400 
M09-0502 German 3 c.1085 G>T heterozygous p.Arg362Leu yes 1/400 
M08-0312 German 3 c.1133 T>G heterozygous p.Leu378Arg yes 0/400 
arRP303 German 3 c.1133 T>C heterozygous p.Leu378Pro yes 0/400 
M08-0586 German  3 c.1153 C>G heterozygous p.Gln385Glu no 2/400 
M07-0320 German 3 c.1153 C>G heterozygous p.Gln385Glu no 2/400 
arRP305 German 3 c.1153 C>G heterozygous p.Gln385Glu no 2/400 





Table S5. Non-Pathogenic Sequence Variants Detected in FAM161 
 
 
    
Exon / Intron Nucleotide change* Protein variant SNP ID 
    
    
E1 c.165G>T p.Ala55= rs4270331 
E2 c.321A>G p.Ile107Met rs11125895 
E3 c.706A>G p.Ile236Val rs17513722 
E3 c.1212C>T p.Cys404= rs4672457 
IVS3 c.1583+705G>A none rs17513666 
IVS3/E3** c.1583+797G>A none/p.Leu555= rs6545910 
    
 
*Numbering relative to entry NM_032180. 
**Depending on the isoform, this variant is either localized in intron 3 or in exon 3a (p.Leu555). 
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I.4	  PAPER	  	  
FAM161A, ASSOCIATED WITH RETINITIS PIGMENTOSA, IS A COMPONENT OF 
THE CILIA-BASAL BODY COMPLEX AND INTERACTS WITH PROTEINS INVOLVED 
IN CILIOPATHIES. 	  
Silvio	   Alessandro	   Di	   Gioia1,	   Stef	   J.F	   Letteboer3,	   Corinne	   Kostic2,	   Dikla	   Bandah-­‐
Rozenfeld4,	   Lissette	   Hetterschijt3,	   Dror	   Sharon4,	   Yvan	   Arsenijevic2,	   Ronald	  
Roepman3,	  and	  Carlo	  Rivolta1.	  	  
1Department	   of	  Medical	   Genetics,	   University	   of	   Lausanne,	   Lausanne,	   Switzerland,	   2	   Unit	   of	   Gene	  Therapy	  and	   Stem	   Cell	   Biology,	   Jules-­‐Gonin	   Eye	   Hospital,	   University	   of	   Lausanne,	   Lausanne,	   Switzerland,	   3	  Department	   of	   Human	   Genetics	   and	   Nijmegen	   Centre	   for	   Molecular	   Life	   Sciences,	   Radboud	   University	  Nijmegen	   Medical	   Centre,	   Nijmegen,	   The	   Netherlands	   and	   4	   Department	   of	   Ophthalmology,	   Hadassah-­‐Hebrew	  University	  Medical	  Center,	  Jerusalem,	  Israel	  
Abstract	  Retinitis	   pigmentosa	   (RP)	   is	   a	  retinal	  degenerative	  disease	  characterized	   by	   the	   progressive	   loss	   of	  photoreceptors.	  We	   have	   previously	   demonstrated	   that	   RP	   can	   be	   caused	   by	   recessive	  mutations	   in	   the	  human	  FAM161A	  gene,	  encoding	  a	  protein	  with	  unknown	  function	  that	  contains	  a	  conserved	  region	  shared	  only	  with	   a	   distant	   paralog,	   FAM161B.	   In	   this	   study,	  we	   show	   that	   FAM161A	   localizes	   at	   the	   base	   of	   the	  photoreceptor	   connecting	   cilium	   in	   human,	  mouse	   and	   rat.	   Furthermore,	   it	   is	   also	   present	   at	   the	   ciliary	  basal	  body	  in	  ciliated	  mammalian	  cells,	  both	  in	  native	  conditions	  and	  upon	  the	  expression	  of	  recombinant	  tagged	  proteins.	  Yeast	  two-­‐hybrid	  analysis	  of	  binary	  interactions	  between	  FAM161A	  and	  an	  array	  of	  ciliary	  and	  ciliopathy-­‐associated	  proteins	  reveals	  direct	   interaction	  with	   lebercilin,	  CEP290,	  OFD1	  and	  SDCCAG8,	  all	  involved	  in	  hereditary	  retinal	  degeneration.	  These	  interactions	  are	  mediated	  by	  the	  C-­‐terminal	  moiety	  of	  FAM161A,	  as	  demonstrated	  by	  pull-­‐down	  experiments	   in	  cultured	  cell	   lines	  and	  in	  bovine	  retinal	  extracts.	  As	   other	   ciliary	   proteins,	   FAM161A	   can	   also	   interact	   with	   the	   microtubules	   and	   organize	   itself	   into	  microtubule-­‐dependent	   intracellular	   networks.	   Moreover,	   small	   interfering	   RNA-­‐mediated	   depletion	   of	  FAM161A	   transcripts	   in	   cultured	   cells	   causes	   the	   reduction	   in	   assembled	   primary	   cilia.	   Taken	   together,	  these	  data	  indicate	  that	  FAM161A-­‐associated	  RP	  can	  be	  considered	  as	  a	  novel	  retinal	  ciliopathy	  and	  that	  its	  molecular	  pathogenesis	  may	  be	  related	  to	  other	  ciliopathies.	  	  	  	  	  	  
In	   this	  paper	   I	  performed	   the	  majority	  of	   the	  experiments,	  with	   the	  only	  exception	  being	  
the	  FAM161A	  staining	   in	  human	  tissue,	  which	  was	  performed	  by	  Bandah-­‐Rozenfeld	   from	  
the	   Sharon	   group.	   I	   performed	   the	   yeast-­‐two-­‐hybrid	   experiments	   and	   some	  
immunostaining	  experiments	   in	  Nijmegen	  under	   the	   supervision	  of	  Ronald	  Roepman	  and	  
his	  team.	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Supplementary Table S1   List of tested pAD ciliopathy constructs used for the binary interaction assay  
0: no blue color after the colorimetric assay or no hybrid colony formed Abbreviations: amino acids (aa); fragments (fr); C2 domain of RPGR and RPGRIP1L (C2); RPGR interacting domain
1: faint blue signal or not well-formed colony (RID); Pleckstrin-like homology binding domain 1 (PH-B1); coiled coil (cc); N terminal (N-term); C terminal (C-term)
2: medium  blu signal and clearly-formed  colony FAM161A full construct (FAM-full); FAM161A-N-term construct (FAM-Nt); FAM161A-C-term (FAM-Ct)
3: strong blue signal and very well formed colony ɲŐĂů;ĂůƉŚĂŐĂůĂĐƚŽƐŝĚĂƐĞĂƐƐĂǇͿ͖ɴŐĂů;ďĞƚĂŐĂůĂĐƚŽƐŝĚĂƐĞĂƐƐĂǇͿ
Protein Gene symbol Entrez ID &DͲĨƵůůɲŐĂů &DͲĨƵůůɴŐĂů &DͲEƚɲŐĂů &DͲEƚɴŐĂů &DͲƚɲŐĂů &DͲƚɴŐĂů
1 MAEA 10296 0 0 0 0 0 0
2 C20orf11  54994 0 0 0 0 0 0
3 YPEL5  51646 0 0 0 0 0 0
4 MKLN1 4289 0 0 0 0 0 0
5 SMU1 55234 0 0 0 0 0 0
6 RANBP10  57610 1 0 0 0 2 2
7 RMND5B  64777 0 0 0 0 0 0
8 RMND5A 64795 0 0 0 0 0 0
9 MAPRE1 22919 0 0 0 0 0 0
10 EPS8 aa 551-822 2059 0 0 0 0 0 0
EPS8 aa 551-616 0 0 0 0 0 0
EPS8 aa 182-248 0 0 0 0 0 0
EPS8 aa 1-211 0 0 0 0 0 0
EPS8 L329P 0 0 0 0 0 0
EPS8 1 1 0 0 0 0
11 ESPN 83715 1 1 0 0 0 0
12 IFT20 90410 1 2 0 0 0 0
13 IFT27 11020 0 0 0 0 0 0
14 IFT52 51098 0 0 0 0 0 0
15 TRAF3IP1 26146 0 0 0 0 0 0
16 IFT57 55081 0 0 0 0 0 0
17 IFT74 80173 0 0 0 0 1 0
18 IFT81 28981 0 0 0 0 0 0
19 IFT88 8100 2 2 0 0 0 0
20 TTC30A 92104 0 0 0 0 0 0
21 IFT140 9742 0 0 0 0 0 0
22 WDR19 57728 0 0 0 0 0 0
23 IFT43 112752 0 0 0 0 0 0
24 NPHP4 fr1 aa 484-784 261734 0 0 0 0 0 0
NPHP4 fr2 aa 484-981 0 0 0 0 0 0
NPHP4 fr3 aa 683-784 0 0 0 0 0 0
NPHP4 fr4 aa 683-981 0 0 0 0 0 0
NPHP4 fr5 aa 591-960 0 0 0 0 0 0
NPHP4 fr6 aa 591-1093 0 0 0 0 0 0
NPHP4 fr7 aa 961-1340 0 0 0 0 0 0
NPHP4 fr8 aa 411-590 0 0 0 0 0 0
NPHP4 fr9 aa 41-683 0 0 0 0 0 0
NPHP4 0 0 0 0 0 0
25 BBS5 fr1 aa 2-150 129880 0 0 0 0 0 0
BBS5 fr2 aa 111-194 0 0 0 0 0 0
BBS5 fr3 aa 151-341 0 0 0 0 0 0
BBS5 PH-B2 aa 124-341 0 0 0 0 0 0
BBS5 0 0 0 0 0 0
26 SDCCAG8 10806 2 2 0 0 0 1
SDCCAG8 fr 1 aa 2-294 3 3 0 0 3 3
SDCCAG8 fr 2 aa 286-541 0 0 0 0 0 0
SDCCAG8 fr 3 aa 533-713 0 0 0 0 0 0
27 C8orf37 157657 0 0 0 0 0 0
28 RPGRIP1 57096 0 0 0 0 0 0
RPGRIP1 C2 short aa 397-551 0 0 0 0 0 0
RPGRIP1 C2 long aa 204-551 0 0 0 0 0 0
RPGRIP1 C2-end aa 584-1259 0 0 0 0 0 0
29 RPGRIP1L C2 C-term+C2 N-term aa 509-914 23322 0 0 0 0 0 0
RPGRIP1L C2 end aa 591-1235 0 0 0 0 0 0
RPGRIP1L RID aa 897-1235 0 0 0 0 0 0
30 CC2D2A 57545 0 0 0 0 0 0
CC2D2A  cc aa 433-637 0 0 0 0 0 0
CC2D2A C2 aa 992-1177 0 0 0 0 0 0
CC2D2A N-term aa 1-446 0 0 0 0 0 0
CC2D2A C2-end aa 992-1561 0 0 0 0 0 0
31 CRB1 human 23418 0 0 0 0 0 0
CRB1 bovine 520406 0 0 0 0 0 0
32 IFT88 N-term aa 1-449 1800 0 0 0 0 0 0
IFT88 C-term aa 442-833 0 0 0 0 0 0
33 WDR35 57539 0 0 0 0 0 0
34 OFD1 328 aa 240-1012 8481 2 2 0 0 1 1
OFD1 369 aa 356-1012 2 2 0 0 2 2
35 LCA5L fr1 aa 2-376 150082 0 0 0 0 0 0
LCA5L fr2 aa 371-670 0 0 0 0 0 0
LCA5L 0 0 0 0 0 0
36 RPGR 6103 0 0 0 0 0 0
RPGR N-term aa 1-401 0 0 0 0 0 0
RPGR C-term aa 404-815 0 0 0 0 0 0
37 NEK4 fr1 aa 2-300 6787 0 0 0 0 0 0
NEK4 fr2 aa 293-566 0 0 0 0 0 0
NEK4 fr3 aa 560-841 0 0 0 0 0 0
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NEK4 0 0 0 0 0 0
38 CEP290 cc4+5+6 aa 703-1130 80184 3 3 0 0 3 3
39 NEK8 284086 0 0 0 0 0 0
40 USH2A 7399 0 0 0 0 0 0
41 GPR98 84059 0 0 0 0 0 0
42 DFNB31 25861 0 0 0 0 0 0
43 USH1C 10083 0 0 0 0 0 0
44 LCA5 167691 1 0 0 0 0 0
LCA5 fr1 aa 1-95 0 0 0 0 0 0
LCA5 fr2 aa 96-305 2 3 0 0 3 3
LCA5 fr3 aa 306-490 0 0 0 0 0 0
LCA5 fr5 aa 1-305 2 3 0 0 2 2
LCA5 fr6 aa 306-697 0 0 0 0 0 0
45 USG1G 124590 1 0 0 0 0 0
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Figure S3. The interacƟon between FAM161A and lebercilin/LCA5 is driven by the C-terminal 
domain of FAM161A. The construct expressing the N-terminal (upper panels - N-term) moiety of 
FLAG-FAM161A (red) localizes in the cytoplasm, whereas HA-LCA5 is present at the level of the 
microtubule network. Conversely, the C-terminal (boƩom panels – C-term) part of FLAG-FAM161A 
(red) decorates microtubules and partly overlaps with HA-LCA5 (green). Scale bars: 10 µm. 
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I.5	  ADDENDUM	  	  	  YEAST-­‐2-­‐HYBRID	  SCREENING	  OF	  HUMAN	  AND	  BOVINE	  RETINAL	  LIBRARIES	  AND	  TANDEM	  AFFINITY	  PURIFICATION	  ANALISYS	  TO	  IDENTIFY	  FAM161A	  SPECIFIC	  INTERACTORS	  	  	  
Silvio	   Alessandro	   Di	   Gioia1,	   Stef	   J.F	   Letteboer2,	   Lisette	   Hetterschijt2,	   Sylvia	   van	  
Beersum2	  ,	  Jeroen	  van	  Reeuwijk2,	  Ronald	  Roepman3,	  and	  Carlo	  Rivolta1.	  	  	  
1Department	  of	  Medical	  Genetics,	  University	  of	  Lausanne,	  Lausanne,	  Switzerland,	   2	  Department	  of	  Human	  Genetics	   and	  Nijmegen	  Centre	   for	  Molecular	   Life	   Sciences,	   Radboud	  University	  Nijmegen	  Medical	   Centre,	  Nijmegen,	  The	  Netherlands.	  	  
Abstract	  
FAM161A	   is	   a	   new	   ciliary	   protein	   involved	   in	   retinitis	   pigmentosa.	   The	   role	   of	   this	   protein	   in	   the	   ciliary	  compartment	  is	  still	  not	  well	  characterized.	  To	  better	  elucidate	  the	  function	  of	  this	  gene	  we	  performed	  two	  different	   high-­‐throughput	   screening	   techniques;	   yeast	   two-­‐hybrid	   screening	   of	   human	   and	   bovine	   retina	  cDNA	   library	   and	   tandem	   affinity	   purification	   analysis	   from	   cell	   extracts	   overexpressing	   FAM161A.	   We	  obtained	   several	   positive	   hits	   using	   these	   two	   techniques	   with	   enrichment	   of	   proteins	   from	   basal	  body/centrosome	  and	  transport	  proteins.	  The	  identification	  of	  several	  proteins	  involved	  in	  intracellular	  and	  ciliary	  trafficking	  as	  interactors	  of	  FAM161A	  could	  suggest	  a	  possible	  role	  of	  this	  protein	  in	  the	  molecular	  transport	   either	   to	   or	   on	   the	   cilium	   and	   therefore	   clarify	   the	   possible	   pathogenic	   mechanism	   linked	   to	  mutation	   in	   this	  gene.	  Confirmation	  of	   these	  results	  using	  biochemical	  analysis	   is	  necessary	   to	  reduce	  the	  false	  positive	  rate	  that	  is	  often	  observed	  for	  these	  techniques.	  
	  	  	  	  	  	  
I	  performed	  this	  work	  mainly	  in	  Nijmegen	  under	  the	  supervision	  of	  Ronal	  Roepman	  and	  his	  
team.	  These	  data	  are	  not	  published.	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  INTRODUCTION	  Retinal	  degenerations	  are	  one	  of	  the	  main	  symptoms	  of	  ciliopathies.	  These	  are	  a	  class	   of	   diseases	   in	   which	   the	   functionality	   of	   the	   cilium,	   an	   important	   organelle	   of	  mammalian	   cells,	   is	   disturbed	   causing	   an	   impairment	   in	   cellular	   trafficking	   or	  development	   [109].	   Interestingly	  several	  papers	  demonstrated	   that	  proteins	   for	  which	  the	  gene	  is	  mutated	  in	  ciliopathies	  often	  interact	  together,	  forming	  molecular	  networks	  that	   also	   interconnect	   different	   classes	   of	   ciliopathies	   [67,	   89,	   110-­‐112].	  We	   recently	  identified	  FAM161A,	  a	  gene	  mutated	  in	  an	  autosomal	  recessive	  retinitis	  pigmentosa,	  as	  a	  new	   ciliary	   gene,	   based	   on	   localization	   studies	   as	   well	   as	   some	   functional	   evidence	  [113].	   In	   line	   with	   our	   findings,	   a	   different	   group	   confirmed	   this	   ciliary	   localization.	  Furthermore,	   they	   investigated	   the	   microtubule	   binding	   activity	   and	   interaction	   of	  FAM161A	  with	   its	  mammalian	  paralog	  FAM161B	   [114]	   and	   they	   suggested	   a	  possible	  role	  of	   this	   family	   in	  microtubule	  network	  stabilization.	  Based	  on	   these	  researches	  we	  used	   two	   different	   high-­‐throughput	   screening	   techniques,	   yeast-­‐2-­‐hybrid	   (Y2H)	   of	  human	   and	   bovine	   retina	   library	   and	   tandem	   affinity	   purification	   (TAP)	   associated	   to	  mass	   spectrometry,	   to	   investigate	   “neighbors”	   of	   FAM161A,	   in	   order	   to	   elucidate	   the	  function	  of	  FAM161A	  itself.	  These	  techniques	  have	  previously	  been	  extensively	  used	  to	  investigate	  the	  interactome	  of	  diverse	  ciliary	  proteins	  [85,	  88,	  111,	  115,	  116].	  	  METHODS	  
DNA	  constructs.	  All	   DNA	   constructs	   and	   plasmids	   for	   FAM161A	   were	   generated	   using	   the	  gateway	   system	   from	   Invitrogen	   (Life	   technology,	   USA),	   using	   the	   plasmid	   described	  previously	   as	   a	   donor	   [113].	   Destination	   plasmids	   for	   Y2H	   assay	  were	   also	   described	  previously	   [113].	   For	   the	  N-­‐terminal	   TAP	   experiment	  we	   cloned	   in	   a	   TAP	   destination	  vector	  presenting	  a	  Steptavidin/FLAG	  (SF)	  at	  the	  N-­‐terminal	  of	  the	  protein.	  
Cell	  culture	  and	  transfection.	  HEK293T	  (human	  embryonic	  kidney)	  cells	  were	  grown	  under	  normal	  conditions	  using	  DMEM	  medium	  with	   Glutamax	   from	   Sigma-­‐Aldrich	   (Switzerland)	   supplemented	  with	  bovine	   serum	  (10%)	  and	  antibiotics.	  The	   transfection	  of	   the	  SF-­‐N-­‐TAP-­‐FAM161A	  was	   obtained	   using	   Effectene	   transfecting	   reagent	   from	   Qiagen	   (Venlo,	   The	  Netherlands).	  Cells	  were	  collected	  48	  hours	  after	  transfection.	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Tandem	  affinity	  purification	  HEK293T	  cells	  were	  transfected	  with	  SF-­‐N-­‐TAP-­‐FAM161A	  and	  harvested	  for	  20	  min	  at	  4°C	  in	  a	  lysis	  buffer	  [30	  mM	  Tris-­‐HCl	  (pH	  7.4),	  150	  mM	  NaCl,	  0.5%	  Nonidet-­‐P40]	  with	   the	   addition	   of	   protease	   inhibitor	   cocktails	   and	   phosphatase	   inhibitor	   cocktail	   1	  and	   2	   (from	   Roche	   Diagnostic,	  Manheim,	   Germany).	   Debris	  were	   pelleted	  with	   10K	   g	  centrifugation	  and	  the	  supernatant	  incubated	  for	  2	  h	  at	  4°C	  with	  Strep-­‐Tactin	  superflow	  (IBA,	  Göttingen,	  Germany).	  After	  3	  washes	  with	  wash	  buffer	  [30	  mM	  Tris	  HCl	  (pH	  7.4),	  150	  mM	  NaCl,	  0.1%	  Nonidet-­‐NP40	  supplemented	  with	  phosphatase	  inhibitors],	  protein	  complexes	  were	  eluted	  with	  2mM	  desthiobiotin	   (IBA)	   in	  Tris–Phosphate	  buffer	   (TBS).	  The	  second	  purification,	  that	  is	  the	  specific	  step	  of	  TAP,	  was	  performed	  using	  anti	  FLAG-­‐M2	  agarose	  (purchased	  from	  Sigma-­‐Aldrich)	  by	   incubating	  them	  with	  the	  eluate	  of	  the	  first	   purification	   for	  2	  h	   at	   4°C.	  After	  3	  washes	  with	  wash	  buffer,	   the	   complexes	  were	  eluted	  with	  FLAG	  peptide	  (200	  μg/ml,	  Sigma-­‐Aldrich)	   in	  TBS.	  A	  part	  of	   the	  eluate	  was	  then	   run	   on	   SDS-­‐PAGE	   gel	   to	   separate	   the	   different	   bands.	   The	   gel	   was	   then	   stained	  using	   silver	   staining	   according	   to	   classical	   protocols.	   The	   remaining	   sample	  was	   then	  precipitated	  with	  chloroform	  and	  methanol	  and	  stored	  at	  -­‐80°C	  
Mass	  spectrometry	  For	   the	   LC-­‐MS/MS	   analysis,	   protein	   precipitates	   were	   subjected	   to	   tryptic	  proteolysis	  [117]	  and	  then	  loaded	  in	  the	  UltiMate	  3000	  nano	  HPLC	  system.	  The	  elution	  was	   obtained	   by	   an	   acetronitrile	   gradient.	   The	   eluate	   was	   then	   analyzed	   by	   mass	  spectrometry	   with	   LTQ	   Orbitrap	   XL	   (Thermo	   Fisher	   Scientific,	   Waltham,	   USA).	   The	  spectra	  obtained	  from	  this	  test	  were	  extracted	  using	  Bioworks	  browser	  (Thermo	  Fisher	  Scientific).	   The	   software	   output	   was	   then	   analyzed	   using	   Sequest	   (vers	   SRF	   v.5,	  ThermoFinningan,	   San	   Jose,	   CA).	   The	   setup	   for	   this	   experiment	   was	   the	   following:	  search	   in	  Uniref100	  database;	   trypsin	  digestion;	   fragment	   ion	  mass	   tolerance	  of	  1	  Da;	  parent	   ion	   tolerance	   1	   PPM.	   Results	   were	   then	   loaded	   in	   Scaffold	   (vers.	   2.02.01,	  Proteome	   Software	   Inc.,	   Portland,	   OR)	   for	   validation	   purposes.	   Criteria	   for	  exclusion/inclusion	  of	  identified	  peptides	  were	  based	  on	  previous	  publications	  [118]	  
	  
Yeast	  two-­‐hybrid	  For	   Y2H	   analysis	   we	   used	   a	   GAL4-­‐based	   assay	   HybriZAP	   from	   Stratagene	   (La	  Jolla,	   CA,	   USA).	   Full-­‐length	   FAM161A	   and	   partial	   constructs	   corresponding	   to	   N-­‐term	  and	  to	  C-­‐term	  of	  FAM161A	  were	  fused	  to	  a	  DNA-­‐binding	  domain	  (GAL4-­‐BD)	  and	  used	  as	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a	   bait	   to	   screen	   human	   and	   bovine	   retinal	   cDNA	   library,	   retro-­‐transcribed	   by	   fresh	  tissue	   extracted	   RNA	   using	   oligo-­‐dT	   primers.	   Both	   bait	   and	   prey	   were	   cloned	   in	   the	  yeast	   strain	   Pj69-­‐4A,	   carrying	   the	   HIS3	   (histidine),	   ADE2	   (adenine),	   MEL1	   (α-­‐galactosidase)	  and	  LacZ	  (β-­‐galactosidase)	  reporter	  genes.	  Interactions	  were	  assessed	  by	  the	   activation	   of	   reporter	   genes,	   such	   as	   the	   ability	   to	   grow	   in	   a	   selective	   media	  (histidine	   and	   adenine	   deprived	   media),	   and	   colorimetric	   assays	   (α-­‐galactoside	   “on	  plate”	  assay	  and	  β-­‐galactoside	  filter	  lift	  assay)	  [119].	  A	  tip	  was	  used	  to	  collect	  traces	  of	  the	  colony	  and	  a	  colony	  PCR	  was	  performed	  using	  primers	  specific	  for	  the	  prey	  plasmid.	  PCR	   product	   was	   then	   purified	   by	   Millipore	   PCRclean	   membrane	   applying	   necessary	  vacuum,	   and	   then	   sequenced	   using	   BigDye	   terminator	   reagent	   v1.1	   (Applied	  Biosystems).	  Capillary	  electrophoresis	  was	  performed	  using	  ABI	  3130XL	   from	  Applied	  Biosystems,	  and	  electropherograms	  were	  analyzed	  using	  CLC	  Bio	  workbench	  v.5.0.	  The	  corresponding	  protein	  was	  identified	  by	  blast	  screening.	  	  
Bioinformatic	  analysis	  Gene	   ontology	   (GO)	   annotations	   were	   performed	   by	   using	   Database	   for	  Annotation,	   Visualization	   and	   Integrated	   Discovery	   (DAVID)	   web	   interface	   from	  National	   Institute	   of	   Allergy	   and	   infectious	   Disease,	   NIH	   (www.david.abcc.ncifcrf.gov)	  [120].	   The	   gene	   interaction	   network	  was	   generated	   using	   GENEMANIA	  web	   interface	  from	   the	   university	   of	   Toronto	   (www.genemania.org).	   Statistical	   analysis	   was	  performed	  using	  the	  Keisan	  on-­‐line	  calculator	  (http://keisan.casio.com)	  RESULTS	  
TAP	   analysis	   reveals	   enrichment	   in	   ribosomal	   protein,	   with	   a	   small	   portion	   of	  
cytoskeletal-­‐associated	  proteins.	  We	  performed	   the	  TAP	  analysis	   using	  FAM161A	   conjugate	   to	   a	  N-­‐term	  SF	   tag.	  The	   efficiency	   of	   transfection	   was	   tested	   by	   SDS-­‐PAGE,	   which	   confirmed	   the	   correct	  expression	   of	   the	   recombinant	   FAM161A	   in	   HEK293T	   cells	   (not	   shown).	   Peptides	  obtained	  by	  this	  analysis	  were	  reported	  with	  associated	  function	  and	  Entrez	  ID	  (Table	  1).	  A	  gene	  ontology	  analysis	  of	   the	  positive	  hits	   revealed	  an	  enrichment	  of	   translation	  proteins	   (64.2%	   of	   the	   total	   unique	   peptides),	   especially	   ribosomal	   proteins,	   both	  cellular	   and	   mitochondrial	   ones,	   and	   other	   proteins	   with	   diverse	   functions.	   Network	  interaction	   analysis	   revealed	   how	   the	   majority	   of	   these	   positive	   hits	   were	   grouped	  together	   in	  the	  center	  of	   the	  network,	  whereas	  a	   few	  outliers	  were	   identified	  and	  they	  were	   not	   linked	   with	   any	   other	   protein	   in	   the	   network	   (Fig.	   1).	   These	   outliers	   were	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DCAF8,	  EML6,	  POC1A,	  CEP78,	  ASPM,	  and,	  connected	  to	  the	  network	  but	  located	  far	  from	  the	  main	  group,	  LRRK2,	  MYO5A	  and	  MYO5C.	   Interestingly,	  a	  gene	  ontology	  analysis	  of	  these	   outliers	   revealed	   an	   enrichment	   of	   proteins	   involved	   in	   cytoskeleton	   or	  microtubule	  organization	  (Fig.	  2	  and	  Table	  2).	  	  
Yeast	   two-­‐hybrid	   screening	   analysis	   identifies	   several	   interactors	   of	   FAM161A	  
involved	   in	   protein	   transport	   along	   the	  microtubule	   network	   and	   proteins	   that	  
localize	  at	  the	  level	  of	  the	  cilium	  or	  basal	  body.	  	  We	   performed	   Y2H	   screening	   using	   all	   previously	   generated	   BD-­‐FAM161A	  constructs	  (FAM161A,	  FAM161A-­‐N-­‐term	  and	  FAM161A-­‐C-­‐term)	  to	  investigate	  a	  human	  retina	   and	   bovine	   cDNA	   library.	   Interestingly	   the	   screening	   of	   human	   retina	   using	   N-­‐term	  construct	  of	  FAM161A	  revealed	  a	  very	   low	  number	  of	  positive	  colonies	   (13)	  and	  many	  of	  them	  did	  not	  pass	  the	  colorimetric	  assay	  (Fig.	  3).	  Among	  the	  positive	  ones,	  not	  all	  passed	  the	  PCR	  screening,	  probably	  resulting	  in	  false	  positive	  results.	  For	  this	  reason,	  the	   N-­‐terminal	   bait	   was	   not	   used	   for	   the	   bovine	   retina	   library	   screening.	   Conversely,	  several	  positive	   colonies	  were	  obtained	  using	  an	  entire	  FAM161A	  construct	  or	  C-­‐term	  FAM161A	   (more	   than	   200	   blue	   colonies	   per	   plates,	   with	   more	   colonies	   for	   full	   form	  compared	  to	  the	  C-­‐term	  construct).	  Due	  to	  a	  technical	  limitation,	  notably	  with	  problems	  in	  the	  quality	  of	   the	  PCR	  sequences,	  not	  all	  colonies	  were	  successfully	  screened	  with	  a	  higher	   success	   rate	   for	   the	   bovine	   retina	   screening	   (Table	   3).	   Positive	   clones	   were	  sequenced	  with	   results	   listed	   here	   (Table	   4).	   All	   the	   listed	   genes	  were	   positive	   in	   the	  colorimetric	  assays.	  Among	  these	  genes	  more	  than	  40%	  were	  also	  present	  in	  the	  ciliary	  proteome	   database	   [121].	   This	   over-­‐representation	   of	   ciliary	   genes	   is	   statistically	  significant	   [cumulative	   hypergeometic	   probabability:	   6.3	   x	   10-­‐6	   considering	   the	   total	  number	   of	   proteins	   listed	   in	   Swissprot	   entry	   mapped	   to	   an	   Entrez	   gene	   identifier	  (18523)	   and	   all	   proteins	   present	   in	   ciliary	   database–see	   table	   3].	   GO	   analysis	   for	   the	  cellular	  component	  of	  the	  identified	  genes	  showed	  an	  enrichment	  of	  proteins	  present	  in	  the	  microtubule	   cytoskeleton,	   centrosome	   and	   cilium,	  with	   significative	   p-­‐values	   (Fig.	  4a).	  Additionally,	  GO	  analysis	  for	  molecular	  function	  indicated	  a	  possible	  role	  in	  motor	  activity	   or	   structural	   molecule	   activity	   (Fig	   4b).	   Network	   analysis	   of	   the	   interactions	  showed	  a	   clear	   interconnection	  between	  many	  of	   the	   identified	  members	   as	  well	   as	   a	  few	  of	   the	   outliers.	   The	   lacking	   of	   functional	   information	   in	   the	   literature	   for	   some	  of	  these	   interactors	  could	  explain	   their	   location	  outside	   the	  main	  network	  (Fig.	  4).	  Three	  branches	  of	  genes	  were	  not	  connected	  to	  the	  main	  nodes.	  These	  isolated	  small	  branches	  were	   composed	   of	   different	   couples	   of	   genes:	   PLEKHM3	   and	   MPRIP;	   GAS8	   and	  MAPK8IP1;	  CCDC155	  and	  C15orf26;	  NIN	  and	  RAB11FIP3.	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DISCUSSION	  We	  recently	  demonstrated	  that	  FAM161A	  is	  a	  new	  ciliary	  gene	  by	  showing	  the	  interaction	  with	  other	  ciliopathy-­‐associated	  proteins.	  In	  the	  previous	  paper	  we	  already	  performed	  a	  binary	  interaction	  assay	  in	  yeast,	  although	  it	  was	  a	  direct	  assay	  in	  which	  we	  tested	   our	   baits	   with	   yeasts	   expressing	   a	   specific	   prey	   corresponding	   to	   one	   of	   the	  already	   known	   ciliary	   proteins.	   This	   technique,	   even	   if	   it	   is	   a	   powerful	   method	   to	  identify	   transients	   or	   weak	   interactions,	   does	   not	   allow	   the	   investigation	   of	   the	   total	  proteome	   of	   the	   cell.	   We	   therefore	   decided	   to	   perform	   two	   more	   comprehensive	  proteomic	  techniques	  to	  investigate	  the	  function	  of	  FAM161A.	  	  The	   first	   technique	  was	   TAP	   analysis.	  With	   this	   system	  we	   overexpressed	   our	  protein	  of	  interest	  in	  standard	  laboratory	  cell	  lines	  and	  isolated	  all	  the	  interactors	  by	  a	  simple	  immunoprecipitation.	  Here,	   in	  contrast	  to	  Y2H	  screening	  in	  which	  direct	  binary	  interactions	  are	  tested,	  large	  molecular	  complexes	  can	  be	  immunoprecipitated,	  allowing	  the	   identification	   of	   non-­‐direct	   interactions.	   This	   technique	   uses	   two	   consecutive	  purification	   steps	  with	   two	  different	   tags	   in	  order	   to	  obtain	   cleaner	   results	   and	   fewer	  proteins	   attached	   to	   the	   complexes,	   so	   they	   can	   easily	   be	   identified	   by	   mass	  spectrometry	  [122].	  TAP	  is	  very	  efficient,	  although	  it	  can	  be	  somewhat	  biased;	  firstly,	  by	  using	   the	   overexpression	  machinery,	   the	   expression	   rate	   of	   the	   protein	   is	   far	   greater	  than	   that	   normally	   observed,	   which	   can	   lead	   to	   mislocalization	   results	   in	   the	  immunoprecipitate.	  Secondly,	  many	  false	  positive	  results	  are	  connected	  to	  the	  stickiness	  of	  the	  TAG	  or	  of	  the	  expressed	  protein,	  which	  could	  lead	  to	  the	  formation	  of	  complexes	  with	  endogenous	  proteins	  that	  are	  much	  more	  abundant	  in	  cells	  compare	  to	  our	  specific	  proteins	  of	  interest.	  Thirdly,	  this	  system	  is	  inefficient	  for	  testing	  transient	  interactions.	  	  In	  our	  experiments	  we	  observed	  an	  enrichment	  of	  ribosomal	  proteins.	  Although	  some	  of	  these	  were	  also	  identified	  in	  other	  ciliary	  proteomic	  studies	  [123],	  this	  result	  is	  unexpected	  and	  does	  not	  agree	  with	  previously	  observed	  experimental	  data.	  A	  possible	  explanation	   for	   this	   is	   that	   ribosomal	   complexes	   necessary	   for	   the	   translation	   of	   the	  protein	  remained	  attached	  to	  the	  growing	  protein	  and	  they	  were	  immunoprecipitated	  as	  complex.	  Even	  though	  we	  cannot	  exclude	  that	  these	  interactions	  are	  real,	  the	  possibility	  that	   they	   were	   due	   to	   a	   technical	   issue	   is	   quite	   large.	   Another	   analysis,	   using	   a	   C-­‐terminal	   TAG,	   could	   help	   to	   clarify	   this	   point.	   Nonetheless,	   with	   the	   exception	   of	  ribosomal	   complexes,	   only	   a	   few	  hits	  were	   completely	  outside	   the	   large	  network	  map	  and	  these	  seemed	  to	  be	  the	  most	  interesting	  for	  further	  investigation.	  They	  were	  mostly	  associated	  to	  microtubule	  binding	  and	  centrosome/basal	  body	  activity,	   reinforcing	   the	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previously	  observed	  data	  on	  FAM161A	  function.	  For	  example	  POC1A,	  a	  gene	  important	  for	   centriole	   and	   basal	   body	   structure	   [124],	   has	   been	   recently	   associated	   to	   a	   new	  ciliopathy,	  with	  dwarfism	  as	  a	  main	  symptom	  [125].	  A	  confirmation	  of	  these	  data	  with	  further	  biochemical	  studies	  is	  required	  to	  finally	  elucidate	  the	  function	  of	  FAM161A.	  	   The	  second	  technique	  we	  performed	  was	  the	  Y2H	  screening.	  With	  this	  system	  it	  is	  possible	  to	  identified	  direct	  binary	  interactions	  between	  two	  proteins.	  The	  strength	  of	  this	  technique	  is	  to	  use	  a	  specific	  library	  of	  cDNA	  from	  the	  tissue	  of	  interest;	  in	  our	  case	  we	   used	   the	   retina	   extracted	   from	  bovine	   and	   from	  human.	   For	   the	   analysis	  we	   used	  previously	   generated	   constructs	   as	   baits.	   Interestingly	   no	   positive	   colonies	   were	  obtained	   using	   the	  N-­‐terminal	   portion	   of	   FAM161A,	   confirming	   the	   importance	   of	   the	  UPF0564	   domain	   for	   interactions.	   Results	   obtained	   from	   this	   analysis	   revealed	   an	  enrichment	   of	   proteins	   for	   the	   cytoskeleton	   network	   or	   in	   the	   cilia	   basal	   body.	   In	  addition	   to	   this	  we	   saw	  a	   statistically	   significant	  3	   fold	   enrichment	  of	   ciliary	  proteins,	  based	   on	   data	   extracted	   from	   the	   ciliary	   proteomic	   database,	   relative	   to	   the	   entire	  proteome.	   These	   data	   confirmed	   the	   observation	   that	   FAM161A	   is	   a	   ciliary	   protein.	  Furthermore,	  a	  gene	  ontology	  analysis	   revealed	   that	  a	  significant	  number	  of	   identified	  hits	   correspond	   to	   proteins	   involved	   in	  molecular	   transport	   through	   the	  microtubule	  network.	  These	  results	  could	  shed	  new	  light	  on	  the	  function	  of	  FAM161A.	  In	  fact	  due	  to	  the	   large	  number	  of	   interactions	  already	  observed	  with	  proteins	  present	   in	  a	  different	  compartment	  of	  photoreceptor	  cilium	  it	  is	  possible	  to	  suppose	  that	  FAM161A	  has	  a	  role	  in	  intraflagellar	  transport	  (IFT)	  or	  vesicle	  transport.	  In	  addition,	  the	  overall	  picture	  from	  the	  interaction	  network	  generated	  from	  Y2H	  positive	  hits,	  showed	  an	  unexpectedly	  high	  degree	  of	  interconnections	  among	  the	  observed	  hits.	  Several,	  if	  not	  all,	  of	  the	  identified	  FAM161A	  interactors	  localize	  to	  the	  connecting	  cilium,	  or	  at	  centrosomes	  in	  non-­‐ciliated	  cells.	  Biochemical	  studies,	  as	  well	  as	  in	  vivo	  studies	  on	  mouse	  models	  for	  some	  of	  these	  genes,	   could	   help	   to	   clarify	   the	   real	   nature	   of	   these	   interactions.	   Another	   interesting	  interactor	   identified	   here	   is	  KIF3C.	   It	   is	   the	   third	   important	  member	   of	   the	   Kinesin-­‐II	  complex	   involved	   in	   ciliogenesis.	  Although	   its	   role	   in	  mouse	  photoreceptor	   cilia	   is	  not	  clear,	   since	   a	   complete	   KO	  mouse	   showed	   a	   perfectly	   healthy	   phenotype[126],	   it	   has	  been	   demonstrated	   to	   interact	   with	   KIF3A	   for	   membrane	   vesicle	   transport	   [127].	  Moreover	  KIF3C	  was	  identified	  in	  several	  ciliary	  proteomes	  and	  a	  recent	  paper	  showed	  the	  importance	  of	  this	  protein	  for	  zebrafish	  ciliogenesis	  [128].	  Whereas	  a	  single	  KO	  fish	  for	  Kif3b	  or	  Kif3c	  seems	  not	   to	  show	  any	  defects	   in	  photoreceptor	  cilium,	  a	  double	  KO	  for	  both	  kinesin	  proteins	  displays	  complete	  loss	  of	  photoreceptor	  cilia	  [128].	  In	  addition	  in	  this	  work	  it	  was	  demonstrated	  the	  redundancy	  of	  kif3b	  and	  kif3c	  functions,	  since	  the	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recovery	  of	  only	  one	  of	  the	  proteins	  is	  enough	  to	  revert	  the	  phenotype.	  Interestingly	  it	  was	   also	   observed	   a	   different	   pattern	   of	   expression	   of	   kif	   proteins	   during	   cilium	  development.	  While	   kif3b	   is	  necessary	   for	   early	   stages	  of	   ciliogenesis,	   the	  presence	  of	  kif3b	  and	  kif3c	  is	  needed	  in	  adult	  stages,	  probably	  indicating	  a	  change	  of	  cargo	  loading	  in	   different	   stages	   of	   photoreceptor	   life.	   It	   is	   interesting	   to	   observe	   that	   FAM161A,	   a	  protein	   that	   is	  expressed	  mainly	  during	  at	   the	  adult	   stage,	   interacts	  with	  KIF3C	  which	  also	  has	  a	  role	  in	  adulthood.	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Table	  1.	  TAP	  analysis	  results.	  Here	  are	  reported	  only	  proteins	  already	  filtered	  for	  typical	  false	  positive	   results,	   found	   in	  TAP	   analysis	   using	   our	   internal	   database	   as	   control	   set.	   In	   green	   are	  enlighten	  all	  the	  genes	  found	  also	  in	  the	  ciliary	  proteome	  (ciliaproteome.org,	  v3).	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Figure	  2.	  GO	  enrichment	  of	  genes	  from	  table	  2.	  	  Enrichment	  analysis	  performed	  using	  DAVID	  bioinformatics	  software.	  It	  is	  shown	  enrichment	  for	  protein	  involved	  in	  cytoskeleton	  structure	  and	  microtubule	  associated	  proteins.	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Figure	  3.	  Colorimetric	  assay	  for	  N-­‐term	  FAM161A	  Y2H	  screening.	  In	  this	  diagram	  colonies	  obtained	  by	  Y2H	  screening	  of	  the	  human	  retina	  library	  using	  a	  FAM161A-­‐N-­‐term	   construct	   are	   shown.	   It	   is	   possible	   to	   appreciate	   that	   only	   a	   few	  colonies	  passed	  the	  colorimetric	  assay	  by	  α-­‐galactosidase	  reaction.	  	  
Figure	  4.	  GO	  enrichment	  analysis	  of	  Y2H	  positive	  hits.	  	  
a)	   Analysis	   of	   cellular	   component	   reveals	   an	   enrichment	   of	   cytoskeleton	   and	   centrosomal	  compartment.	  The	  numbers	  of	  genes	   indicated	  for	  each	  subcategory	  is	  reported,	  as	  well	   the	  P-­‐value	   by	   a	   EASE	   score	   using	   a	   modified	   Fisher	   test	   exact	   P-­‐value.	   b)	   Analysis	   with	  molecular	   function	   by	   gene	   ontology	   terms,	   revealed	   a	   possible	   function	   in	   microtubule	  motor	  activity.	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Table	   4.	   List	   of	   positive	   hits	   found	   by	   Y2H	   screening	   of	   human	   and	   bovine	   retina	   cDNA	  
library.	  Gene	  name,	  EntrezID,	  cellular	  localization	  and	  function	  based	  on	  Uniprot	  database	  is	  reported.	  A	  cross	   indicates	   in	   each	   column	   if	   the	   hit	  was	   found	   in	   human	   retina	   (Human	   column),	   bovine	  retina	  (Bovine	  column),	  and	  if	  it	  was	  obtained	  using	  BD-­‐FAM161A	  (Full)	  or	  FAM161A-­‐C-­‐term	  (C-­‐term)	  as	  bait.	  In	  green	  are	  the	  genes	  found	  to	  be	  present	  in	  the	  ciliary	  proteome.	  At	  the	  bottom	  the	  statistical	  calculation	  for	  the	  ciliary	  protein	  enrichment	  is	  displayed.	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Total	  protein	  in	  
Swissprot	  
database	  






Total	  hits	  in	  Y2H	  







18523	   2726	   52	   21	   2.6	   6.3	  x	  10-­‐6	  	  	  
	   86	  
	  	  
Figure	  5.	  Interaction	  network	  of	  Y2H	  positive	  hits.	  	  Purple	  lines	  indicate	  when	  two	  proteins	  are	   found	  together	   in	  co-­‐expression	  studies,	   light	  green	  when	  are	  found	  in	  the	  same	  pathway,	  yellow	  when	  they	  are	  sharing	  the	  same	  protein	  domains.	  Grey	  circles	  are	  the	  connecting	  genes	  not	  directly	  identified	  by	  this	  screening.	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I.6	  DISCUSSION	  AND	  PERSPECTIVES	  	  	  	   In	  this	  first	  part	  of	  the	  dissertation	  we	  demonstrate	  that	  non-­‐sense	  mutations	  in	  
FAM161A	   cause	   retinitis	   pigmentosa	   in	   humans,	   and	   we	   discovered	   that	   the	   protein	  encoded	  by	  this	  gene	  is	  a	  new	  ciliary	  protein,	  with	  a	  possible	  role	  in	  cellular	  and	  ciliary	  trafficking.	  	  	   FAM161A	   is	   a	   member,	   alongside	   FAM161B,	   of	   the	   FAM161	   family	   found	   in	  mammals.	  They	  share	  a	  specific	  and	  unique,	  large	  and	  uncharacterized	  domain	  at	  the	  C-­‐terminal	   of	   the	   protein,	   called	   UPF0564.	   Multiple	   alignments	   for	   this	   domain	   show	   a	  widespread	  conservation	  among	  different	  species	  and	  phyla,	  from	  complexes	  organism,	  to	  parasites,	  unicellular	  eukaryotes	  or	  prokaryotes,	  such	  as	  yeasts	  and	  simple	  bacterial	  cells	   or	   unicellular	   algae.	   Interestingly,	   a	   search	   for	   protein	   containing	   UPF0564	   in	  different	  species	  revealed	  that	  this	  is	  rarely	  present	  in	  association	  with	  other	  domains	  in	  these	   proteins,	   suggesting	   an	   unconventional	   specialization	   for	   this	   domain.	  Furthermore,	   it	  covers,	  on	  average,	  more	  than	  60%	  of	   the	  entire	  protein	  and,	  a	  search	  for	   the	   UPF0564	   domain	   across	   multiple	   species	   showed	   enrichment	   in	   cilia	   or	  flagellated	  organisms	  (among	  the	  kingdom	  Plantae,	  for	  example,	  it	  is	  only	  conserved	  in	  the	   flagellate	   algae	   Chlamydomonas,	   the	   model	   organism	   for	   IFT)	   confirming	   the	  possible	   role	   of	   this	   protein	   family	   in	   cilium	   or	   flagellum	   function.	   In	   our	   work	   we	  clearly	   show	   how	   the	   UPF0564	   domain	   is	   necessary	   for	   interactions	   with	   FAM161A	  partners	  and	   for	   linking	  with	   the	  microtubule	  network,	  demonstrating	   the	   importance	  of	  this	  domain	  in	  protein	  function.	  We	   identified	  mutations	   in	   FAM161A	  as	   the	   cause	   of	  RP28-­‐associated	   retinitis	  pigmentosa.	  The	  original	  RP28	  family	  had	  a	  homozygous	  p.Arg229X	  in	  exon	  3,	  whereas	  we	  identified	  p.Arg437X	  in	  a	  homozygous	  state	  in	  affected	  patients	  from	  three	  families	  from	  Germany.	  Although	  these	  families	  were	  unrelated	  and	  came	  from	  different	  regions,	  they	  presented	  the	  same	  haplotype	  in	  the	  FAM161A	  gene,	  suggesting	  a	  founder	  effect	  for	  this	  mutation.	  Relevant	  to	  our	  paper,	  a	  publication	  from	  the	  Sharon	  group	  in	  Israel	  [129]	  demonstrated	   that	   mutations	   in	   FAM161A	   is	   one	   of	   the	   most	   common	   causes	   for	  autosomal	   recessive	   retinal	   degeneration	   among	   patients	   from	   Israel	   and	   the	  Palestinian	  territories,	  with	  a	  frequency	  of	  almost	  12%	  among	  affected	  individuals.	  They	  identified	  several	  families	  with	  a	  frameshift	  mutation,	  p.Thr452SerfsX3,	  on	  exon	  3,	  and	  two	  other	  non-­‐sense	  variants	  specific	  for	  these	  populations,	  p.Arg523X	  and	  p.Arg596X,	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in	  exon	  3	  and	  5,	   respectively.	   Interestingly,	   these	  mutations	  were	   found	   in	  each	  of	   the	  three	  different	  ethnic	  groups	  from	  Israel	  and	  the	  Palestinian	  territories,	  demonstrating	  a	  relatively	   ancient	   origin	   of	   these	   mutations.	   We	   identified	   the	   same	   mutation,	  p.Thr452SerfsX3,	   in	   a	   homozygous	   state	   in	   two	   different	   patients	   of	   our	   cohort	   from	  United	   States.	   It	   is	   likely	   that	   these	   two	   patients	   had	   an	   Ashkenazy	   Jewish	   ancestry,	  demonstrating	   the	   founder	   effect	   of	   these	   changes.	   Interestingly,	   all	   the	   mutations	  reported	  so	   far	  are	   frameshift	  or	  non-­‐sense	   located	   in	   the	  middle	  of	   the	  gene.	   In	  silico	  analysis	  revealed	  that	  they	  should	  cause	  the	  complete	  knock-­‐out	  of	  the	  transcript,	  due	  to	  mRNA	  degradation	  induced	  by	  the	  Non-­‐sense	  mediated	  mRNA	  decay	  (NMD)	  machinery.	  We	  confirmed	  this	  hypothesis	  showing	  that	  by	  inhibiting	  NMD	  machinery	  with	  emetine	  or	   cycloexamide	   in	   lymphoblastoid	   cell	   lines	   derived	   from	   patients	   carrying	   the	  p.Thr452SerfsX3	  mutation	  we	   induced	   the	   recovery	   of	   the	  FAM161A	   transcript	   to	   the	  level	  of	  healthy	  controls	  (not	  shown).	  This	  demonstrated	  that	  this	  mutation	  generated	  a	  null	   allele,	   as	   with	   other	   similar	   mutations	   that	   induce	   a	   premature	   stop	   in	   the	  transcript.	  So,	  the	  complete	  depletion	  of	  FAM161A	  seems	  necessary	  to	  cause	  disease.	  In	   addition	   to	   the	   genetic	   study,	   we	   characterized	   the	   expression	   profile	   of	  
FAM161A.	  We	   found	   this	   gene	   to	  be	   expressed	   in	  different	   tissues	  both	   in	  human	  and	  mouse,	  although	   the	  highest	  expression	  was	  observed	   in	   the	  retina	  and	   the	   testis.	  The	  testis	  expresses	  more	  than	  70%	  of	  all	  human	  transcripts	  at	  a	  high	  level	  [130],	  therefore	  for	  our	  first	  analysis	  we	  considered	  it	  as	  background	  noise.	  However,	  according	  to	  our	  new	   findings	   of	   the	   role	   of	   FAM161A	   in	   cilium,	  maybe	   the	   importance	   of	   this	   gene	   in	  testis	  and	  other	  ciliated	  cells	  should	  be	  reconsidered.	  The	  retina	  specificity	  of	  FAM161A	  was	   also	   confirmed	   by	   the	   identification	   a	   two	   specific	   Cone-­‐Rod	   homeoboX	   (CRX)	  binding	  domains	  at	  in	  the	  promoter	  and	  first	  intron	  of	  the	  gene.	  CRX	  is	  a	  photoreceptor	  specific	  transcription	  factor	  active	  during	  development	  as	  well	  as	  for	  maintaining	  adult	  retinal	   cell	   function[131].	   Mutations	   in	   CRX	   cause	   different	   retinal	   diseases,	   such	   as	  cone-­‐rod	  dystrophy	  and	  LCA	  [132,	  133].	  Several	  genes	   involved	   in	  retina	   function	  and	  which	   are	   mutated	   in	   diseases	   of	   retinal	   degeneration	   are	   under	   the	   control	   of	   CRX	  [134],	   demonstrating	   the	   importance	   of	   this	   gene	   in	   maintaining	   the	   expression	   of	  retinal	  related	  genes	  during	  adult	  photoreceptor	  life.	  Although	  several	  ciliopathy	  genes	  (CEP290,	  RP1,	  RPGRIP1…)	  have	  a	  CBR	  in	  their	  promoter	  sequences	  as	  identified	  by	  CRX-­‐specific	   ChIP-­‐seq	   studies	   [134],	   the	   importance	   of	   this	   transcription	   factor	   in	   cilium	  biology	  has	  not	  been	  well	  studied	  up	  to	  now.	  Recently,	  the	  discovery	  that	  the	  expression	  of	  another	  cilia	  associated	  gene	  MAK	   [135]	   is	  driven	  by	  CRX,	  suggests	  an	  active	  role	  of	  this	  transcription	  factor	  in	  maintaining	  and	  expressing	  ciliary	  genes	  in	  photorceptors.	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In	   our	   studies	   we	   also	   performed	   a	   co-­‐localization	   analysis	   to	   elucidate	   the	  function	   of	   FAM161A	   in	   the	   retina	   structure.	   Our	   first	   analysis	   identified	   the	   protein	  signal	  in	  the	  IS	  and	  within	  the	  OPL	  in	  adult	  murine	  retina,	  whereas	  the	  signal	  was	  absent	  in	   mice	   younger	   than	   P10.	   This	   pattern	   matches	   the	   mRNA	   expression	   of	   fam161a	  during	  mouse	  development,	  starting	  at	  P10	  when	  the	  OS	  is	  developing.	  Subsequently	  we	  refined	  the	  localization	  of	  FAM161A	  to	  the	  BB,	  proximal	  CC	  and	  partially	  in	  the	  IS.	  The	  increase	  of	  resolution	  was	  achieved	  using	  freshly	  dissected	  and	  unfixed	  murine	  retinas	  giving	  a	  better	  preservation	  of	  the	  intracellular	  structures,	  and	  in	  particular	  of	  the	  ciliary	  region,	  compared	  to	  paraformaldehyde	  or	  methanol	  fixed	  tissues.	  FAM161A	  co-­‐localized	  with	  specific	  basal	  body	  markers,	  such	  as	  RPGRIP1L	  and	  partially	  with	  centrin,	  a	  marker	  for	  the	  whole	  connecting	  cilium.	  The	   lack	  of	  co-­‐localization	  with	  RP1,	  a	  marker	   for	  the	  ciliary	  axoneme,	  demonstrated	  that	  the	  protein	  has	  a	  restricted	  expression	  to	  the	  IS	  part	  of	   the	   cilium.	   Clear	   staining	  was	   also	   observed	   in	   the	   IS,	   in	   particular	   at	   the	   interface	  between	  the	  IS	  and	  the	  ONL.	  This	  area	  corresponds	  roughly	  to	  the	  location	  of	  the	  Golgi	  apparatus,	   where	   all	   protein	   involved	   in	   photoreceptor	   function	   are	   assembled,	   and	  then	  transported	  to	  the	  other	  cellular	  compartments	  through	  microtubule-­‐based	  vesicle	  transport.	   Our	   finding	   of	   several	   different	   proteins	   involved	   in	   Golgi-­‐centrosome/BB	  transport	   by	   yeast-­‐2-­‐hybrid	   screening	   using	   FAM161A	   as	   bait	   for	   bovine	   and	   human	  retina	  library	  could	  somehow	  explain	  this	  peculiar	  localization.	  An	  intriguing	  hypothesis	  is	  that	  FAM161A	  could	  act	  as	  a	  scaffold	  molecule	  for	  the	  transport	  of	  specific	  complexes	  between	   these	   two	   different	   compartments	   of	   the	   cell	   and	   then	   partially	   across	   the	  cilium	  with	  the	  IFT	  complex.	  Although	  data	  we	  currently	  have	  are	  insufficient	  to	  confirm	  this	   hypothesis,	   they	   give	   some	   further	   indication.	   For	   example,	   we	   clearly	  demonstrated	  that	  FAM161A	  interacts	  with	   lebercilin,	  a	  ciliary	  protein	  encoded	  by	  the	  gene	  LCA5,	  and	  associated	  with	  LCA.	  Recently	  it	  was	  demonstrated	  a	  direct	  interaction	  between	  lebercilin	  and	  the	  IFT	  complex	  [136].	  Moreover	  mutations	  in	  LCA5	  induce	  the	  disruption	  of	  the	  IFT	  complex	  with	  subsequently	  problems	  in	  OS	  formation	  [136].	  In	  our	  direct	  1-­‐on-­‐1	  screening	  assays	  we	  observed	  the	  interaction	  between	  FAM161A	  and	  two	  very	  distinct	  IFTs,	  IFT20	  and	  IFT88.	  In	  contrast	  to	  other	  IFT	  proteins,	  IFT20	  is	  localized	  in	  the	  Golgi	  complex,	  as	  well	  as	   in	  the	  BB	  [137],	  and	  a	  direct	  role	  of	   this	   IFT	   in	  vesicle	  formation	   between	   the	   Golgi	   and	   BB	   has	   been	   shown,	   since	   the	   depletion	   of	  photoreceptor	  cells	  causes	  an	  accumulation	  of	  opsin	  in	  the	  IS	  [60].	  Conversely,	  IFT88	  is	  a	  typical	  IFT	  protein	  found	  in	  the	  BB	  and	  it	  has	  been	  shown	  to	  interact	  with	  many	  other	  ciliary	  proteins	   involved	   in	  retinal	  degeneration,	  such	  as	  RPGR	  [138].	  The	  depletion	  of	  IFT88	  causes	  defects	  in	  cilium	  elongation	  as	  well	  as	  the	  accumulation	  of	  opsin	  molecules	  in	  the	  IS	  [59].	  Although	  these	  interactions	  have	  not	  yet	  been	  confirmed	  by	  biochemical	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studies,	   an	   intriguing	   hypothesis	   is	   that	   FAM161A,	   and	   consequently	   the	   UPF0564	  protein	   complex	   could	   be	   a	   new	   member	   of	   the	   IFT	   machinery.	   To	   support	   this	  hypothesis,	   the	   identification	   of	   several	   hits	   by	   yeast-­‐2-­‐hybrid	   screening	   for	   proteins	  involved	   in	   transport	   either	   from	   the	   Golgi	   or	   the	   cilium,	   such	   as	   kinesin-­‐2,	   and	   in	  particular	  the	  interaction	  with	  KIF3C,	  suggest	  that	  investigations	  should	  continue	  in	  this	  direction.	   This	   hypothesis,	   could	   also	   explain	   the	   observed	   interactions	   between	  FAM161A	  and	  other	  ciliary	  protein	   such	  as	  CEP290,	  CEP250	  or	  SDCCAG8.	  The	  correct	  localization	   of	   these	   proteins	   in	   the	   BB	   or	   CC	   is	   fundamental	   to	   understand	   their	  function,	   as	   it	  has	  been	  well	  demonstrated	   for	  CEP290.	   Specifically,	   the	  knockdown	  of	  CEP290	  destroys	  the	  subcellular	  localization	  of	  different	  molecular	  complexes	  involved	  in	  cilia	  regulation,	  such	  as	  PCM1	  and	  CP110	  [77].	   In	  addition	  to	  this,	  CEP290	  has	  been	  shown	   to	   directly	   interact	   with	   several	   proteins	   that	   we	   identified	   in	   the	   FAM161A	  interactome,	   such	   as	  NIN	   [74].	   From	  our	   data,	   however,	  we	   cannot	   conclude	  whether	  CEP290	  is	  necessary	  for	  FAM161A	  localization	  and	  function,	  or	  vice-­‐versa.	  The	  analysis	  of	   FAM161A	   localization	   in	   the	   rd16	  mouse,	   carrying	   a	   large	   in-­‐frame	   deletion	   in	   the	  CEP290	  gene,	  could	  help	  to	  elucidate	  this	  point.	  Moreover,	  the	  IFT	  process	  is	  necessary	  for	  the	  elongation	  and	  formation	  of	  a	  new	  cilium	  during	  ciliogenesis,	  since	  the	  reduction	  or	   knockout	   of	   IFT	   proteins	   is	   often	   associated	  with	   defective	   cilium	   elongation	   [139,	  140].	   For	   FAM161A,	   we	   observed,	   although	   with	   less	   intensity,	   a	   reduction	   in	   the	  number	  of	  ciliated	  cells,	  probably	  indicating	  an	  impairment	  of	  ciliogenesis.	  This	  milder	  effect	  could	  be	  related	  to	  the	  specific	  cell	  line	  in	  which	  siRNA	  silencing	  was	  performed,	  which	  are	  not	  ciliated	  photoreceptor	  cells.	  A	  knockout	  mouse	  model	  of	  FAM161A	  would	  definitely	  help	  to	  clarify	  the	  pathogenic	  processes	  caused	  by	  the	  lack	  of	  this	  protein.	  	  Relevant	  to	  our	  paper,	  another	  publication	  investigated	  the	  role	  of	  FAM161A	  in	  both	   cell	   lines	   and	   photoreceptors	   [114].	   Using	   electron	   microscopy,	   the	   authors	  observed	   the	   localization	   of	   FAM161A	   in	   the	   BB	   and	   connecting	   cilium,	   which	   is	  consistent	  with	  our	  data.	  In	  addition	  they	  emphasized	  a	  possible	  role	  of	  FAM161A	  as	  a	  microtubule	   binding	   protein,	   and	   in	   particular	   as	   a	   microtubule	   stabilizing	   protein.	  These	   results	   were	   obtained	   by	   the	   ectopic	   expression	   of	   recombinant	   FAM161A	   in	  ciliated	   cells,	  where	   they	   observed	   a	   staining	   corresponding	   to	   FAM161A	   all	   over	   the	  microtubule	   network.	   They	   showed	   a	   direct	   binding	  with	   tubulin,	   although	   they	  were	  not	   able	   to	   demonstrate	   the	   direct	   involvement	   of	   FAM161A	   in	   tubulin	   modulation,	  either	   in-­‐vitro	   or	   in-­‐vivo.	   In	   addition,	   we	   never	   observed	   a	   native	   FAM161A	   signal	  outside	   the	   BB	   or	   centrosome	   in	   ciliated	   cells,	   and	   both	   EM	   data	   and	   IF	   data	   did	   not	  reveal	   any	   signal	   in	   the	   microtubule	   network	   of	   photoreceptors.	   We	   think	   that	   the	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hypothesis	   that	   FAM161A	   as	   a	   new	   microtubule	   associated	   protein	   (MAP),	   with	   a	  function	   in	   regulating	   the	   microtubule	   stability	   (such	   as	   RP1	   in	   the	   axoneme	   [50])	  should	   be	   reconsidered	   unless	   further	   research	   proves	   otherwise.	   However,	   the	  microtubule	   binding	   activity	   demonstrated	   in	   this	   research	   fits	   perfectly	   with	   our	  proposed	  model	   of	   FAM161A	   as	   a	   new	   IFT	   component.	   In	   fact	   IFT	   proteins	  move	   on	  microtubule	  network	  by	  interacting	  with	  motor	  molecules,	  and	  were	  localized	  primarily	  at	  the	  level	  of	  the	  BB	  or	  CC,	  with	  an	  expression	  pattern	  similar	  to	  FAM161A.	  In	  addition	  other	  centrosomal	  or	  kinesin	  proteins	  have	  been	   localized	  to	  the	  microtubule	  network	  when	   expressed	   ectopically.	   This	   has	   also	   been	   observed	   for	   LCA5,	   which	   is,	   as	  previously	  mentioned,	  implied	  in	  IFT	  transport	  or	  regulation.	  	  To	  conclude,	  although	  our	  data	  are	  not	  conclusive	  enough	  to	  clearly	  establish	  the	  function	  of	  FAM161A,	  we	  have	  nonetheless	  taken	  further	  steps	  in	  the	  understanding	  of	  this	  protein.	  In	  early	  2010,	  FAM161A	  was	  simply	  one	  of	  the	  many	  unknown	  genes,	  with	  unknown	  function	  and	  an	  enigmatic	  meaningless	  name.	  Today	  we	  know	  that	  this	  gene	  is	  involved	   in	   retinal	  degeneration,	   that	   is	  one	  of	   the	  most	   common	  causes	  of	  autosomal	  recessive	  RP	  in	  Israel	  and	  the	  Palestinian	  territories,	  that	  is	  involved	  in	  cilium	  function	  and	   that	   it	   interacts	   with	   other	   ciliary	   protein.	   But	   this	   is	   just	   the	   beginning	   of	   an	  interesting	  story	  where	  the	  best	  has	  yet	  to	  come.	  	   	  	  	  
“Now	  this	  is	  not	  the	  end.	  It	  is	  not	  even	  the	  beginning	  of	  the	  end.	  But	  it	  is,	  perhaps,	  the	  end	  of	  
the	  beginning”.	  Winston	  Churchill,	  English	  statesman,	  1965.	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   II.1	  INTRODUCTION	  	  
1.1 INNATE	  IMMUNE	  SYSTEM	  AND	  INFLAMMATION	  	  
“Heat	  cannot	  be	  separated	  from	  fire,	  or	  beauty	  from	  the	  Eternal”,	  Dante	  Alighieri,	  Italian	  poet,	  1321	  	  	   The	   immune	   system	   is	   the	   watcher	   of	   our	   body.	   It	   is	   responsible	   to	   identify,	  block	  and	  destroy	  any	  known	  pathological	  agent,	  such	  as	  viruses,	  bacteria,	  parasites	  and	  even	  own	  cells	  that	  are	  damaging	  for	  the	  system.	  The	  immune	  system	  can	  be	  divided	  in	  two	   components:	   the	   innate	   immune	   system	   (IIS)	   and	   the	   acquired	   (or	   adaptative)	  immune	  system	  (AIS).	  Whereas	  the	  latter	  is	  highly	  specific	  and	  efficient	  to	  recognize	  and	  destroy	   a	   specific	   agent,	   the	   former	   is	   less	   selective	   though	   not	   less	   important.	   These	  two	  components	  work	  together	  for	  the	  host	  defense.	  	  The	  innate	  immune	  system	  represents	  the	  first	  protection	  of	  our	  body.	  The	  first	  defensive	   elements	   of	   the	   IIS	   are	   physical	   barriers	   that	   hinder	   the	   entering	   of	   a	  pathogenic	   agent	   inside	   the	   organism.	   They	   evolved	   to	   be	   almost	   inaccessible	   to	   any	  organism	   using	   different	   system	   of	   safeguard	   (for	   example	   tears	   for	   the	   eye,	   or	  keratinization	  for	  the	  skin).	  But	  in	  case	  that	  an	  agent	  manages	  to	  enter	  the	  body,	  it	  can	  encounter	   other	   defense	   mechanisms	   of	   the	   IIS,	   composed	   of	   specific	   cells.	   Some	   of	  these,	   such	  as	  macrophages,	   dendritic	   cells	   and	  mastocytes,	   are	   located	  at	   the	   level	   of	  entering	  tissues,	  and	  they	  have	  the	  capability	  of	  internalizing	  the	  pathogen	  and	  activate	  a	  response	  known	  as	  inflammation.	  	  Inflammation	  comprises	  a	  series	  of	  macroscopic	  and	  molecular	  changes	  aimed	  to	  create	  a	   setting	   in	  which	   the	  pathogenicity	  of	   the	  agent	   is	   reduced,	  whereas	   the	  capability	  of	  the	  host	  to	  respond	  the	  attack	  is	  increased.	  Macroscopic	  changes	  are:	  1. Increase	  of	   the	  vascularization	  at	   the	   level	  of	   the	   injury	   that	   causes	   the	   typical	  redness	  of	  the	  infected	  area.	  2. 	  Increase	  of	  body	  temperature,	  since	  some	  pathogens	  are	  sensible	  to	  high	  inner	  body	  temperature	  [141].	  This	  event	  is	  known	  as	  fever.	  	  3. Pain,	   that	  works	   as	   an	   alarm	   for	   the	   body.	   It	   is	   caused	   by	   the	   release	   of	   pain	  molecules	  that	  stimulates	  nerves.	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4. Swelling,	  due	  to	  the	  accumulation	  of	  fluid	  in	  the	  injured	  tissue	  and	  it	  is	  due	  to	  the	  increased	  blood	  flow	  and	  to	  the	  cellular	  infiltration.	  All	   these	   changes	   are	   driven	   by	   the	   release	   of	   different	   inflammatory	   molecules,	  among	  them	  the	  inflammatory	  cytokines,	  which	  are	  synthetized	  by	  the	  cells	  in	  response	  to	  the	  pathological	  stress.	  	  Among	   inflammatory	   cytokines,	   some	   are	   main	   actors	   in	   starting	   the	   acute	  inflammation	  reaction,	  especially	  in	  case	  of	  a	  bacterial	  infection.	  These	  are	  the	  members	  of	  the	  interleukin-­‐1	  superfamily,	  IL-­‐1β	  and	  IL-­‐18	  [142].	  They	  mediate	  various	  effects	  of	  the	   inflammation	   and	   participate	   in	   lymphocytes	   activation.	   The	   expression	   of	   these	  cytokines	   is	   initiated	  by	  class	  of	  pattern	   recognizer	   receptors	   called	   toll-­‐like	   receptors	  (TLRs),	  which	  recognize	  a	  specific	  pathogen-­‐associated	  molecular	  pattern	  (PAMPs),	  like	  the	  lipopolysaccharide	  (LPS)	  of	  external	  bacterial	  membrane	  [143].	  This	  pathway	  leads	  to	  the	  release	  of	  NF-­‐κB	  and	  the	  expression	  of	  pro-­‐IL-­‐1β.	  However,	   the	  pro-­‐IL-­‐1β	  is	  not	  active	  as	  pro-­‐protein,	  but	  it	  needs	  a	  cleavage	  step	  to	  be	  released	  in	  an	  active	  state.	  This	  cleavage	  is	  mediate	  by	  the	  Caspase-­‐1	  (CASP-­‐1).	  It	   is	   interesting	  to	  notice	  that,	  whereas	  the	   activation	   of	   all	   the	   other	   cytokines	   is	   controlled	   at	   the	   transcriptional	   level,	   this	  additional	   control	   step	   was	   observed	   only	   for	   IL-­‐1β	   and	   IL-­‐18	   [144]	   .	   Similarly,	   the	  activation	  of	   the	  CASP-­‐1	   itself	   is	   strictly	   controlled.	  This	  molecule	   is	   produced	  as	  pro-­‐CASP-­‐1	   and	   an	   important	   intracellular	   complex,	   called	   inflammasome,	   drives	   its	  maturation	  in	  response	  to	  a	  pathogenic	  agent.	  This	   large	  protein	  complex	  (700	  kDa)	  is	  sufficient	   in	   vitro	   to	   activate	   CASP-­‐1	   [145].	   It	   is	   mainly	   composed	   by	   a	   group	   of	  intracellular	   protein	   known	   as	   NOD-­‐Like	   Receptors	   (NLRs)	   that	   usually	   presents	   a	  specific	   and	   well	   conserved	   molecular	   structure	   (Fig.	   1a):	   a	   CARD	   or	   pyrin	   effector	  domain	   (PYD)	   at	   the	   N-­‐terminal	   or	   C-­‐terminal	   of	   the	   protein,	   responsible	   for	   the	  interaction	  with	  other	  effector	  proteins;	  a	  central	  NACHT	  domain	  that	  binds	  ATP	  and	  it	  is	   necessary	   for	   the	   self-­‐oligomerization	   of	   these	   proteins;	   at	   C-­‐terminal	   a	   variable	  numbers	  of	  leucine-­‐rich	  repeats	  (LRRs).	  Similar	  to	  the	  extracellular	  TLRs,	  NLRs	  work	  as	  intracellular	   pattern	   recognition	   receptors	   and	   can	   recognize	   specifically	   intracellular	  pathogenic	  elements	  such	  as	  LPS	  or	  bacterial	  flagellin	  thanks	  to	  their	  LRRs	  domains.	  It	  is	  the	   CARD	   (Caspase	   activator	   and	   recruitment	   domain)	   or	   the	   PYD	   (with	   the	  participation	   of	   other	   accessory	   CARD	   containing	   protein,	   such	   as	   ASC)	   that	   directly	  recruits,	   by	   the	   interaction	   with	   CASP-­‐1	   CARD	   domain,	   the	   pro-­‐CASP-­‐1	   and	   all	   other	  mediators	   of	   the	   proteolysis.	   Each	   pathogenic	   agent	   can	   recognize	   and	   activate	   the	  specific	  inflammasome	  that	  takes	  its	  name	  from	  the	  most	  represented	  NLRs	  (fig	  1b).	  For	  example,	   in	   human	   several	   different	   bacterial	   PAMPs	   can	   activate	   the	   IPAF	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inflammasome	   (e.g:	   Salmonella	   [146]	   and	   Pseudomonas	   aeuruginosa	   [147]),	   whereas	  NALP1	  inflammasome	  is	  activated	  by	  the	  lethal	  toxin	  of	  Bacillus	  anthracis	  [148].	  Another	  important	   complex	   is	   the	  NALP3/cryopyrin	   inflammasome.	   It	   is	   activated	  by	  different	  PAMPS	   such	   as	   the	   LPS,	   peptidoglycans	   and	   also	   nucleotide	   sequences	   [149,	   150].	  Mutation	   in	  NALP3	  and	   in	  proteins	   that	   interact	  directly	  with	   this	   complex	  have	  been	  associated	  with	  a	  very	  well	  defined	  class	  of	  diseases	  in	  which	  the	  inflammation	  system	  is	  impaired,	   the	  autoinflammatory	  syndromes.	  The	  main	  role	  of	  all	  other	  known	  NLRs	   in	  the	   context	   of	   the	   inflammasome	   is	   not	   well	   described,	   but	   their	   identity	   at	   the	  structural	  level	  suggests	  a	  similar	  or	  overlapping	  functions.	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	   1.	   Schematic	   representation	   of	   NLR	   proteins	   structure	   and	   of	   relative	  
inflammasomes.	  	  a)	  The	  picture	  shows	  a	  schematization	  of	  protein	  domains	   found	  in	  NLRs.	  Each	  domain	   is	  indicated	   by	   a	   square	   shape	   and	   by	   a	   different	   color	   as	   reported	   in	   the	   legend.	   	   b)	   A	  schematic	   cartoon	   representing	   some	   of	  most	   studied	   inflammasomes,	   each	   activated	   by	  different	   stimuli.	   It	   is	   possible	   to	   observe	   that	   the	   NLRP3	   inflammasome	   requires	   the	  interaction	   with	   another	   CARD	   domain	   containing	   protein	   ASC,	   whereas	   other	  inflammasomes	   such	   as	   NLRP1	   already	   have	   a	   CASP	   domain	   in	   its	   structure.	   The	  interaction	   of	   ASC	   and	   NAIP	   with	   the	   IPAF	   inflammasome	   is	   not	   clear.	   (Abbreviations:	  FIND,	   function	   to	   find;	   BIR,	   baculovirus	   IAP	   repeat;	   LRR,	   leucine-­‐rich	   repeats;	   NACHT,	  conserved	   in	   NAIP,	   CIITA,	   HET-­‐E	   and	   TP-­‐1	   domain;	   CARD,	   caspase	   recruitment	   domain;	  PYD,	  pyrin	  domain;	  HIN,	  HIN-­‐200	  domain.).	  (Adapted	  by	  Schroder	  and	  Tschopp,	  2010).	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1.2	  AUTOINFLAMMATORY	  SYNDROMES	  (AIS)	  	  
“If	  you	  do	  not	  conquer	  self,	  you	  will	  be	  conquered	  by	  self”,	  Napoleon	  Hill,	  American	  writer,	  1883	  Autoinflammatory	  diseases	  are	  a	  group	  of	  disorders	  characterized	  by	  precise	  attacks	  of	   apparently	   unprovoked	   inflammation,	   without	   the	   identification	   of	   autoreactive	  lymphocytes	  [151].	  Differently	  from	  autoimmune	  diseases,	  such	  as	  lupus	  erythematous	  and	   rheumatoid	  arthritis,	  where	  adaptive	   immunity	   is	   the	  main	   target,	   it	   is	   the	   innate	  immune	   system	   that	   is	   affected	   in	   autoinflammatory	   diseases.	   It	   is	   worth	   bearing	   in	  mind,	  however,	   that	  new	  evidence	   reinforces	   the	   idea	  of	   a	   clinical	   continuity	  between	  these	   two	   systems	   [152].	   From	   a	   clinical	   point	   of	   view	   the	   symptoms	   of	   an	  autoinflammatory	  disease	  include	  classical	  symptoms	  of	  systemic	  inflammation	  such	  as	  fever,	  cutaneous	  rash	  or	  joint	  swelling,	  as	  well	  as	  other	  co-­‐occurring	  symptoms,	  such	  as	  headache,	  diffuse	  pain,	  ulceration	  and	  aphthous	  stomatitis.	  Regarding	  genetics,	  which	  is	  the	  basis	  of	  most	  of	   these	  syndromes,	   the	  majorities	  are	   inherited	  as	  Mendelian	   traits,	  although	   a	   strong	   environmental	   influence	   has	   also	   been	   suggested	   for	   some	   of	   them	  (e.g.,	  gout	  in	  which	  susceptibility	  seems	  connected	  to	  the	  NLRP3	  inflammasome	  [153]).	  Furthermore,	  the	  number	  of	  individuals	  with	  a	  clear	  clinical	  classification,	  but	  for	  whom	  the	  genetic	  causes	  have	  not	  been	  found,	  is	  recently	  increasing	  in	  number	  [152].	  From	  a	  molecular	   point	   of	   view,	   AIS	   can	   be	   categorized	   based	   on	   which	   pathway	   of	   innate	  immunity	   is	   affected	   [154]:	  1)	   IL-­‐1β	  activation;	  2)	  NF-­‐κB	  activation;	  3)	  problems	  with	  molecular	   folding	   of	   some	   protein	   involved	   in	   the	   innate	   immune	   systems;	   4)	  complement	   disorders;	   5)	   cytokine	   signaling;	   6)	   macrophage	   activation.	   The	   most	  common	   forms	  of	   autoinflammatory	  disease	  belong	   to	   the	   first	   three	   groups	   and	   they	  will	  be	  here	  discussed	  in	  details	  (Fig	  2).	  As	  previously	  described,	   the	  key	  molecule	   in	   the	  activation	  of	   the	   innate	   immunity	  response	   is	   IL-­‐1β.	   This	   molecule	   alone,	   in	   small	   amounts,	   can	   promote	   fever	   in	   vivo	  [142]	  along	  with	  other	  systemic	  effects.	  The	  production	  and	  release	  of	   IL-­‐1β	   is	  strictly	  regulated,	  and	  so	  it	   is	  clear	  how	  the	  effect	  of	  a	  molecular	  disruption	  in	  a	  component	  of	  this	  pathway	  could	  cause	  an	  autoinflammatory	  disease	  (Fig.	  2a).	  For	  example	  a	  mutation	  in	  NLRP3,	  the	  key	  molecule	  of	  the	  cryopyrin	  inflammasome	  causes	  a	  pleiotropic	  class	  of	  autosomal	   dominant	   autoinflammatory	   syndromes	   known	   as	   Cryopyrin-­‐associated	  periodic	   syndromes	   (CAPS	   or	   cryopyrinopathies).	   The	   milder	   form	   of	   CAPS	   is	   called	  familial	  cold	  autoinflammatory	  urticaria	  (FCAS)	  and	  it	  leads	  to	  a	  few	  symptoms	  such	  as	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cold-­‐induced	   fever	   and	   urticaria.	   A	   more	   severe	   form	   of	   CAPS	   is	   Muckel-­‐Wells	  syndrome,	   characterized	   by	   fevers,	   hives,	   sensoneural	   hearing	   loss	   and	   cold-­‐induced	  arthritis.	  Finally,	  the	  most	  severe	  form	  is	  the	  neonatal-­‐onset	  multisystem	  inflammatory	  disease	   (NOMID)	  with	   fever,	   urticarial,	   overgrowth	   of	   long	   bones	   and	   chronic	   aseptic	  meningitis	   [155].	   Mutations	   in	   NLRP3	   have	   a	   gain	   of	   function	   effect	   leading	   to	   a	  continuous	  inflammasome	  activation	  with	  overproduction	  of	  active	  IL-­‐1β,	  demonstrated	  by	  overexpression	  of	  mutant	  NLRP3	  in	  monocytes	  cells	  [156].	  	  Another	  gene	   involved	   in	  the	  IL-­‐1β	  activation	  pathway	  is	  MEVF,	  which	  encodes	   for	  the	   protein	   pyrin	   or	   marenostrin	   (Fig.	   2a).	   Mutations	   in	   this	   gene	   cause	   another	  common	   autoinflammatory	   syndrome	   known	   as	   Familiar	  Mediterranean	   Fever	   (FMF).	  This	   disease	   is	   characterized	   by	   recurrent	   fever	   attacks	   with	   peritonitis,	   pleural	  inflammation	   and	   arthritis.	   The	  name	   is	   derived	   from	   the	  high	   rate	   of	  mutated	   alleles	  found	   in	   populations	   from	   the	   Mediterranean	   basin	   and	   Middle	   East	   [157],	   probably	  caused	   by	   a	   selective	   advantage	   of	   the	   heterozygous	   population	   for	   these	   alleles	   to	   a	  specific	   endemic	   infectious	   diseases.	   FMF	   is	   transmitted	   as	   a	   recessive	   trait,	   although	  this	  seems	  somewhat	  contradictory	  considering	  the	  functional	  data	  published	  on	  pyrin.	  In	  fact,	  pyrin	  seems	  to	  have	  both	  inflammatory	  and	  anti-­‐inflammatory	  effects,	  shown	  by	  several	   functional	   experiments	   using	   siRNA	   to	   inhibit	  MEFV	   [158,	   159].	   Also	   other	   in	  
vivo	   experiments	   on	   lymphocytes	   derived	   from	   healthy	   donors	   or	   affected	   controls	  confirmed	  this	  dual	  function	  of	  pyrin	  [158,	  159].	  Recently,	  a	  new	  mouse	  model	  for	  FMF	  seems	   to	   support	   the	   anti-­‐inflammatory	   hypothesis,	   showing	   an	   increase	   in	   IL-­‐1β	  release	   by	   KO	   mutant	   macrophages	   in	   response	   to	   inflammatory	   stimuli	   [160].	   One	  possible	  explanation	  for	  this	  dual	  role	  of	  pyrin	  is	  linked	  to	  its	  function.	  Pyrin	  presents	  a	  PYR	  domain	   at	  N-­‐terminal,	   like	  NLRP3.	  This	   domain	   is	   responsible	   for	   the	   interaction	  with	   ASC,	   one	   of	   the	   key	  molecules	   of	   the	   inflammasome.	   It	   has	   been	   postulated	   that	  pyrin	   could	  work	   either	   to	   inhibit	   IL-­‐1β	   activation	   as	   antagonist	   of	   Caspase-­‐1	  binding	  with	   ASC	   [161],	   or	   by	   being	   directly	   part	   of	   the	   NLRP3-­‐inflammasome	   [162].	   It	   is	  therefore	   possible	   that	   these	   two	   different	   pathways	   could	   be	   activated	   at	   different	  moments	   and	   by	   different	   stimuli.	   To	   confirm	   this	   hypothesis,	   an	  ASC	   dependent,	   but	  NLRP3-­‐	   independent,	   activation	   of	   the	   inflammasome	   has	   been	   reported	   [163].	   This	  dual	   role	   of	   pyrin	   function	   could	   explain	   why	   in	   certain	   cases	   MEFV	  mutations	   are	  associated	  with	  autosomal	  dominant	  inheritance	  with	  a	  possible	  gain	  of	  function	  effect.	  Interestingly	  healthy	  carriers	  with	  a	  recessive	  mutation	  may	  as	  well	  have	  some	  evidence	  of	   perturbed	   inflammation	   [164],	   or	   just	   show	   a	   limited	   phenotype	   for	   a	   short	   time	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[165],	  demonstrating	  a	  non-­‐linear	  effect	  of	  these	  mutations	  on	  the	  general	  inflammation	  pathway.	  	  
	   Among	   the	   autoinflammatory	   recurrent	   fevers,	   hyperimmunoglomulinemia	  D	  with	  periodic	   fever	   syndrome	   (HIDS)	  deserves	  a	  mention.	  This	  disease	   is	  due	   to	  autosomal	  dominant	   mutations	   in	   the	   gene	   MVK,	   for	   which	   the	   product	   is	   the	   ubiquitously	  expressed	   enzyme	  mevalonate	   kinase	   (Fig.	   2a)	   [166].	   The	   functional	   link	  between	   the	  
Figure	  2.	  Pathways	  involved	  in	  autoinflammatory	  diseases.	  	  
a)	  Schematic	  representation	  of	  a	  cell	  and	  some	  of	   the	  molecules	   involved	   in	  active	  IL1-­‐Beta	  release.	   The	   diagram	   shows	   the	   involvement	   and	   interaction	   between	   these	   molecules.	  NLRP3	   interacts	   with	   ASC,	   forming	   the	   NLRP3	   inflammasome	   to	   activate	   IL-­‐1Beta.	   The	  involvement	   of	   Pyrin	   and	  Mevalonate	   Kinase	   (MK)	   is	   shown.	   Other	  molecules	   involved	   in	  other	   autoinflammatory	   diseases,	   such	   as	   PSTPIP1	   (causing	   Pyogenic	   Arthritis	   with	  Pyoderma	  gangrenosum	  and	  Acne	  –PAPA	  syndrome)	  and	  IL1-­‐RA	  (causing	  Deficiency	  of	   the	  Interleukin-­‐1	  receptor	  syndrome	  -­‐	  DIRA)	  are	  drawn.	  Different	  stimuli	  activating	  this	  pathway	  are	   indicated	   at	   the	   top	   of	   the	   figure.	   	   b)	   NF-­‐κB	   activation	   in	   recurrent	   fever.	   Here	   the	  components	  of	  NF-­‐kb	  activation	  are	  reported.	  As	  described	  already	  in	  the	  text	  NLRP12	  has	  a	  negative	  effect	  on	  NF-­‐κB	  activation	  that	  drives	  to	  the	  production	  of	  inflammatory	  cytokines.	  NOD2	   interacts	   with	   the	   cell	   wall	   component	   of	   bacteria	   muramyl	   dipeptide	   (MDP)	   and	  indirectly	   activates	   NF-­‐κB.	   c)	   TRAPs	   associated	   disease	  mechanism.	   In	   case	   of	   TRAPS,	   the	  disease	  mechanism	   is	   connected	   to	   an	   increase	   of	   unfolded	   proteins	   in	   the	   cytoplasm	   that	  leads	   to	   cellular	   stress	   and	   cell	   death.	   Moreover	   the	   presence	   of	   this	   stress	   increases	   the	  number	  of	   stress	  molecules	  such	  as	   JNK	  and	  MAPK	  making	  the	  cell	  much	  more	  sensitive	  to	  inflammatory	  stimuli.	  All	  proteins	  indicated	  with	  an	  asterisk	  are	  found	  to	  be	  associated	  with	  an	  autoinflammatory	  syndrome.	  (Adapted	  from	  Masters	  et	  al.,	  2009).	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inflammasome	   and	   this	   protein	   was	   not	   overly	   clear,	   considering	   that	   homozygous	  recessive	  mutations	  in	  MVK	  cause	  a	  severe	  form	  of	  mevalonic	  aciduria,	  an	  early	  deadly	  disease	  [167].	  In	  fact	  it	  seems	  that	  mutations	  in	  only	  one	  allele	  of	  this	  gene	  is	  enough	  to	  protect	   the	   body	   from	  mevalonic	   aciduria	   symptoms,	   but	   not	   enough	   to	   save	   it	   from	  HIDS.	  It	  has	  been	  clearly	  demonstrated	  that	  the	  missing	  link	  between	  the	  inflammasome	  and	   MVK	   is	   found	   in	   the	   mevolanate	   kinase	   pathway,	   which	   is	   important	   for	   the	  production	  of	  protein	  kinase	  B,	  one	  of	  the	  key	  factors	  in	  caspase-­‐1	  activation	  [168].	  Moving	  onto	  the	  class	  of	  the	  NF-­‐κB	  disorders	  (Fig.	  2b)	  is	  a	  syndrome	  called	  familial	  cold	   associated	   periodic	   syndrome	   2	   (FCAS2),	   better	   known	   as	   Guadalupe	   variant	  periodic	   fever	   syndrome.	   This	   disease	   is	   associated	   with	   non-­‐sense	   and	   splice	   site	  mutations	  in	  the	  NLRP12	  gene	  and	  presents	  some	  symptoms	  that	  are	  common	  to	  CAPS,	  like	   recurrent	   episodes	   of	   fevers	   triggered	   by	   cold	   exposure,	   arthralgia	   and	   myalgia	  [169].	  This	  protein	   seems	   to	  be	  directly	   involved	   in	   the	   inhibition	  of	  NF-­‐κB	  activation	  [170].	   Therefore,	   dominant	   non-­‐sense	   and	   frameshift	   mutations	   cause	  haploinsufficiency	   with	   consequent	   constant	   activation	   of	   the	   NF-­‐κB	   inflammatory	  pathway.	   Recently,	   a	   recurrent	   heterozygous	   missense	   mutation	   in	  NLRP12	   has	   been	  connected	   to	   a	   gain-­‐of-­‐function	   phenotype	   and	   to	   a	   functional	   defect	   in	   the	  inflammasome	   [171],	   revealing	   a	   new	   important	   role	   of	   this	   protein	   in	  autoinflammatory	  disease.	  The	   last	  AIS	  discussed	  here	  belongs	  to	  the	  class	  of	  protein	   folding	  disorders	  and	   is	  known	  as	  TNF	  receptor-­‐associated	  periodic	  syndrome	  (TRAPS)	  (Fig.	  2c).	  This	  disease	  is	  caused	  by	  a	  mutation	  in	  the	  TNF	  receptor-­‐1	  gene	  (TNFRSF1A)	  [172].	  It	  is	  characterized	  by	   periodic	   fever	   with	   severe	   abdominal	   pains,	   arthritis,	   migratory	   skin	   rash	   and	  periorbital	   edema,	   with	   amyloidosis.	   Also	   TRAPS	   is	   transmitted	   as	   an	   autosomal	  dominant	   disease	  without	   geographic	   preference	   and	  with	   a	   clear	  mutational	   hotspot	  located	  mainly	  to	  the	  extracellular	  domain	  of	  the	  receptor	  [154].	  It	  has	  been	  shown	  that	  many	  of	   the	  mutations	  causing	  TRAPS	  have	  an	  effect	  on	  protein	   folding	  and	  cause	   the	  aggregation	   of	   the	   receptor	   in	   the	   ER	   as	   well	   as	   the	   inhibition	   of	   trafficking	   to	   the	  membrane	   [173].	   Furthermore,	   a	   reduction	   in	   the	   binding	   capacity	   of	   TNF	   has	   been	  demonstrated	   [174].	   Another	   mechanism	   involved	   in	   the	   disease	   is	   linked	   to	   the	  decrease	  of	  receptor	  shedding	  and	  consequential	  accumulation	  in	  the	  ER.	  For	  example,	  it	  has	  been	  observed	  that	  mutations	  affecting	  the	  proteolitic	  sites	  on	  the	  protein	  sequence	  causes	   a	   reduced	   receptor	   shedding	   with	   not	   correct	   folding	   of	   the	   same	   [175].	  Moreover,	   it	   has	   been	   also	   observed	   that	   the	   intracellular	   accumulation	   of	   TNFRSF1A	  induces	   the	   intrinsic	   activation	   of	   several	   death	   pathways	   and	  MAPK	   kinases	  making	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cells	  that	  express	  a	  mutant	  TNF	  receptor	  more	  sensitive	  to	  the	   inflammatory	  response	  [175].	  Recently	  a	  new	  role	  of	  defective	  autophagy	  due	   to	  a	  mutation	   in	  TNFRSF1A	  has	  been	  proposed	  for	  TRAPS	  induced	  inflammation	  as	  an	  important	  mechanism	  in	  TRAPS	  pathogenesis.	   It	   is	   likely	   that	   the	   sum	   of	   these	   different	   defects	   cause	   the	   different	  spectrum	  of	  the	  TRAPS	  phenotypes.	  We	  have	  just	  briefly	  described	  some	  AIS	  for	  which	  a	  specific	  genetic	  cause	  has	  been	  identified.	   For	   other	   AIS	   however,	   the	   genetic	   cause	   has	   not	   been	   found	   or	   even	  postulated,	  and	  the	  etiology	  is	  still	  unclear.	  Among	  these	  there	  is	  the	  periodic	  fever	  with	  aphtous	  stomatitis	  and	  cervical	  adenitis	  (PFAPA)	  syndrome.	  	  
1.3 PFAPA	  SYNDROME	  	  
“She	  gives	  me	  hot	  and	  cold	  fever,	  then	  she	  leaves	  me	  in	  a	  cool,	  cool	  sweet…”,	  from	  song	  Crazy	  Little	  
Thing	  Called	  Love	  by	  Freddie	  Mercury,	  British	  rocker	  ,	  1987.	  	  	  	   Firstly	  described	  by	  Marshall	  in	  1987	  [176],	  this	  autoinflammatory	  syndrome	  is	  characterized	   by	   two	   or	   three	   days	   of	   high	   fever	   (higher	   than	   39°C)	   that	   reoccurs	  regularly	   every	   month,	   alongside	   at	   least	   one	   of	   these	   other	   symptoms:	   aphthous	  stomatitis,	  pharyngitis	  and	  cervical	  adenitis	  [177].	  Other	  clinical	  manifestations	  can	  be	  associated	   with	   PFAPA,	   such	   as	   headache,	   nausea,	   abdominal	   pain,	   and	   cutaneous	  rashes,	  even	  if	  these	  other	  symptoms	  are	  quite	  rare.	  It	  is	  an	  early	  onset	  disease,	  with	  a	  median	   age	   of	   5	   years	   old,	   and	   the	   syndrome	   usually	   shows	   a	   complete	   resolution	   of	  attacks	  after	  adolescence.	  However,	  cases	  of	  PFAPA	  not	  resolved	  after	  adolescence	  have	  been	   reported	   in	   the	   literature	   [178-­‐181].	   In	   most	   cases,	   patients	   are	   otherwise	  asymptomatic	  during	   the	  episodes,	  without	  any	  problem	   in	  development	  or	  growth.	  A	  molecular	   profile	   based	   on	   inflammation	   molecules	   expression	   does	   not	   show	   any	  difference	   between	   healthy	   controls	   and	   affected	   individuals	   during	   asymptomatic	  stages	   between	   two	  PFAPA	   flare-­‐ups	   [182].	  Diagnosis	   of	   PFAPA	   is	   based	  mainly	   upon	  symptoms,	  but	  since	  they	  mostly	  overlap	  with	  other	  autoinflammatory	  fever	  diseases,	  a	  genetic	  screening	  is	  often	  recommended	  in	  order	  to	  exclude	  other	  recurrent	  fevers	  like	  FMF,	  HIDS,	  TRAPS	  and	  CAPS.	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   Recently	   new	   molecular	   and	   clinical	   aspects	   of	   PFAPA	   have	   been	   revealed,	  showing	   a	   completely	   different	   molecular	   profile	   compared	   with	   other	  autoinflammatory	   syndromes.	   In	   fact,	   during	   flares,	   PFAPA	   patients	   present	   classical	  symptoms	   of	   inflammation	   with	   non-­‐specific	   leukocytosis,	   neutrophilia	   and	   elevated	  levels	   of	   C-­‐reactive	   protein	   and	   fibrinogen	   [183].	   In	   addition	   to	   this,	   the	   expression	  profile	  of	  inflammatory	  genes	  during	  a	  flare	  seems	  to	  be	  very	  specific	  for	  PFAPA,	  with	  a	  general	   increase	   in	   inflammatory	   genes,	   both	   interferon	   γ	   and	   interleukin-­‐1	   related.	  Moreover,	  a	  general	  increase	  in	  the	  activation	  of	  the	  adaptive	  immune	  system	  has	  been	  observed	  [182].	  The	  involvement	  of	  IL-­‐1β	  pathway	  in	  PFAPA	  also	  seems	  to	  be	  confirmed	  by	   the	   relevant	   increase	  of	   IL-­‐1β,	   IL-­‐1	   receptor	  antagonist	   and	  other	   cytokines	  during	  the	  febrile	  attack	  in	  the	  affected	  patients	  compared	  to	  healthy	  controls,	  and	  compared	  to	  levels	  in	  the	  same	  patient	  during	  the	  different	  stages	  of	  the	  disease	  [184].	  	  	   The	   most	   suitable	   treatment	   for	   PFAPA	   is	   still	   mostly	   based	   on	   treating	   the	  symptoms.	   The	   use	   of	   corticosteroids,	   such	   as	   prednisone,	   is	   the	   golden	   standard	   for	  treatment,	  even	  though	  a	  possible	  side	  effect	  is	  a	  decrease	  in	  the	  time	  window	  between	  two	   flares	   [177].	   Another	   drug	   used	   in	   the	   treatment	   of	   FMF,	   the	   microtubule	  destabilizer	   drug	   cimetidine,	   has	   been	   tested	   also	   on	   PFAPA	  patients,	   although	   it	  was	  only	   effective	   in	   a	   portion	   of	   them	   (almost	   30%)[185].	   Additionally,	   despite	   being	  controversial	   due	   to	   the	   invasiveness	   of	   the	   technique,	   the	   surgical	   removal	   of	   the	  tonsils	  has	  been	  proposed,	   and	   it	  has	   led	   to	   the	   complete	   remission	  of	   symptoms	   in	  a	  high	   percentage	   of	   cases	   [186-­‐188].	   Recently,	   a	   new	   innovative	   treatment	   has	   been	  investigated	   based	   on	   the	   finding	   of	   inflammasome	   involvement	   in	   the	   disease.	   The	  validity	   of	   IL-­‐1	   inhibitors,	   such	   as	   Anakinra	   (IL-­‐1RA),	   has	   been	   shown	   to	   lead	   to	   a	  remission	  of	  the	  attacks	  in	  a	  small	  cohort	  of	  patients	  and,	  due	  to	  the	  low	  side	  effects	  of	  this	  treatment,	  could	  became	  the	  standard	  for	  treating	  this	  disease	  [182].	  	  	   The	  genetic	  origin	  of	  PFAPA	  is	  one	  of	  the	  most	  debated	  issues	  of	  this	  syndrome.	  Several	   different	   theories	   on	   its	   etiology	   have	   been	   proposed,	   although	   the	   official	  definition	  is	  to	  consider	  it	  as	  sporadic	  disease	  [189,	  190].	  Some	  evidence	  supports	  this	  hypothesis:	   1)	   it	   is	   present	   in	   people	  with	   different	   ethnic	   backgroups;	   2)	   it	   seems	   to	  resolve	   spontaneously	   and	  with	   tonsil	   removal;	   3)	   it	   has	   a	   very	   early	  onset,	  when	   the	  immune	   system	   is	   not	   completely	   efficient,	   suggesting	   environmental	   factors.	   On	   the	  other	  hand	  several	  clues	  lean	  towards	  a	  hereditary	  hypothesis.	  Among	  these	  is	  the	  fact	  that	  no	  trace	  of	  any	  pathological	  agent	  has	  been	  found	  in	  the	  throat	  of	  affected	  children	  during	   the	   attacks	   as	   well	   as	   the	   responsiveness	   to	   steroids	   but	   not	   to	   antimicrobial	  agents	  and	  the	  periodicity	  of	   the	  phases	  between	  flares,	  which	  can	  often	  be	  accurately	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predicted	   [190].	   In	   addition	   to	   this,	   the	   discovery	   of	   siblings	   with	   PFAPA	   seems	   to	  reinforce	  the	  idea	  of	  an	  inherited	  disease	  [191,	  192].	  Our	  collaborators	  Dr.	  Hofer	  and	  Dr.	  Cochard,	  from	  the	  pediatric	  department	  of	  the	  University	  of	  Lausanne	  Hospital,	  showed	  a	   clear	   positivity	   in	   family	   history	   (e.g.,	   via	   a	   questionnaire)	   for	   episodes	   of	   recurrent	  fevers	   in	   almost	  45%	  of	   families	   in	   the	   total	   analyzed	  PFAPA	   cohort	   (composed	  of	  85	  patients).	   When	   the	   same	   survey	   was	   administrated	   to	   comparable	   families	   of	   non-­‐PFAPA	   controls	   only	   12%	   these	   gave	   positive	   results	   [193].	  Moreover,	   a	   recent	   paper	  showed	  a	  high	  percentage	  of	   family	  history	   for	   recurrent	   fevers	   in	  PFAPA	  patients,	   in	  which	  the	  disease	  persisted	  through	  to	  adulthood,	  probably	  indicating	  the	  presence	  of	  a	  milder	   and	   a	  more	   severe	   form	   of	   this	   disease	   [194].	   Although	   these	   studies	   seem	   to	  indicate	   a	   genetic	   predisposition,	   it	   cannot	   be	   excluded	   that	   this	   is	   due	   to	   specific	  variants	   present	   in	   known	   inflammatory	   genes.	   For	   this	   reason	   several	   works	  investigate	   the	   involvement	   of	   FMF,	   TRAPS,	   MVK	   and	   NLRP3	   mutations	   in	   PFAPA	  cohorts.	  For	  example	  in	  Dagan	  et	  al.	  [195],	  common	  mutations	  of	  FMF,	  TRAPS,	  CAPS	  and	  of	  the	  gene	  involved	  in	  Blau	  Syndrome,	  CARD15,	  were	  screened	  in	  a	  cohort	  of	  57	  PFAPA	  patients.	  In	  this	  cohort,	  27%	  of	  the	  patients	  carried	  a	  variant	  in	  MEFV,	  though	  this	  can	  be	  expected	   as	   this	   population	   had	   a	   high	   number	   of	   patients	   from	   the	   Mediterranean	  basin,	  where	  the	  carrier	  frequencies	  of	  MEFV	  variant	  is	  about	  1	  in	  every	  4.	  Furthermore,	  5.3%	  carried	  a	  mutation	  in	  CARD15,	  around	  2%	  in	  TNFRSF1A	  and	  in	  NLRP3.	  The	  others	  were	   genetically	   negative	   for	   each	   screened	  mutation.	   Of	   course	   clear	   limitations	   are	  evident	   in	   this	   analysis	   and	   in	   similar	   studies.	   Firstly,	   not	   the	  whole	   gene	   is	   screened,	  but	   only	   predominant	   mutations,	   so	   more	   specific,	   new	   variants,	   or	   even	   functional	  polymorphisms,	   could	   cause	   the	   PFAPA	   phenotype.	   Secondly,	   the	   inclusion	   criteria	  based	  on	  clinical	  data	  are	  not	  always	  enough	  to	  distinguish	  PFAPA	  patients	  from	  other	  milder	   forms	   of	   autoinflammatory	   fevers.	   Another	   paper	   proposed	   a	   possible	   link	  between	   MVK	   mutations	   and	   PFAPA,	   based	   simply	   on	   the	   high	   level	   of	   IgD	   in	   some	  PFAPA	  patients,	  but	  it	  failed	  to	  find	  pathogenic	  changes	  in	  the	  MVK	  gene	  [196].	  A	  more	  comprehensive	   study	   revealed	   that	   among	   199	   patients	   that	   completely	   fulfilled	   the	  PFAPA	   clinical	   criteria,	   the	  majority	   of	   them	  were	   found	   negative	   for	   any	   variants	   in	  inflammatory	  genes.	  Of	   the	   remaining	  part,	  32	  patients	  were	   found	   to	  have	  mutations	  already	   known	   to	   cause	   another	   inflammatory	   disease	   (they	   were	   probably	  misdiagnosed	  PFAPA	   subjects),	  whereas	  more	   than	   37	   carried	   either	   heterozygous	   or	  rare	   polymorphism	   with	   not	   clear	   pathological	   effect	   in	   one	   of	   the	   known	   recurrent	  fever	  associated	  gene	  [197].	  Another	  more	  recent	  study,	  performed	  by	  the	  group	  of	  our	  collaborator	  Dr.	  Hofer	  here	  in	  Lausanne,	  based	  on	  57	  patients	  affected	  by	  PFAPA,	  found	  variants	  in	  other	  inflammatory	  syndrome	  genes	  in	  25%	  of	  their	  cohort,	  with	  12	  patients	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with	  a	  NLRP3	  variant,	  4	  with	  MEFV	  variants	  and	  1	  with	  MVK	  and	  TNFRSF1A	  variants	  [184].	   Interestingly	  all	  variants	  were	  present	   in	  a	  heterozygous	  state,	   including	  MEFV,	  and	   were	   mainly	   low	   penetrance	   variants,	   or	   rare	   polymorphisms	   with	   unknown	  phenotype.	   The	   presence	   of	   rare	   polymorphisms	   in	   these	   genes	   with	   frequencies	   of	  around	  2%	  in	  healthy	  controls	  raises	  the	  question	  whether	  these	  variants	  should	  really	  be	  considered	  as	  a	  cause	  of	  autoinflammatory	  diseases	  and	  how	  they	  are	   linked	  to	  the	  PFAPA	  phenotype.	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   II.2	  METHODS	  	  2.1	  PATIENT	  SELECTION,	  DNA	  COLLECTION	  AND	  PEDIGREE	  ANALYSIS	  	   The	   families	   participating	   in	   this	   study	  were	   from	   a	   large	   collection	   of	   PFAPA	  patients	   whom	   were	   examined	   and	   selected	   by	   Dr.	   Michaël	   Hofer,	   at	   the	   Lausanne	  University	   Hospital.	   The	   familiarity	   and	   inheritance	   pattern	   was	   investigated	   by	  administrating	   a	   specific	   survey	   to	   family	   members	   of	   the	   affected	   patients.	   PFAPA	  phenotype	  was	  defined	  according	  to	  published	  clinical	  criteria	  [198],	  and	  for	  the	  cases	  where	   the	   phenotype	   was	   unclear	   or	   a	   specific	   ethnicity	   was	   ascertained,	   a	   genetic	  screening	  for	  the	  most	  common	  recurrent	  fever	  genes	  was	  performed.	  Informed	  consent	  was	  provided	  according	  to	  the	  human	  rights	  ethical	  directives.	  Blood	  from	  all	  available	  members	  of	  15	  small	  and	  unrelated	  Swiss	  families	  was	  collected	  and	  high	  quality	  ultra	  pure	  DNA	  was	  extracted	  from	  the	  blood	  using	  a	  NucleonBaCC3	  DNA	  extraction	  kit	  (GE	  Healthcare	   Life	   Science).	   Some	   of	   the	   blood	   was	   kept	   to	   isolate	   the	   peripheral	   blood	  mononucleate	  cells	  (PBLs)	  for	  EBV-­‐driven	  lymphoblastoid	  transformation.	  Pedigrees	  of	  collected	   families	   were	   drawn	   according	   clinical	   records,	   and	   the	   inheritance	   pattern	  was	   directly	   derived	   from	   pedigrees	   analysis.	   As	   controls	   for	   the	   screening	   of	   rare	  variants,	   data	   obtained	   by	   exome	   sequencing	   of	   416	   healthy	   anonymous	   individuals	  from	   a	   large	   population	   based	   study	   done	   in	   Lausanne	   (the	   CoLaus	   study)	  were	   used	  [199].	  	  2.2	  PBLS	  TRANSFORMATION	  BY	  EPSTEIN-­‐BARR	  VIRUS	  (EBV)	  INFECTION	  	   PBLs	   from	   affected	   and	   non-­‐affected	   members	   of	   each	   family	   were	   collected	  from	   whole	   blood	   using	   Ficoll-­‐Paque	   Plus	   (GE	   Healthcare,	   Lifescience),	   by	   density	  gradient	   centrifugation	   separation.	   Once	   isolated,	   cells	   were	   treated	   for	   EBV	  immortalization	  using	   classical	   protocols	   [200],	   optimized	   for	   our	   requirements.	  After	  three	  washes	  with	  PBS	  supplemented	  with	  2%	  FCS,	  1x106	  PBLs	  cells	  were	  put	  in	  a	  10	  ml	  Falcon	  tube,	  diluted	  in	  1	  ml	  of	  LCC	  medium	  (RPMI	  1640	  medium,	  20%	  serum,	  2	  μg/ml	  Cyclosporine	  A)	  and	  put	  in	  direct	  contact	  with	  EBV	  virus	  suspension	  for	  1h.	  Cells	  were	  then	  plated	   into	  a	  well	   of	   a	  12	  well	  plate	  and	  medium	  changed	  when	  necessary.	  After	  about	   one	   month	   in	   culture,	   cells	   were	   completely	   immortalized	   and	   then	   frozen	   in	  RPMI	  1640	  with	  20%	  serum	  and	  10%	  DMSO	  to	  cryopreserve	  them.	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  2.3	  GENOTYPING	  AND	  LINKAGE	  ANALYSIS	  	   	  Six	   out	   of	   15	   families	   were	   selected,	   based	   on	   the	   availability	   of	   clinical	  information	  and	  the	  size	  of	  the	  family	  trees.	  All	  members	  of	  each	  of	  these	  families	  were	  whole	   genome	   genotyped	   by	   Illumina	   Human	   Linkage12	   panel	   (Illumina,	   CA),	  containing	   more	   than	   6000	   highly	   heterozygous	   SNPs,	   with	   an	   average	   distance	  between	   each	   SNPs	   of	   about	   441Kb.	   Output	   was	   then	   analyzed	   using	   the	   software	  Illumina	  Genotype	  Studio	  (Illumina	  Inc.,	  CA)	  and	  the	  SNPs	  calls	  were	  filtered	  out	  based	  on	  quality	  and	  the	  presence	  of	  Mendelian	  inconsistencies.	  Genotype	  data	  were	  handled	  using	   the	   commercial	   software	   Progeny	   7(Progeny	   Software	   LLC)	   to	   generate	  appropriates	  files	  for	  linkage	  analysis	  software.	  	   Linkage	   analysis	  was	   carried	   out	  with	  Merlin	   software	   using	   the	   Vital-­‐IT	   high	  performance	   computer	   structure	   (Swiss	   Institute	   of	   Bioinformatic,	   Lausanne,	  www.vital-­‐it.ch).	   Both	   parametric	   and	   not-­‐parametric	   analysis	   models	   were	   tested.	  Because	  of	  the	  lack	  of	  data	  on	  genetic	  background	  for	  this	  disease,	  we	  could	  not	  perform	  a	   classical	   computational	   approach	   to	   estimate	   the	   penetrance	   factor.	   Therefore,	  penetrance	   factor	   for	   parametric	   analysis	   was	   empirically	   calculated	   based	   on	   the	  observed	   families	   as	   a	   ratio	   between	   the	   number	   of	   affected	   patients	   and	   the	   total	  number	  of	  subjects	  predicted	  to	  be	  affected	  based	  on	  the	  model.	  2.4	  NGS	  EXPERIMENTS	  	   We	   performed	   two	   NGS	   experiments.	   In	   the	   first	   we	   captured	   all	   exons	   and	  boundary	   introns	   of	   all	   the	   annotated	   genes	   (based	   on	   NCBI	   build	   3.1	   annotations)	  present	   in	   the	   identified	   linkage	   interval	   for	   only	   three	   affected	   individuals.	   The	  homemade	   chip	   was	   designed	   in	   collaboration	   with	   Genotypic	   Ltd	   (Bangalore,	   India)	  and	   was	   performed	   using	   SureSelect	   on-­‐array	   chip	   capturing	   (Agilent,	   US).	   Captured	  DNA	   was	   sequenced	   by	   Fasteris	   (Geneva)	   facilities	   in	   Switzerland,	   with	   the	   Genome	  Analyzer	   II	   from	   Illumina.	   Reads	   were	   aligned	   to	   the	   whole	   genome	   using	   CLC	   bio	  Genetic	  Workbench	  software	  (CLC	  bio,	  Denmark).	  	  	   In	  the	  second	  NGS	  experiment	  we	  performed	  the	  whole-­‐exome	  capturing	  of	  two	  affected	   members	   from	   four	   unrelated	   families	   of	   our	   cohort,	   plus	   four	   individual	  patients.	  This	  was	  done	  at	  the	  Lausanne	  Genomic	  Facility	  (GTF)	  in	  collaboration	  with	  Dr.	  Andrea	  Superti	  Furga.	  Exons	  were	  captured	  using	  SureSelect	  Exome	  kit	  V5	  (Agilent,	  US),	  and	  sequenced	  by	  Illumina	  GAII	  with	  paired	  ends.	  Reads	  were	  aligned	  to	  the	  reference	  
	   106	  
genome	  hg19	  release	  taken	  by	  UCSC	  website.	  We	  used	  for	  our	  analysis	  alignment	  data	  obtained	  from	  the	  sequencing	  service,	  and	  from	  our	  homemade	  pipeline	   for	  alignment	  specifically	  developed	  for	  this	  purpose	  for	  comparison	  reasons.	  2.5	  BIOINFORMATICS	  ANALYSIS	  	   A	   specific	   home	  made	   pipeline	  was	   developed	   for	   the	   alignment	   of	   sequenced	  reads	   to	   the	  whole	   genome.	  This	  was	  necessary	   to	   reduce	   the	   abnormal	   false	  positive	  rates	   present	   in	   the	   variant	   file	   provided	   by	   the	   sequencing	   facility.	   This	   high	   false	  positive	  rate	  call	  was	  probably	  due	  to	  a	  suboptimal	  quality	  of	  some	  of	  the	  DNA	  samples.	  The	   homemade	   pipeline	   implemented	   in	   the	   analysis	   used	   the	   best	   combination	  available	   of	   aligner	   software	   (Novoalign-­‐	   from	   Novosoft)	   and	   genotype	   calling	   tools	  (UnifiedGenotyper	   tool	   from	   GATK)	   as	   already	   demonstrated	   in	   other	   publications	  [201].	   A	   schematic	   diagram	   showing	   all	   steps	   and	   software	   used	   for	   the	   pipeline	   is	  presented	  here	  (Fig.	  3).	  Specific	  parameters	  used	  for	  the	  analysis	  are	  indicated.	  VCF	  files	  were	   annotated	   and	   variants	   analyzed	   using	   Ingenuity	   Variant	   Analyzer	   software	  (Ingenuity	  System,	  CA).	  	  	  	  	  	  	  	  	  	  	   	  	  Figure	  3.	   Scheme	  of	  bioinformatics	  analysis	  performed	  with	   the	  homemade	  pipeline	  to	  obtain	  a	  variant	  calling	  file.	  The	  alignment	  part	  is	  indicated	  in	  green	  and	  requires	  almost	  12	  hours.	  Preparing	  steps	  for	  genotype	  calling	  are	  in	  blue	  and	  require	  almost	  6	  hrs.	  Variant	  calling	  is	  in	  orange	  and	  it	  requires	  about	  4-­‐5	  hours	  to	  be	  completed.	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   II.3	  RESULTS	  	  3.1	  PFAPA	  SYNDROME	  PRESENTS	  AN	  AUTOSOMAL	  DOMINANT	  INHERITANCE	  WITH	  INCOMPLETE	  PENETRANCE	  	   Pedigree	  analysis	  (Fig.	  4)	  showed	  a	  clear	  pattern	  of	  inheritance.	  It	  must	  be	  noted	  however,	   that	   affected	   pathogenic	   status	   was	   clinically	   determined	   only	   for	   the	  most	  recent	  generation,	  whereas	  for	  previous	  generations	  it	  was	  inferred	  from	  questionnaires	  completed	   by	   family	   members.	   Based	   on	   the	   pedigree	   analysis,	   we	   propose	   an	  autosomal	   dominant	   with	   incomplete	   penetrance	   inheritance	   for	   the	   majority	   of	  families.	  Because	  of	  the	  lack	  of	  genetic	  data	  for	  this	  disease	  to	  infer	  the	  penetrance	  factor	  from	   the	   literature,	   we	   empirically	   determined	   it	   (around	   30%)	   by	   simple	   pedigree	  analysis.	  	  
Figure	  4.	  Pedigrees	  of	  selected	  families.	  An	  arrow	  indicates	  subjects	  that	  were	  full	  exome	  sequenced.	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  3.2	  LINKAGE	  ANALYSIS	  REVEALS	  A	  SHARED	  REGION	  ON	  CHROMOSOME	  8	  	  	   In	   collaboration	  with	   Dr.	   Hofer,	  we	   selected	   all	  members	   of	   some	   of	   the	  most	  informative	  families	  (families	  A,	  B,	  C,	  H,	  K,	  L,	  O),	  to	  perform	  a	  genome	  wide	  genotyping	  using	   Linkage12	   Chip	   from	   Illumina.	  We	   obtained	   an	   extremely	   high	   quality	   call	   rate	  (>98%),	  and	  low	  Mendelian	  inconsistency	  (less	  than	  0.2%).	  Multifamily	  whole	  genome	  analysis	  revealed	  a	  single	  peak	  with	  a	  LOD	  score	  of	  3.4	  on	  the	  short	  arm	  of	  chromosome	  8	  considering	  a	   fully	  penetrant	  model	  (in	  which	  the	  obliged	  carriers	  are	  considered	  as	  affected)	   (Fig.	   5b).	   The	   LOD	   score	   is	   reduced	   to	   2.4	   when	   applying	   the	   reduced	  penetrance	  model,	   although	   the	   unique	   peak	   on	   chromosome	  8	   is	   still	   confirmed	   (Fig	  5c).	   The	   same	   result	   was	   obtained	   when	   using	   a	   non-­‐parametric	   model,	   where	   any	  postulation	   on	   the	   genetic	   inheritance	   pattern	   is	   contemplated.	   For	   this	   model	   no	  penetrance	   was	   considered,	   and	   we	   only	   included	   individuals	   that	   presented	   clinical	  symptoms	  in	  the	  analysis.	  In	  this	  case	  we	  obtained	  a	  maximum	  LOD	  score	  of	  2.9,	  but	  it	  was	  again	   the	  only	  positive	  peak	  obtained	  with	   this	  analysis	   (Fig	  5a).	  We	  performed	  a	  simulation	  study	  to	  test	  the	  strength	  of	  the	  observed	  linkage,	  and	  this	  excluded	  that	  the	  positive	   peak	   was	   obtained	   by	   chance.	   The	   identified	   region	   was	   localized	   between	  8q24.1	  and	  8q24.3	  band	  of	  the	  long	  arm	  of	  chromosome	  8,	  and	  was	  11	  Mb	  large	  (Fig	  5d).	  At	  the	  time	  of	  the	  linkage	  we	  used	  Hg17	  release	  of	  the	  human	  genome,	  and	  that	  region	  contained	  only	   40	  RefSeq	   genes	   (table	   1).	   Among	   these	   genes	   (Fig	   5e),	  we	  decided	   to	  screen	  one	  candidate	  of	  interest,	  the	  gene	  Src-­‐like	  adaptor	  protein	  1	  (SLA),	  located	  in	  the	  intronic	   region	   of	   the	   thyroglobulin	   gene.	   The	   screening	   of	   all	   exons	   and	   intron	  boundaries,	   in	   all	   affected	   members,	   as	   well	   as	   the	   screening	   of	   the	   glucocorticoid	  binding	  domain	  did	  not	  revealed	  any	  pathological	  variant.	  To	  complete	  the	  screening	  of	  all	  other	  genes	  in	  the	  interval	  we	  decided	  to	  perform	  a	  custom	  gene	  capture	  of	  all	  exons	  and	   intron	   boundaries	   for	   each	   of	   these	   40	   genes.	  We	   performed	   the	   screening	   over	  three	  affected	   individuals	   from	  three	  different	   families	   (B1,	  L1,	  C2).	  Unfortunately,	   the	  capture	   procedure	   gave	   some	   unexpected	   technical	   issues,	  with	   unwanted	   noise,	   that	  spoiled	  a	   correct	   alignment.	  This	   could	  be	   related	   to	   the	  high	  number	  of	  pseudogenes	  and	  repetitive	  sequences	  present	  in	  this	  region	  that	  impaired	  the	  capture	  process.	  
















































Figure	  5.	  Linkage	  analysis.	  	  
a)	   Output	   of	   Merlin	   linkage	   analysis	   for	   the	   non-­‐parametric	   model.	   b)	   Output	   for	  parametric	   model	   with	   complete	   penetrance.	   c)	   Reduced	   penetrance	   model.	   d)	   Linkage	  analysis	   revealed	   a	   peak	   on	   the	   long	   arm	   of	   chromosome	   8	   between	   the	   two	   indicated	  markers.	  Genes	  present	  in	  the	  interval	  are	  reported.	  e)	  Among	  these	  genes,	  we	  performed	  a	  complete	  sequencing	  of	  all	  exons	  of	  the	  gene	  SLA.	  	  
	  
Table	  1.	  Genes	  present	  in	  the	  linkage	  interval.	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3.3	  EXOME	  SEQUENCING	  SHOWS	  NO	  CLEAR	  COMMON	  VARIANT	  ASSOCIATED	  WITH	  PFAPA	  PHENOTYPE.	  	  	   Since	   custom	  capture	   sequencing	   failed,	  we	  decided	   to	  directly	  perform	  whole	  exome	  sequencing	  for	  some	  affected	  individuals	   from	  our	  families,	  as	  well	  as	   for	  a	   few	  independent	  samples	  (samples	  A1,	  A2,	  B1,	  B7,	  O1,	  O5,	  R1,	  R2,	  F1,	  2940,	  2941,	  2942	  –	  12	  samples	   sequenced	   in	   total)	   in	   collaboration	   with	   Dr.	   Andrea	   Superti-­‐Furga.	   The	  sequencing	  procedure	  worked	  well,	  although	  the	  percentage	  of	  correctly	  aligned	  reads	  was	  not	  equal	  for	  all	  samples	  (in	  particular	  for	  sample	  A2,	  B7,	  O1	  and	  O5	  the	  percentage	  of	  aligned	  sequence	  was	  around	  the	  75%,	  compared	  to	  the	  others	  that	  had	  an	  average	  of	  95%	   of	   correctly	   aligned	   sequences).	   To	   improve	   this	   output	   we	   performed	   a	   new	  alignment	  protocol	  using	  a	  homemade	  pipeline.	   In	   this	  way	  we	  reduced	   the	  error	  rate	  linked	   to	   computational	   mistakes	   for	   low	   quality	   samples.	   Variants	   called	   with	   both	  alignments	  were	  considered	  to	  be	  highly	  consistent.	  	  To	   begin	   with,	   we	   searched	   for	   rare	   variants	   on	   the	   isolated	   region	   of	  chromosome	  8.	  We	   could	  not	   identify	   any	   shared	   gene	   carrying	   one	  or	  more	  possible	  pathogenic	   variants	   in	   this	   region,	   nor	   on	   the	   whole	   of	   chromosome	   8.	   Then	   we	  investigated	   the	   whole	   exome	   for	   genes	   presenting	   rare	   variants	   that	   were	   shared	  between	  all	  affected	  patients.	   In	  Table	  2	  are	  reported	  genes	  where	  rare	  variants	  (MAF	  <2%)	   that	  were	   found	   to	   be	   present	   in	  more	   than	  90%	  of	   the	   analyzed	   samples	   (this	  value	  was	  chosen	  because	  we	  could	  not	  asses	  the	  clinical	  status	  of	  sample	  R2).	  Many	  of	  the	  identified	  genes	  belonged	  to	  the	  MUC	  family.	  These	  were	  excluded	  from	  subsequent	  analysis	   because	   of	   their	   high	   sequence	   identity	   that	   usually	   impairs	   the	   correct	  alignment	  of	  the	  sequences.	  Similarly,	  all	  the	  other	  common	  genes	  were	  excluded,	  either	  because	  the	  changes	  were	  not	  found	  in	  both	  alignments,	  or	  because	  we	  observed	  	  many	  novel	   and	   rare	   variants	   also	   in	   totally	   unrelated	   controls	   (sequenced	   with	   the	   same	  machine,	   and	   aligned	   with	   the	   same	   pipeline),	   suggesting	   problems	   at	   the	   level	   of	  repetitive	  sequences,	  or	  a	  badly	  annotated	  reference.	  Indeed,	  by	  this	  analysis,	  we	  could	  not	  identify	  any	  common	  mutated	  gene(s)	  involved	  in	  PFAPA.	  	   Since	   the	   genetic	   background	   for	   this	   disease	   is	   not	   very	   well	   defined,	   we	  decided	   the	   to	   investigate	   the	  possibility	  of	  genetic	  heterogeneity,	  by	  considering	  only	  rare	  variants	  present	  in	  some,	  but	  not	  all,	  of	  the	  samples	  but	  present	  in	  all	  the	  affected	  members	  of	  the	  same	  family.	  These	  genes	  are	  listed	  in	  Table	  3.	  It	  is	  possible	  to	  observe	  that	   some	   of	   these	   variants	   were	   shared	   by	   only	   two	   or	   three	   different	   families,	   and	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therefore	  we	   initially	  excluded	  them	  in	   this	   first	  analysis.	  Among	  the	  remaining	  genes,	  an	   interesting	  candidate	  was	  SARM1,	  a	  gene	  involved	   in	   the	   innate	   immunity	  pathway.	  We	  identified	  a	  novel	  variant	  p.G49A	  both	  in	  heterozygous	  and	  homozygous	  states	  in	  6	  different	   samples	   out	   of	   12.	   Although	   both	   alignment	   pipelines	   positively	   called	   this	  variant,	   it	   was	   not	   confirmed	   by	   Sanger	   sequencing.	   Another	   interesting	   gene	   was	  
C16orf11.	  We	   identified	   two	  novel	  missense	  changes	  p.R3Q	  and	  p.R29Q	   in	  patients	  B1	  and	  O1	  respectively,	  whereas	  a	  very	  rare	  variant	  p.R106W	  (rs4551533)	  was	  identified	  in	  samples	  A1,	  A2	  and	  2940.	  Two	  other	  less	  rare	  variants	  were	  identified	  in	  sample	  F1	  and	  R1	  (p.G379D	  –	  rs200682205	  and	  p.G502S-­‐	  rs74459225).	  The	  function	  of	  this	  gene	  is	  unknown,	  but	  the	  fact	  that	  it	  was	  only	  found	  in	  one	  of	  the	  two	  affected	  family	  members	  of	   family	   B	   did	   not	   support	   a	   role	   for	   this	   gene	   in	   the	   disease.	   Sanger	   sequencing	  confirmation	   is	   in	   progress.	  Moreover	  we	   identified	   several	   novel	   and	   non-­‐annotated	  variants,	  which	  were	  unique	  for	  each	  family.	  The	  role	  of	   these	  variants	   in	  the	  frame	  of	  PFAPA	   is	   not	   clear	   and	   it	   is	   very	   difficult	   to	   ascertain.	   All	   identified	   novel	   variants	  divided	  per	  family	  are	  reported	  in	  Table	  6.	  	  






cases	   Exclusion	  Criteria	  
Found	   in	   both	  
alignment	  
WNK1	   54	  
	   	  
100%	   Alignment	  mistake	   No	  
MUC6	   40	  
	   	  
100%	   Mucin	  gene	   yes	  
MUC2	   19	  
	   	  
100%	   Mucin	  gene	   Yes	  
NBPF15	   11	  
	   	  
100%	  
Many	   novel	   variants	   presents	   also	  
in	  controls	   Yes	  
ZNF384	   1	  
	   	  
100%	   Bad	  reference	   Yes	  
OR4C45	   1	  
	   	  
100%	  
Many	   novel	   variants	   presents	   also	  
in	  controls	   Yes	  
MUC17	   91	  
	   	  
90%	   Mucin	  gene	   Yes	  
MUC16	   26	  
	   	  
90%	   Mucin	  gene	   Yes	  
TTN	   18	  
	   	  
90%	   Low	  coverage	  regions	   Yes	  
ZNF492/ZN
16	  
	   	  
90%	  
Many	   novel	   variants	   presents	   also	  
Yes	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F98	   in	  controls	  
GOGAL6L1	   14	  
	   	  
90%	   Not	  well	  annotated	  gene	   Yes	  
PCMTD1	   8	  
	   	  
90%	  
Many	   novel	   variants	   presents	   also	  
in	  controls	   Yes	  
C11orf40	   3	  
	   	  
90%	   Suspected	  False	  positive	   No	  
KIAA1751	   2	  
	   	  
90%	   Suspected	  False	  positive	   No	  
	  3.4	  SCREENING	  OF	  AUTOINFLAMMATORY	  FEVER	  GENES	  DOES	  NOT	  SUPPORT	  THEIR	  INVOLVEMENT	  PFAPA	  ETIOLOGY	  	  	   Since	   the	  presence	  of	   rare	  variants	   in	  other	   inflammatory	  genes	  could	  have	  an	  affect	  on	  PFAFA	  phenotype,	  we	  decided	  to	  search	  specifically	   for	  variants	   in	  all	  known	  autoinflammatory	   genes	   in	   our	   cohort.	  We	   identified	   some	   rare	   variants	   in	  MEFV	   for	  samples	  O1	  (p.I591T,	  rs11466045,	  minor	  allele	  frequency	  –	  MAF	  -­‐	  in	  Lausanne	  controls	  0.07),	  R1	  (p.F425Y,	  rs104895169,	  not	  present	  in	  Lausanne	  cohort),	  A1	  and	  A2	  (p.E148Q,	  rs3732930,	  MAF	  0.06).	  Another	  more	  common	  variant	  (p.R202Q,	  rs224222,	  MAF	  0.18)	  was	   identified	   in	   a	   heterozygous	   state	   in	   samples	   2940,	   2942,	   F1,	   R2	   and	   in	   a	  homozygous	   state	   for	   sample	  B7.	   Interestingly,	  patients	  A1	  and	  A2	  also	  presented	   the	  heterozygous	   variant	   in	   NLRP3	   p.Q703K	   (rs35829419,	   MAF	   0.04),	   whereas	   a	   rare	  variant	  often	  associated	  with	  a	  milder	  form	  of	  CAPS	  p.V198M	  (rs121908147,	  MAF	  0.05)	  was	   found	   in	   a	   heterozygous	   state	   only	   in	   the	   obligated	   carrier	   O5	   and	   not	   in	   the	  affected	   member	   of	   the	   family	   O1.	   The	   rare	   functional	   polymorphism	   p.R121Q	  (rs4149584,	  MAF	  0.018)	  of	  TNFRSF1A,	  usually	  associated	  with	  milder	  forms	  of	  TRAPS,	  was	   only	   identified	   in	   family	   B	   and	   it	   co-­‐segregates	  with	   all	   affected	  members	   of	   the	  family.	   Interestingly,	   we	   also	   identified	   a	   novel	   change	   in	   a	   heterozygous	   state	   in	  
NLRP12	   associated	   with	   FCAS2	   in	   patients	   R1	   (p.R211C,	   novel),	   but	   this	   was	   also	  present	   in	   an	   clinically	   unaffected	   sister.	   This	   change	   was	   found	   in	   a	   well	   conserved	  region,	   in	   the	  NACHT	  domain	  of	   this	  protein.	  No	  variants	  were	   found	   in	  MVK	  with	   the	  exception	  of	  the	  frequent	  polymorphism	  p.S52N	  (rs7957619,	  MAF	  0.14)	  present	  in	  A1,	  R1	  and	  2940	  (Table	  4).	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Table	  3.	  Genes	  in	  common	  in	  a	  few	  families.	  Genes	  under	  investigation	  are	  marked	  in	  orange.	  
Gene	  name	   Families	  
Nrs.	   of	  
variants	   Percentage	  	  
Exclusion	  
criteria	  





MLL3	   A-­‐B-­‐2940	   3	  
	  
100%	  
Two	   different	  
variants	   in	   B1	  
and	  B7	   No	   No	  




No	   No	  
	  AGRN	   A-­‐O-­‐2940	   3	  
	   	   	  
Yes	   No	  
	  




tolerated	   No	   No	  




Yes	   No	  




Yes	   No	  
	  
KALRN	   A-­‐O-­‐2941	   2	  
	  
100%	  
One	   is	   3'UTR	  
variant	   Yes	   No	  
	  PCLO	   A-­‐O	   2	  
	  
100%	   Bad	  alignment	   Yes	   No	  
	  C6orf170	   A-­‐O-­‐F-­‐2941	   1	  
	  
100%	   0.05	  MAF	   Yes	   No	  




No	   No	  
	  




variants	   in	  
controls	   Yes	   No	  




Yes	   No	  
	  




variants	   Yes	   No	  
	  




positive	   No	   No	  
	  




positive	   No	   No	  
	  TBP	   B-­‐O	   1	  
	  
100%	   In-­‐frame	  indel	   No	   No	  




Yes	   No	  




Yes	   In	  progress	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Yes	   No	  




Yes	   No	  
	  
RIMS2	  
B1,A1,	   294,	  









42	   1	  
	  
100%	  
Low	   coverage,	  
False	  positive	   Yes	  
yes	   (not	  
confirmed	  	  3.5	  SEVERAL	  RARE	  VARIANTS	  WERE	  PRESENT	  IN	  INFLAMMASOME-­‐RELATED	  GENES	  	   Since	  patients	  affected	  by	  PFAPA	  syndrome	  showed	  an	  impairment	  in	  IL-­‐1β	  and	  NF-­‐κB	  signaling	  and	  production,	  we	  decided	  to	  look	  closely	  at	  all	  known	  genes	  belonging	  to	   the	   inflammasome	   complex,	   with	   particular	   attention	   to	   genes	   involved	   in	   the	  production	  of	  mature	   IL-­‐1β.	  All	   identified	   variants	   in	   these	   genes	   are	   listed	   (Table	  5).	  We	  identified	  two	  non-­‐annotated	  changes	  in	  NLRP5,	  for	  patients	  2940	  and	  F1	  (p.R274Q,	  and	   p.N255S	   respectively).	   Again,	   patient	   2940	   presented	   another	   rare	   variant	   in	   the	  gene	   NLRP2,	   p.L607P	   (rs182098487,	   MAF	   0.001).	   A	   novel	   change	   was	   found	   in	   this	  same	   gene,	   p.G504D	   (novel),	   in	   patient	   B7,	   although	   it	   was	   not	   found	   in	   the	   affected	  cousin.	   Moreover,	  NLRP2	  was	   also	   the	   NLR	   gene	   that	   showed	   the	   highest	   number	   of	  variants	   among	   PFAPA	   subjects,	   even	   if	   these	   were	   quite	   common	   in	   the	   control	  Lausanne	  cohort	  (p.S4L,	  rs142463014,	  for	  2492,	  MAF	  0.09;	  p.I331V,	  rs61735077,	  for	  R1	  and	  R2,	  MAF	  0.05).	  Another	  common	  variant	  in	  NLRP4	  is	  p.T162M	  (rs117212164,	  MAF	  0.03),	  co-­‐segregating	  in	  family	  O.	  It	  caused	  a	  change	  in	  a	  very	  conserved	  residue	  in	  the	  NACHT	  domain	  of	  NLRP4.	  Among	  other	  NLRP	  family	  member	  genes	  we	  identified	  a	  rare	  change	   in	  NLRP10,	  p.I384T	  (rs150112481,	  MAF	  0.01)	  although	  only	   in	  patient	  O1,	  and	  the	   change	   p.S1025L	   (rs11671248,	   MAF	   0.08)	   in	   NLRP11	   for	   patient	   2940.	   Even	   if	  
NLRP1	  has	  a	  major	  role	  in	  IL-­‐1β	  activation,	  not	  many	  rare	  variants	  were	  identified	  in	  the	  coding	   region	  of	   this	   gene,	  with	   the	  only	   exception	  being	  p.V939M	  (rs61754791,	  MAF	  0.01)	  found	  only	  in	  patient	  2942.	  Interestingly,	  however	  both	  patient	  2941	  and	  family	  R	  shared	   a	   common	   rare	   haplotype	   composed	   by	   different	   missense	   polymorphisms	  located	   at	   the	   C-­‐terminal	   of	   the	   protein	   (Table	   6).	   This	   haplotype	   has	   been	   recently	  associated	   with	   an	   impairment	   of	   IL-­‐1β	   processing	   by	   the	   inflammasome.	   Common	  polymorphisms	   in	  CARD8	  were	   found	   in	   a	  heterozygous	   state	   in	  our	   cohort	   and	   these	  have	   been	   previously	   associated	   with	   other	   inflammatory	   system	   defects.	   These	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polymorphisms	  were	  p.C10X	  (rs2043211,	  MAF	  0.30)	  found	  in	  patients	  A1,	  B7,	  F1,	  2940	  and	   p.V148fs	   (rs140826611,	   MAF	   0.06)	   in	   A2,	   F1,	   2941	   and	   2942.	   Among	   other	  inflammasome	  genes,	  we	  discovered	  a	  heterozygous	  missense	  change	  in	  NLRC4,	  better	  known	  as	   IPAF,	  p.G786V	  (rs149451729,	  MAF	  0.03)	   in	  patient	  2941;	  a	  novel	   change	   in	  
NOD1	   (p.C241G)	   in	   patient	   2942,	   again	   in	   the	   NACTH	   domain	   of	   this	   protein.	   A	   table	  (Table	   4)	   summarizes	   all	   identified	   changes	   in	   inflammasome	   genes	   for	   each	   gene	  family.	  	   Although	  we	  found	  several	  rare	  changes	  in	  these	  affected	  patients,	  we	  wanted	  to	  investigate	   if	   these	   observations	  were	   statistically	   significant.	   To	  perform	   this	   test	  we	  took	  advantage	  of	  high	  throughput	  sequencing	  data	  obtained	  by	  the	  collection	  of	  CoLaus	  samples,	   that	   correspond	   to	   400	   fully	   exome	   sequenced,	   healthy	   individuals	   from	  Lausanne.	   These	   individuals	   were	   sequenced	   using	   the	   same	   facility	   as	   our	   PFAPA	  cohort,	   reducing	   background	   noise	   linked	   to	   the	   platform	   and	   to	   the	   machine.	   We	  compared	   the	   groups	   using	   a	   standard	   χ2	  test,	   the	   frequency	   of	   finding	   a	   rare	   variant	  (MAF<2%)	   in	   the	   inflammasome	   gene	   in	   our	   cohort	   compared	   to	   the	   frequency	   of	  finding	   a	   rare	   variant	   in	   the	   same	   genes	   in	   the	   400	   healthy	   controls.	   A	   graph	   (Fig.	   5)	  summarizes	   the	   results,	   and	   we	   showed	   that	   none	   of	   the	   genes	   were	   statistically	  significant	  in	  our	  cohort	  compared	  to	  the	  control	  population.	  Values	  close	  to	  significance	  were	  obtained	  for	  NLRP2,	  NLRP10,	  and	  MEFV	  (respectively	  p<0.09,	  p<0.06,	  and	  p<0.08)	  but	  the	  small	  size	  of	  our	  cohort	  gives	  us	  low	  statistical	  power	  for	  this	  type	  of	  analysis.	  A	  summary	  of	  all	  analyzed	  variants	  identified	  in	  inflammasome	  genes	  per	  single	  individual	  is	  reported	  in	  Table	  5.	  
	  
Figure	  5.	  Frequencies	  of	  rare	  variants	  of	   inflammasome	  related	  genes	  compared	  to	  their	  
frequencies	   in	   controls.	   In	   this	   graph	   frequencies	   of	   rare	   variants	   (MAF	  <2%)	   found	  at	   least	  once	   in	  a	  PFAPA	  patients	  are	  compared	  with	   the	   frequencies	  of	   rare	  variants	   in	   the	  same	  gene	  extracted	   from	   data	   obtained	   by	   416	   controls	   exomes.	   For	   any	   of	   these	   genes	   the	   statistic	  analysis	  was	  significant	  (χ2	  test	  analysis)	  	  
0	  0.05	  0.1	  
0.15	  0.2	  0.25	  
0.3	  0.35	  0.4	  
PFAPA	  Control	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Table	  4.	  Variants	  found	  in	  NLR	  genes	  and	  the	  position	  in	  the	  functional	  domains	  
IPAF	  genes	  
	   	   	   	   	  GENE	   rs	  number	   Patients	   AA	  change	   MAF	   Domain	  
IPAF	  
(NLRC4)	   149451729	   2941	   p.G786V	   0.004	   LRR6	  
NAIP	   61757629	   B7	   p.A161T	   0.02	   BIR2	  
	  	  
	   	   	   	   	  NLRP	  genes	  
	   	   	   	   	  GENE	   rs	  number Patients	   AA	  change	   MAF	   Domain	  
NLRP1	   61754791	   2942	   p.V939M	   0.02	   LLR5	  
NLRP2	   142463014	   2942	   p.S4L	   0.01	   DAPIN	  
	  	   novel	   B7	   p.G504D	   0	   NACHT	  
	  	   182098487	   2940	   p.L607P	   0.005	   between	  NACHT	  and	  LRR1	  
NLRP3	   121908147	   O5	   p.V200M	   0.01	   between	  DAPIN	  and	  NACHT	  
	  	   35829419	   A1,A2	   p.Q703K	   0.05	   between	  NACHT	  and	  LRR1	  
NLRP4	   117212164	   O1,O5	   p.T162M	   0.004	   NACHT	  
NLRP5	   novel	   F1	   p.N255S	   0.001	   between	  DAPIN	  and	  NACHT	  
	  	   novel	   2940	   p.R274Q	   0.001	   between	  DAPIN	  and	  NACHT	  
NLRP10	   150112481	   O1	   p.I384T	   0.001	   NACHT	  
NLRP11	   11671248	   2940	   p.S1025L	   0.01	   C-­‐terminal	  
NLRP12	   novel	   R1,R2	   p.R211C	   0.001	   NACHT	  
	  	  
	   	   	   	   	  NOD	  genes	  
	   	   	   	   	  GENE	   rs	  number Patients	   AA	  change	   MAF	   Domain	  
NOD1	  
(CARD4)	   novel	   2942	   p.C241G	   0	   NACHT	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NOD3	  
(NLRC3)	   novel	   2940	   p.R1005Q	   0	   LRR15	  
NOD4	   16965150	   2941,	  F1	   p.S210L	   0.03	   before	  NACHT	  domain	  
NOD5	  
(NLRX1)	   150153921	   B7	   p.L193V	   0.007	   NACHT	  




	   	   	   	   	  GENE	   rs	  number Patients	   AA	  change	   MAF	   Domain	  
NWD1	   149694092	   F1	   p.S306L	   0.006	   Between	  WD	  and	  NACTH	  	  
Table	  5.	  Variants	  in	  NLR	  genes	  per	  family.	  
FAMILY	  A	  
	   	   	   	   	   	   	   	  Gene	   rs	  Number	   NT	  change	   AA	  change	   MAF	   A1	   A2	   SIFT	   Polyphen	  





NLRP3	   35829419	   c.2113C>A	   p.Q705K	   0.04	   +/-­‐	   +/-­‐	  
Tolerat
ed	   Benign	  
CARD8	   2043211	   c.304T>A	   p.F52I	   0.3	   +/-­‐	   +/-­‐	  
Damag
ing	   Damaging	  
	  	   140826611	   c.440_441dupAA	   p.Val148LysfsX26	   0.04	  
+/
+	   +/-­‐	  
Damag
ing	   Damaging	  
FAMILY	  B	  
	   	   	   	   	   	   	   	  Gene	   rs	  Number	   NT	  change	   AA	  change	   MAF	   B1	   B7	   SIFT	   Polyphen	  










CARD8	   2043211	   c.304T>A	   p.F52I	   0.3	   +/-­‐	   +/-­‐	  
Damag
ing	   Damaging	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NLRP2	   novel	   c.1511G>A	   p.G504D	   -­‐	  
+/





NAIP	   61757629	   c.481G>A	   p.A161T	   0.03	  
+/





NOD1	   150153921	   c.577C>G	   p.L193V	   0.007	  
+/






	   	   	   	   	   	   	   	  FAMILY	  O	  
	   	   	   	   	   	   	   	  Gene	   rs	  Number	   NT	  change	   AA	  change	   MAF	   O1	   O5	   SIFT	   Polyphen	  
NLRP4	   117212164	   c.485C>T	   p.T162M	   0.036	   +/-­‐	   +/-­‐	  
Damag
ing	   Damaging	  
NLRP10	   150112481	   c.1151T>C	   p.I384T	   0	   +/-­‐	   +/+	  
Damag
ing	   Damaging	  





NLRP3	   121908147	   c.592G>A	   p.V200M	   0.007	  
+/
+	   +/-­‐	  
Tolerat
ed	   Benign	  
	  	  
	   	   	   	   	   	   	   	  FAMILY	  R	  
	   	   	   	   	   	   	   	  Gene	   rs	  Number	   NT	  change	   AA	  change	   MAF	   R1	   R2	   SIFT	   Polyphen	  
NLRP12	   NOVEL	  
	  
p.R211C	   .	   +/-­‐	   +/-­‐	  
Damag
ing	   Damaging	  
MEFV	   104895169	  
c.1274A>T;	  c.1760-­‐










	  	   201671223	   c.1807C>T	   p.R603C	   0.001	   +/-­‐	   +/-­‐	  
Tolerat
ed	   Bening	  
	  	  
	   	   	   	   	   	   	   	  Patient	  F	  
	   	   	   	   	   	   	   	  
Gene	   rs	  Number	   NT	  change	   AA	  change	   MAF	   F1	   SIFT	  
Polyph
en	  
	  NLRP5	   NOVEL	   c.764A>G	   p.N255S	   -­‐	   +/-­‐	   Tolerated	   Benign	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NOD4	   16965150	   c.629C>T	   p.S210L	   0.03	   +/-­‐	   Tolerated	  	   Benign	  
	  NWD1	   149694092	   c.917C>T	   p.S305L	   0.007	   +/-­‐	   Tolerated	   Benign	  
	  	  	  
	   	   	   	   	   	   	   	  Patient	  
2940	  
	   	   	   	   	   	   	   	  
Gene	   rs	  Number	   NT	  change	   AA	  change	   MAF	  
29




NLRP2	   182098487	   c.1889T>C	   p.L608P	   0.005	   +/-­‐	   Damag.	  
Damag
.	  
	  NLRP5	   NOVEL	   c.821G>A	   p.R274Q	   .	   +/-­‐	   Activate	   Benign	  
	  NLRP11	   11671248	   c.3074C>T	   p.S1025L	   0.01	   +/-­‐	   Damag.	  	   Benign	  
	  NOD3	   NOVEL	   c.3014G>A	   p.R1005Q	   .	   +/-­‐	   Tolerated	   -­‐	  
	  	  	  
	   	   	   	   	   	   	   	  Patient	  
2941	  
	   	   	   	   	   	   	   	  
Gene	   rs	  Number	   NT	  change	   AA	  change	   MAF	  
29
40	   SIFT	  
Polyph
en	  
	  IPAF	   149451729	   c.2357G>T	   p.G786V	   0.004	   +/-­‐	   Tolerated	   Possibly	  damaging	  
NOD4	   16965150	   c.629C>T	   p.S210L	   0.03	   +/-­‐	   Tolerated	   Benign	  
	  NLRP1	   35596958	   c.3265A>G	   p.M1089V	   0.05	   +/-­‐	   Activate	   Benign	  
	  	  	   34733791	   c.2994C>T	   p.T965I	   0.05	   +/-­‐	   Tolerated	   Benign	  
	  	  	   11657747	   c.2633C>T	   p.T878M	   0.05	   +/-­‐	   Tolerated	   Benign	  
	  	  	   52795654	   c.2345C>G	   p.T782S	   0.05	   +/-­‐	   Tolerated	   Benign	  
	  	  	   11651595	   c.737C>G	   p.T246S	   0.05	   +/-­‐	   Tolerated	   Benign	  
	  
CARD8	   140826611	   c.440_441dupAA	   p.Val148LysfsX26	   0.04	  
+/
+	   Damag.	  
Damag
ing	  
	  	  	  
	   	   	   	   	   	   	   	  Patient	  
2942	  
	   	   	   	   	   	   	   	  
Gene	   rs	  Number	   NT	  change	   AA	  change	   MAF	  
29
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NLRP1	   61754791	   c.2815G>A	   p.V939M	   0.02	   +/-­‐	   Tolerated	   Possibly	  damaging	  
NLRP2	   142463014	   c.11C>T	   p.S4L	   0.01	   +	  
	   	   	  NOD1	   NOVEL	   c.721T>G	   p.C241G	   .	   +/-­‐	   Tolerated	   Benign	  
	  
CARD8	   140826611	   c.440_441dupAA	   p.Val148LysfsX26	   0.04	  
+/
+	   Damag.	   Damag	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   II.4	  DISCUSSION	  AND	  PERSPECTIVES	  	   	  	   PFAPA	   syndrome	   is	   one	   of	   most	   common	   autoinflammatory	   periodic	   fever	  syndromes	   in	   young	   children	   [154].	   The	   impact	   on	   quality	   of	   life	   of	   the	   child	   is	   not	  overly	  dramatic,	  with	  no	  adverse	  effect	  on	  growth	  or	  cognitive	  development.	  However,	  it	  creates	   undesired	   suffering	   to	   families	   and	   to	   patients,	   especially	   during	   attacks.	   The	  syndrome	  usually	   resolves	   after	   adolescence,	   but	   several	   adult-­‐onset	   or	  non-­‐resolving	  cases	  of	  the	  disease	  have	  been	  recently	  reported	  [178].	  Due	  to	  the	  previously-­‐described	  clinical	   features,	   the	   diagnosis	   of	   this	   disease	   has	   always	   been	   problematic,	   and	  guidelines	   for	   the	   correct	   diagnosis	   have	   rapidly	   changed	  many	   times	  during	   the	  past	  few	  years	  [177,	  183,	  197].	  Clearly	  the	  etiology	  of	  the	  disease	  is	  linked	  to	  an	  impairment	  in	   the	   immune	   system,	   but	   no	   clear	   genetic	   base	   has	   been	   demonstrated	   up	   to	   now.	  Since	  we	  had	  a	   large	  cohort	  of	   families	  with	  PFAPA	  we	  therefore	  decided	  to	  perform	  a	  genetic	  study	  on	  these	  subjects.	  	  	   All	  patients	  were	  diagnosed	  with	  PFAPA	  based	  solely	  on	  clinical	  observation.	  For	  a	   few	   special	   cases	   (e.g.,	   origin	   of	   the	   ancestors,	   responsiveness	   to	   some	   specific	  treatment...)	   a	   genetic	   analysis	   of	   other	   inflammatory	   genes	   was	   performed	   (FMF,	  TRAPS	   and	   CAPS).	   Pedigrees	   and	   affected	   status	   were	   inferred	   by	   submitting	  questionnaires	  to	  other	  family	  members	  of	  the	  patients,	  and	  the	  pedigree	  drawing	  was	  based	  upon	  their	  responses.	  For	  a	  few	  cases,	  where	  another	  young	  affected	  subject	  was	  available,	   a	   clinical	   screening	   was	   performed.	   This	   approach	   showed	   some	   clear	  limitations.	   In	   fact,	   even	   though	   often	   used	   by	   physicians,	   a	   questionnaire-­‐based	  diagnosis	  does	  not	  have	  a	  high	  level	  of	  specificity	  or	  sensitivity,	  and	  the	  effectiveness	  of	  this	   method	   mostly	   relies	   on	   the	   trustworthiness	   of	   the	   answer	   [202].	   Notably,	   the	  selection	   of	   good	   families	   is	   crucial	   for	   a	   correct	   genetic	   analysis,	   and	   self-­‐reported	  clinical	  status	  for	  family	  members	  could	  hinder	  the	  subsequent	  genetic	  analysis.	  	  	   Based	  on	  pedigrees,	  we	  inferred	  an	  autosomal	  dominant	  model	  with	  incomplete	  penetrance,	  with	  a	  penetrance	  factor	  of	  almost	  30%.	  Furthermore	  some	  families	  showed	  a	   fully	  penetrant	  model	   (e.g.	   family	  K),	  whereas	   for	  others	   a	   recessive	   status	   could	  be	  inferred	   (e.g.	   family	   F).	   However,	  we	   could	   not	   exclude	   a	   low	   penetrance	  model,	   or	   a	  multigenic	  or	  non-­‐Mendelian	  inheritance	  pattern	  because	  of	  the	  few	  number	  of	  affected	  members	  and	  the	  size	  of	  each	  family	  pedigree.	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We	  selected	  certain	   families	   (according	   to	  some	  quality	  values:	   family	  size	  and	  availability	  of	  samples,	  clinical	  features	  and	  presence	  of	  affected	  siblings	  or	  cousins),	  for	  which	   we	   performed	   whole	   genome	   SNPs	   genotyping	   from	   collected	   blood.	   The	  subsequent	   linkage	   analysis	   revealed	   a	   clear	   peak	   on	   the	   long	   arm	   of	   chromosome	   8,	  notably	   between	   8q24.1	   and	   8q24.3.	   This	   region	   contained	   few	   genes	   and	   was	   very	  close	   to	   the	   telomeres	   of	   chromosome	   8.	   The	   validity	   of	   the	   identified	   area	   was	  confirmed	  also	  using	  a	  non-­‐model-­‐restricted	  analysis,	  non-­‐parametric	  analysis,	   and	  by	  comparing	  genotypes	  of	  affected	  individuals	  against	  non-­‐affected	  ones.	  Interestingly	  the	  identified	   region	   contained	   several	   lncRNAs	   and	   many	   miRNAs,	   as	   well	   as	   other	  unknown	  genes	  or	  genes	  without	  clear	   function.	  The	  screening	  of	   the	  most	   interesting	  candidate,	  SLA,	  did	  not	   reveal	  any	  possible	  pathological	  variant.	  This	  gene	  was	  chosen	  based	   on	   its	   function	   in	   B	   and	   T	   cell	   development	   [203]	   and,	   moreover,	   for	   its	  involvement	  in	  antigen-­‐activated	  mast	  cells	  regulation	  [204].	  Interestingly,	  SLA	  presents	  a	   strong	   responsive	   site	   to	   corticosteroids	   (corticosteroid	  binding	   site	   -­‐	   CBS)	   and	   it	   is	  one	   of	   the	   most	   responsive	   genes	   to	   glucocorticoid	   action	   [205].	   Unfortunately,	   the	  screening	  of	  CBS	  in	  all	  affected	  patients	  did	  not	  reveal	  any	  variants	  either.	  Therefore	  we	  decided	   to	   perform	  a	   custom	   sequence	   capture	   of	   all	   exons	   of	   all	   known	   genes	   in	   the	  interval.	  The	  custom	  capture	  chip	  was	  designed	  based	  on	  annotation	  of	  build	  Hg35.1	  of	  the	  human	  genome.	  This	  implies	  that	  we	  missed	  some	  recently	  discovered	  genes,	  and	  all	  the	  hypothetical	  genes	  and	  lncRNAs	  that	  corresponded	  to	  the	  majority	  of	  genes	  present	  in	  the	  locus.	  In	  addition	  to	  this,	  some	  technical	  issues,	  mostly	  linked	  to	  the	  quality	  of	  the	  capture,	   hindered	   a	   correct	   alignment	   to	   the	   linkage	   region	   and	   did	   not	   reveal	   any	  positive	  hits.	  	  	   As	   a	   consequence	   of	   this	   failure,	   we	   decided	   to	   perform	   a	   complete	   exome	  sequencing	  for	  some	  of	  the	  affected	  members	  of	  these	  families,	  plus	  a	  few	  extra	  isolated	  cases.	  We	  chose	   them	  based	  on	   the	  quality	  and	  availability	  of	  DNA.	  Unfortunately,	   the	  quality	   of	   the	   alignment	  was	   not	   equal	   for	   all	   samples,	  with	   a	   consequent	   increase	   of	  false	  positive	  rate	  calls	   for	  some	  of	  these	  samples.	  To	  decrease	  this	  rate	  we	  decided	  to	  remap	   the	   raw	   reads	   using	   our	   homemade	   pipeline,	   which	   had	   more	   stringent	   and	  controlled	   quality	   filters,	   compared	   to	   the	   mapping	   performed	   by	   the	   sequencing	  facility.	  We	  decided	  that	  all	  variants	  called	  by	  both	  pipelines	  were	  more	  likely	  to	  be	  truly	  positive,	  giving	  to	  them	  higher	  scores	  compared	  to	  variants	  found	  in	  only	  one	  of	  the	  two	  alignments.	   Careful	   screening	   of	   the	   whole	   of	   chromosome	   8	   did	   not	   reveal	   any	  particular	  rare	  or	  pathological	  variant	  shared	  by	  all	  of	  the	  affected	  subjects,	  suggesting	  a	  possible	  erroneous	  result	  for	  the	  chromosome	  8	  linkage.	  Conversely,	  if	  we	  consider	  the	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whole	  exome,	  we	   identified	  some	  novel	   sequence	  variants	   in	  common	  genes	   (table	  1),	  but	   a	   more	   accurate	   analysis	   of	   these	   genes	   revealed	   that	   they	   mainly	   represented	  experimental	   noise.	   As	   a	   confirmation	   of	   this,	   these	   variants	  were	   found	   in	   very	   high	  number	   in	   the	   same	   genes,	   and	   they	   were	   different	   between	   the	   two	   alignments,	  confirming	  that	  they	  are	  simply	  mistakes	  of	  alignment,	  maybe	  due	  to	  the	  high	  similarity	  of	  these	  gene	  families	  (e.g.	  mucin	  genes)	  or	  due	  to	  the	  bad	  annotation	  of	  the	  reference	  genome	   (e.g	   LOC	   or	   ZNF	   genes).	   Not	   surprisingly,	   the	   error	   rate	   was	   far	   higher	   in	  samples	  that	  presented	  the	  lowest	  percentage	  of	  correctly	  aligned	  reads.	  	   Since	  we	  could	  not	  completely	  exclude	  the	  possibility	  of	  a	  misdiagnosis,	  we	  also	  decided	   to	   analyze	   rare	   variants	   that	   were	   in	   common	   in	   a	   subset	   of	   families.	   In	  particular	  we	  selected	  genes	  that	  had	  the	  highest	  number	  of	  different	  rare	  variants	  and	  with	  the	  highest	  quality	  scores.	   In	  our	   first	  analysis	  we	  excluded	  all	  genes	  shared	  only	  between	  two	  or	  three	  independent	  families	  and	  concentrated	  our	  attention	  on	  ones	  that	  were	  shared	  by	  more	  than	  three	  independent	  families	  and	  that	  were	  confirmed	  in	  both	  alignments.	  Among	  these	  we	  identified	  the	  novel	  variant	  p.G49A	  in	  the	  gene	  Sterile	  alpha	  
and	  TIR	  motif	  containing	  1	  (SARM1).	  The	  Protein	  encoded	  by	  this	  gene	  is	  involved	  in	  the	  negative	   regulation	   of	   the	   TLR	   pathway	   by	   the	   activation	   of	   NF-­‐κB	   [206].	   Although	   it	  was	   present	   in	   almost	   all	   families,	   in	   a	   homozygous	   state	   for	   some	  members,	   Sanger	  sequencing	  confirmed	  it	  as	  being	  an	  artifact.	  The	  second	  candidate	  was	  C16orf11,	  a	  gene	  with	   an	   unknown	   function.	  We	   identified	   two	   novel	   changes	   and	   a	   very	   rare	   variant	  present	   in	   some	   of	   the	   families	   (A,	   O,	   B	   and	   2940),	   whereas	   other	   more	   common	  variants	  were	  represented	  in	  samples	  R1	  and	  F1.	  The	  protein	  encoded	  by	  this	  gene	  does	  not	  have	  any	  known	  protein	  domain,	  and	  it	  is	  partially	  conserved	  among	  other	  species.	  We	   cannot	   propose	   any	   hypothesis	   on	   the	   function	   of	   this	   gene,	   and	   its	   potential	  involvement	   in	   PFAPA	  without	   the	   complete	   screen	   of	   ethnically	  matched	   controls.	   A	  deep	  functional	  dissection	  of	   the	   function	  of	   the	  protein	   for	  this	  gene	   is	  needed	  before	  any	  conclusions	  can	  be	  drawn.	  	  	   We	   then	   decided	   to	   investigate	   the	   possibility	   that	   mild	   mutations,	   or	   rare	  polymorphisms	   in	   other	   known	   autoinflammatory	   genes	   could	   cause	   the	   PFAPA	  phenotype.	   This	   hypothesis	   is	   currently	  matter	   of	   debate,	   and	   the	   diagnosis	   of	  milder	  forms	  of	  autoinflammatory	  disease	  and	  PFAPA	  is	  often	  overlapping,	  leading	  to	  confusion	  in	   patients	   and	   their	   families.	   In	   particular,	   rare	   polymorphisms	   (common	   in	   2-­‐4%	  of	  the	   healthy	   population)	   have	   been	   associated	   to	   PFAPA	   or	   milder	   forms	   of	  autoinflammatory	  disease,	  mostly	  because	  no	  other	  strong	  changes	   in	  candidate	  genes	  have	  been	  identified	  [195,	  197,	  207].	  Our	  analysis	  revealed	  that	  although	  we	  identified	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some	  rare	  missense	  changes	  in	  some	  of	  the	  inflammatory	  genes,	  the	  frequencies	  of	  these	  variants	   were	   not	   different	   from	   those	   that	   were	   present	   in	   the	   general	   population,	  demonstrating	  that	  they	  are	  probably	  not	  enough	  alone	  to	  cause	  the	  disease.	  Moreover,	  some	  of	  these	  changes	  did	  not	  co-­‐segregate	  with	  the	  phenotype,	  or	  were	  also	  present	  in	  healthy	   members	   of	   the	   family.	   One	   example	   is	   the	   novel	   change	   found	   in	   NLRP12,	  p.R211C,	   present	   in	   a	   well	   conserved	   domain	   and	  with	   a	   predicted	   strong	   impact	   on	  protein	   function.	  Recently	   a	   similar	  missense	  mutation	   (p.R352C)	   in	   the	   same	  NACTH	  domain	  of	  this	  gene	  was	  associated	  with	  genetically	  unexplained	  periodic	  fevers	  [171],	  with	  a	  PFAPA-­‐like	  phenotype,	  and	  was	  shown	  to	  cause	  a	  functional	  defect	  in	  Caspase-­‐1	  signaling.	  The	  fact	  that	  the	  unaffected	  members	  of	  a	  family	  carried	  this	  mutant	  allele	  did	  not	   exclude	   the	   involvement	   of	   this	   gene	   in	   the	   etiology	   of	   the	   autoinflammatory	  syndrome,	   but	   it	   could	   indicate	   a	   reduced	   penetrance	   effect	   probably	   due	   to	   some	  genetic	  modifiers.	   It	   is	   interesting	   to	   notice	   that	   the	   affected	  patient	   (R1)	   also	   carried	  another	   very	   rare	   change	   in	   the	   gene	   MEFV	   (p.F425Y)	   with	   function	   unknown.	   The	  intriguing	  hypothesis	  of	  digenic	  or	  multigenic	  mutations	  causing	  the	  impairment	  of	  the	  inflammasome	  seemed	  to	  be	  confirmed	  by	  the	  identification	  of	  two	  rare	  polymorphisms	  often	  associated	  with	  the	  disease	  in	  family	  A.	  In	  fact	  we	  identified	  a	  change	  in	  the	  MEFV	  gene	  (p.E148Q)	  and	  in	  NLRP3	  (p.Q703K),	  both	  common	  polymorphisms	  with	  a	  possible	  functional	   effect	   on	   the	   protein.	   In	   particular,	   for	   p.Q703K,	   functional	   impairment	   of	  
NLRP3	   has	   been	   clearly	   demonstrated	   [208].	   Unfortunately	   this	   digenic	   pattern	   of	  inheritance	  was	  not	  identified	  in	  the	  other	  affected	  subjects,	  reducing	  the	  strength	  of	  our	  finding.	   Nevertheless	   we	   cannot	   exclude,	   based	   on	   this	   observation,	   that	   other	   rare	  variants	   present	   in	   other	   inflammasome-­‐associated	   genes	   could	   be	   involved	   in	   the	  etiology	  of	  PFAPA.	  To	  check	  this	  possibility	  we	  carefully	  screened	  some	  of	  the	  genes	  that	  compose	   the	   inflammasome	   set	   (in	   particular	   the	   NLR	   family	   members)	   based	   on	  current	  literature	  [209-­‐211].	  	  	   We	  identified	  a	  few	  novel	  variants	  in	  NLRP2,	  NLRP5	  and	  NOD1,	  as	  well	  as	  some	  very	   rare	   variants	   in	   other	   inflammasome-­‐associated	   genes,	   such	   as	  NLRP10,	  NLRP4,	  
NLRP11	  and	  NLRC4.	   Interestingly,	   the	  majority	   of	   these	   genes	  were	   involved	   in	   IL-­‐1β	  inflammasome	   activation,	   or	   in	   the	   NF-­‐κB	   pathway.	   For	   example,	   new	   evidence	  demonstrated	   the	   high	   similarity	   and	   redundancy	   between	   the	   structure	   of	   NLRP1,	  NLRP6,	   NLRP10,	   NLRP3	   and	   NLRP12	   [212].	   Although	   the	   function	   within	   the	  inflammasome	   for	   many	   of	   these	   members	   has	   not	   yet	   been	   clarified,	   structural	  similarities	   among	   NLRs	   suggest	   that	   all	   these	   components	   could	   somehow	   mediate	  inflammation	   in	   response	   to	   different	   stimuli	   and	   trigger	   IL-­‐1β	   production	   [211].	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Moreover,	  we	   identified	   two	  samples	   carrying	  a	   specific	   rare	  haplotype	   in	  NLRP1	   that	  has	  recently	  been	  associated	  to	  vitiligo	  and	  autoimmune	  diseases,	  and	  connected	  to	  an	  increase	  of	  IL-­‐1β	  release	  in	  patients	  carrying	  the	  haplotype	  [213].	  In	  addition,	  dominant	  mutations	  in	  the	  same	  gene	  have	  been	  shown	  to	  cause	  systemic	  inflammation	  in	  mouse	  models	  [214].	  Another	  interesting	  observation	  from	  the	  analysis	  on	  the	  effect	  of	  protein	  structure	   was	   that	   the	   majority	   of	   identified	   variants	   seemed	   to	   be	   present	   in	   the	  NACHT	  or	  very	  close	  to	  the	  NACHT	  domain.	  This	  domain	  has	  an	  ATPase	  activity	  and	  is	  crucial	  for	  the	  self-­‐oligomerization	  (usually	  heptamers	  or	  examers)	  of	  NLRs	  to	  form	  the	  structure	  necessary	  for	  inflammasome	  assembly	  [215].	  NACTH	  domain	  mutations	  have	  been	   associated	   with	   structural	   changes	   that	   lead	   to	   a	   continuous	   activation	   of	   the	  inflammasome	   complex.	   A	   link	   between	   mutations	   affecting	   NACHT	   and	   different	  autoinflammatory	   diseases	   has	   been	   observed	   in	  NLRP3	  and	  NOD1	   for	   example	   [155,	  216],	   reinforcing	   the	   hypothesis	   of	   a	   gain-­‐of-­‐function	   effect	   of	   these	  mutations	   on	   the	  complex	   formation.	   It	   is	   interesting	   to	  discover	   that	  every	  single	  affected	   individual	   in	  this	  cohort	  presents	  more	  than	  one	  rare	  variant	  in	  one	  of	  the	  inflammasome-­‐composing	  genes.	   To	   test	   if	   this	   observation	   was	   statistically	   significant,	   we	   compared	   the	  probability	  of	  finding	  a	  rare	  change	  in	  one	  of	  these	  genes	  in	  our	  cohort	  compared	  to	  the	  general	   population.	   To	   reduce	   the	   error	   due	   to	   the	   different	   chemistry	   and	   output	   of	  different	  machines,	  we	  performed	   this	   analysis	  by	  extracting	  data	   from	  a	   collection	  of	  400	  exomes	  of	  healthy	  subjects	  from	  a	   large	  screening	  project	  performed	  in	  Lausanne.	  Unfortunately	   there	   were	   no	   statistically	   significant	   values	   for	   tested	   genes,	   although	  relatively	   low	  p	  values	  were	  seen	   for	  NLRP10,	  NLRP2	  and	  MEFV	   genes.	   It	   is	   likely	   that	  the	   size	   of	   the	   cohort	   was	   too	   small	   to	   obtain	   enough	   statistical	   power.	   Another	  technical	  limitation	  was	  linked	  to	  the	  fact	  that	  we	  could	  not	  analyze	  the	  genotype	  of	  the	  NLR	   genes	   in	   controls	   individuals,	   reducing	   the	   power	   of	   this	   analysis.	   A	   specific	  pipeline	   should	   be	   designed	   to	   extract	   this	   data	   from	   the	   VCF	   files	   of	   the	   control	  individuals.	  	  	   To	   conclude,	   although	   we	   did	   not	   successfully	   identify	   any	   common	   genes	  involved	   in	  PFAPA,	   the	   fact	   that	   several	   rare	   variants	  were	  present	   in	   inflammasome-­‐associated	  genes,	  and	  in	  particular	  in	  the	  NACHT	  domain,	  could	  suggest	  the	  implication	  of	   these	   in	   the	  etiology	  of	   this	  disease,	  although	  the	  analyzed	  dataset	  was	   too	  small	   to	  drive	   any	   clear	   conclusion.	   Moreover,	   since	   for	   many	   autoinflammatory	   diseases	   the	  causative	   variant	   has	   not	   been	   found,	   or	   the	   same	   mutation	   has	   been	   associated	   to	  different	   severities	   of	   the	  disease	   [155],	   the	  presence	  of	  more	   than	  one	  variant	   in	   the	  autoinflammatory	  genes	  could	  indicate	  a	  more	  complex	  genetic	  basis	  of	  these	  diseases.	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For	   this	   reason,	   the	   exome	   sequencing	   of	   all	   these	   patients	   with	   unsolved	  autoinflammatory	   disease,	   and	   a	   more	   complete	   check	   of	   inflammasome-­‐associated	  genes	   could	   help	   to	   elucidate	   the	   genotype-­‐phenotype	   correlation	   for	   all	   of	   these	  syndromes,	  and	  maybe	  clarify	  the	  causes	  of	  PFAPA.	  	  
	  “And	   now	   here	  my	   secret,	   a	   very	   simple	   secret;	   is	   only	  with	   the	   heart	   that	   one	   can	   see	  
rightly,	  what	   is	  essential	   is	   invisible	   to	   the	  eye.”	  Antoine	  de	  Saint-­‐Exupery,	  French	  writer,	  
1900	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Table	  6.	  List	  of	  novel	  variants	  found	  in	  each	  family.	  
FAMILY	  A	  
	   	   	   	   	   	  Gene	   NT	  change	   AA	  change	   A1	   A2	   SIFT	   Polyphen	  
LPCAT1	   c.1241C>T	   p.P414L	   +/-­‐	   +/-­‐	   Damaging	   Benign	  
PWWP2A	   c.1972A>T	   p.I658F	   +/-­‐	   +/-­‐	   Damaging	   Probably	  damaging	  
MAPK9	   c.212A>C	   p.Y71C	   +/-­‐	   +/-­‐	   Damaging	   Probably	  damaging	  
KPNA7	   c.1487T>C	   p.L496S	   +/-­‐	   +/-­‐	   Damaging	   Benign	  
PGM5	   c.1553C>T	   p.T518I	   +/-­‐	   +/-­‐	   Damaging	   Probably	  damaging	  
PNLIPRP1	   c.854A>G	   p.Y285C	   +/-­‐	   +/-­‐	   Damaging	   Probably	  damaging	  
SPON1	   c.2044A>C	   p.K682Q	   +/-­‐	   +/-­‐	   Damaging	   Probably	  damaging	  
E2F8	   c.2461G>A	   p.E821K	   +/-­‐	   +/-­‐	   Damaging	   Probably	  damaging	  
VWF	   c.236G>T	   p.G79V	   +/-­‐	   +/-­‐	   Damaging	   Probably	  damaging	  
TMOD2	   c.365C>T	   p.A122V	   +/-­‐	   +/-­‐	   Damaging	   Benign	  
MEF2A	   c.1024_1026delCGA	   p.342delQ	   -­‐/-­‐	   -­‐/-­‐	   -­‐	   -­‐	  
GFOD2	   c.1100C>T	   p.T367M	   +/-­‐	   +/-­‐	   Damaging	   Probably	  damaging	  
MAPK12	   c.611C>T	   p.T204M	   +/-­‐	   +/-­‐	   Damaging	   Probably	  damaging	  
	  
FAMILY	  B	  
	   	   	   	   	   	  
Gene	   NT	  change	  
AA	  
change	   B1	   B7	   SIFT	   Polyphen	  
NEMF	   c.2353T>C	   p.S785P	   +/-­‐	   +/-­‐	   Damaging	   Probably	  damaging	  
BRF1	   c.14150A>G	   p.N35S	   +/-­‐	   +/-­‐	   Tolerated	   Probably	  damaging	  
ERVV-­‐1	   c.129A>G	   p.N432D	   +/-­‐	   +/-­‐	   Activating	   -­‐	  
	  
FAMILY	  O	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Gene	   NT	  change	  
AA	  
change	   O1	   O5	   SIFT	   Polyphen	  
AGRN	   c.1729G>A	   p.E577K	   +/-­‐	   +/-­‐	   Damaging	   Probably	  Damaging	  
POU3F1	   c.744T>G	   p.D248E	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
LRRC41	   c.974G>A	   p.R325Q	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
ADAMTSL4	   c.1432G>A	   p.G478R	   +/-­‐	   +/-­‐	   Damaging	   Probably	  Damaging	  





+/-­‐	   +/-­‐	  
	   	  
MTMR14	  
c.1433+946C>T;	  
c.1498C>T	   p.R500C	   +/-­‐	   +/-­‐	   Damaging	   Benign	  
LOC100287163/ZNF717	   c.392G>A	   p.G131E	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
CLRN1	   c.34A>G	   p.M12V	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  








c.4426+3828C>T	   p.P1820L	   +/-­‐	   +/-­‐	  
	  
Benign	  
DDX60L	   c.3266A>G	   p.D1089G	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
MTMR12	   c.1748C>T	   p.T583I	   +/-­‐	   +/-­‐	   Damaging	   Probably	  Damaging	  
ORC3	   c.22T>A;	  c.451T>A	  
p.L151M;	  
p.L8M	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
AIMP2	   c.452C>T	   p.T151M	   +/-­‐	   +/-­‐	   Damaging	   Possibly	  Damaging	  
PCLO	   c.14965G>A	   p.V4989I	   +/-­‐	   +/-­‐	  
	  
Benign	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FLNC	  
c.5200-­‐400C>G;	  
c.5208C>G	   p.D1736E	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  






+/-­‐	   +/-­‐	  
	   	  
SNX16	   c.869G>A;	  c.956G>A	  
p.C319Y;	  
p.C290Y	   +/-­‐	   +/-­‐	   Activating	   Benign	  
SPAG1	   c.1870A>G	   p.K624E	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
CSMD3	  




p.T2293I	   +/-­‐	   +/-­‐	   Damaging	   Possibly	  Damaging	  
PLEC	  
c.3044C>T;	   c.2948C>T;	  
c.3455C>T;	   c.3056C>T;	  








p.P983L	   +/-­‐	   +/-­‐	  
	  
Possibly	  Damaging	  
UBAC1	   c.704C>T	   p.P235L	   +/-­‐	   +/-­‐	   Damaging	   Possibly	  Damaging	  
NOTCH1	   c.6130G>A	   p.A2044T	   +/-­‐	   +/-­‐	   Tolerated	   Possibly	  Damaging	  
RPP30	   c.23A>G	   p.D8G	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
ABCC2	   c.3762G>A	   p.W1254*	   +/-­‐	   +/-­‐	  
	   	  SEC23IP	   c.907G>A	   p.V303I	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
MUC2	   c.*5438G>T	   p.C1813F	   +/-­‐	   +/-­‐	  
	   	  
RTN3	  






p.T493I	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
PVRL1	   c.1318G>T	   p.V440F	   +/-­‐	   +/-­‐	   Damaging	   Benign	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M6PR	  
c.684C>G;	   c.454-­‐
503C>G	   p.F228L	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
KLRC3	   c.692T>C	   p.I231T	   +/-­‐	   +/-­‐	   Damaging	   Benign	  
STAB2	   c.3461G>A	   p.R1154Q	   +/-­‐	   +/-­‐	   Tolerated	   Probably	  Damaging	  
ACAD10	  
c.772G>C;	  
c.690+670G>C	   p.V258L	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
FRY	   c.724G>C	   p.A242P	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  






c.1179+1190C>T	   p.P487L	   +/-­‐	   +/-­‐	   Tolerated	  
	  EIF3J	   c.599C>T	   p.T200I	   +/-­‐	   +/-­‐	   Tolerated	   Possibly	  Damaging	  
KIF7	   c.1643C>T	   p.P548L	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
IFT140	   c.1244A>C	   p.Q415P	   +/-­‐	   +/-­‐	   Tolerated	   Probably	  Damaging	  
SSH2	   c.197G>A	   p.R66Q	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
ADCYAP1	   c.483G>C	   p.R161S	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
ODF3L2	   c.551C>T	   p.T184M	   +/-­‐	   +/-­‐	   Damaging	   Probably	  Damaging	  
MUC16	   c.22355G>C	   p.S7452T	   +/-­‐	   +/-­‐	  
	  
Benign	  
RASAL3	   c.2822G>T	   p.R941L	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
C19orf44	   c.1567G>A	   p.V523M	   +/-­‐	   +/-­‐	   Tolerated	   Probably	  Damaging	  
ZNF772	   c.118_120delGAG	   p.40delE	   +/-­‐	   +/-­‐	  






p.A352T	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  







p.D681N	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
MN1	   c.1058C>T	   p.P353L	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
LARGE	   c.52C>T	   p.L18F	   +/-­‐	   +/-­‐	   Tolerated	   Benign	  
mir-­‐658;	  ANKRD54	   c.-­‐101C>T	  
	  
+/-­‐	   +/-­‐	  
	   	  MAGEC2/MAGEC3	   c.656C>T	   p.T219M	   +/-­‐	   +/-­‐	   Damaging	   Benign	  
	  
Patient	  F	  	  
	   	   	   	   	  Gene	   NT	  change	   AA	  change	   F1	   SIFT	   Polyphen	  
MYOM3	   c.3571delG	   p.V1191fs	  
-­‐
/+	  
	   	  
AGL	  






































g	   Benign	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c.29783_29784insAGA;	  
c.33515_33516insAGA	  
FAM171B	   c.129_130insCAGCAG	   p.43_44insQQ	   -­‐/-­‐	  
	   	  
QARS	   c.2290C>T	   p.R764*	  
-­‐
/+	  
	   	  




g	   Benign	  


















g	   Benign	  











g	   Possibly	  Damaging	  
ZNF141	   c.1423T>G	   p.*475G	  
-­‐
/+	  
	   	  
KLB	   c.2327_2329delTCT	   p.777delF	  
-­‐
/+	  
	   	  
PDCL2	   c.327_329delAGA	   p.109delE	  
-­‐
/+	  
	   	  




g	   Benign	  
IL6ST	  
c.1469T>C;	   c.1652T>C;	  









C	   p.21_22insGSG	  
-­‐
/+	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g	   Benign	  




g	   Benign	  




g	   Benign	  




g	   Benign	  
HDGFL1	   c.542_543insGGC	   p.181_182insA	  
-­‐
/+	  
	   	  HIST1H2BA;	  
HIST1H2AA	  
c.87_88insT;	   c.-­‐
469insA	   p.K30fs	  
-­‐
/+	  
	   	  


















	   	  
FERD3L	   c.236_237insGGA	   p.79_80insE	  
-­‐
/+	  
	   	  
TMEM229A	   c.599_601delAGC	   p.200delQ	  
-­‐
/+	  
	   	  







UBE2W	   c.67T>C	   p.S23P	  
-­‐
/+	  
	   	  




	   	  




g	   Possibly	  Damaging	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g	   Possibly	  Damaging	  
OR51B5;	  OR51B6	  
c.-­‐3386-­‐5174T>C;	  











































c.392C>T;	   c.308C>T;	  
c.179C>T	  





g	   Benign	  











g	   Possibly	  Damaging	  
mir-­‐368	  
	   	  
-­‐
/+	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DNAH3	   c.262_263insAAC	   p.87_88insQ	  
-­‐
/+	  
	   	  
ERN2	   c.2816_2818delTCC	   p.939delL	  
-­‐
/+	  
	   	  














	   	  




	   	  
FAM20A	   c.727C>T;	  c.313C>T	   p.R243*;	  p.R105*	  
-­‐
/+	  
	   	  




g	   Possibly	  Damaging	  




g	   Benign	  











g	   Benign	  
BEST2	   c.101G>A	   p.R34Q	  
-­‐
/+	   Tolerated	   Possibly	  Damaging	  




g	   Possibly	  Damaging	  




g	   Benign	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KRTAP19-­‐3	   c.161delG	   p.G54fs	  
-­‐
/+	  
	   	  






UBL4A;	  SLC10A3	   c.-­‐863A>G;	  c.*60A>G	   	  	  
-­‐
/+	   	  	   	  	  
	  
Patient	  2940	  
	   	   	   	   	   	  







CCTGGAGGC	   p.121_129delARAQRALEA	   -­‐/+	  
	   	   	  CDCP2	   c.1224_1225insGC	   p.M409fs	   -­‐/-­‐	  
	   	   	  ARHGAP29	   c.2876C>T	   p.A959V	   -­‐/+	   Tolerated	   Benign	  




OR10K1	   c.835A>C	   p.T279P	   -­‐/+	   Damaging	  
Probably	  
Damaging	  





FMO3	   c.133-­‐2007A>G	  
	  
-­‐/+	  
	   	   	  
CFHR5	   c.437A>G	   p.E146G	   -­‐/+	   Damaging	  
Possibly	  
Damaging	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DNAH14	   c.1258C>G	   p.R420G	   -­‐/+	   Damaging	   Benign	  
	  TMEM18	   c.107C>T	   p.A36V	   -­‐/+	   Activating	   Benign	  
	  
NCOA1	   c.484G>A	   p.V162M	   -­‐/+	   Damaging	  
Possibly	  
Damaging	  
IL36B	   c.13+1G>A	  
	  
-­‐/+	  
	   	   	  IMP4	   c.832T>C	   p.Y278H	   -­‐/+	   Damaging	   Benign	  
	  LRP1B	   c.5456C>T	   p.S1819F	   -­‐/+	   Damaging	   Benign	  
	  
CWC22	   c.952C>T	   p.R318C	   -­‐/+	   Damaging	  
Probably	  
Damaging	  
FSIP2	   c.257C>T	   p.A86V	   -­‐/+	   Damaging	  
	   	  FSIP2	   c.1895A>T	   p.Y632F	   -­‐/+	   Damaging	  






A	   p.1473_1474insQ	   -­‐/+	  




c.508A>G	   p.I126V;	  p.I170V	   -­‐/+	   Damaging	  
Possibly	  
Damaging	  







c.*341insGCCT	   p.A378fs;	  p.A68fs	   -­‐/+	  
	   	   	  
DSPP	  
c.3654_3656delCA
G	   p.1219delS	   -­‐/+	  
	   	   	  RRH	   c.730delA	   p.I244fs	   -­‐/+	  
	   	   	  PPID	   c.437_438delAT	   p.H146fs	   -­‐/+	  
	   	   	  C5orf42	   c.3130C>T	   p.R1044C	   -­‐/+	   Damaging	   Benign	  
	  ARSB	   c.29C>T	   p.P10L	   -­‐/+	   Damaging	   Benign	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MCC	   c.63_64insGGC	   p.21_22insG	   -­‐/-­‐	  
	   	   	  SNX2	   c.*127insACAC	  
	  
-­‐/+	  




c.427C>T	   p.R143C	   -­‐/+	   Damaging	  
Possibly	  
Damaging	  
MAPK13	   c.564C>G	   p.Y188*	   -­‐/+	  
	   	   	  
POLR1C	   c.766T>C	   p.C256R	   -­‐/+	   Damaging	  
Probably	  
Damaging	  








FAM120B	   c.2017+212C>T	  
	  
-­‐/+	  






	   	   	  FTSJ2	   c.542C>A	   p.T181N	   -­‐/+	   Damaging	   Benign	  
	  LOC389458;	  
RBAK-­‐
LOC389458	   c.273_275delTGC	   p.92delA	   -­‐/+	  
	   	   	  SMO	   c.47_48insGCT	   p.16_17insL	   -­‐/+	  
	   	   	  ZNF425	   c.1376_1377insGC	   p.H460fs	   -­‐/+	  
	   	   	  MBOAT4;	  
LEPROTL1	  
c.730G>A;	   c.280-­‐
4751C>T	   p.V244M	   -­‐/+	   Activating	   Benign	  
	  TRPS1	   c.1157A>T	   p.K386I	   -­‐/+	   Damaging	   Benign	  
	  
FER1L6	   c.1607T>C	   p.L536P	   -­‐/+	   Damaging	  
Probably	  
Damaging	  
NDUFB9	   c.347C>T	   p.P116L	   -­‐/+	   Damaging	  
Probably	  
Damaging	  
EPPK1	   c.2569C>T	   p.R857C	   -­‐/+	   Damaging	  
Possibly	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Damaging	  
PDCD1LG2	   c.542G>A	   p.R181H	   -­‐/+	   Damaging	  
Probably	  
Damaging	  
TUSC1	   c.142_143insGCG	   p.47_48insG	   -­‐/+	  
	   	   	  
FOXE1	  
c.505_510delGCCG
CC	   p.169_170delAA	   -­‐/-­‐	  











CTCGGG	   p.6_9delGARG	   -­‐/+	  
	   	   	  
TLL2	   c.2432G>C	   p.G811A	   -­‐/+	   Damaging	  
Probably	  
Damaging	  










c.38_40delAGG	   p.78delE;	  p.14delE	   -­‐/+	  
	   	   	  MUC2	   c.4745C>G	   p.T1582R	   -­‐/+	  
	  
Benign	  
	  MUC2	   c.*4913C>T	   p.T1638I	   -­‐/+	  
	   	   	  MUC2	   c.*5394C>G	   p.N1798K	   -­‐/+	  







p.S2242F;	   p.S2306F;	  
p.S2309F;	   p.S1370F;	  
p.S2365F	   -­‐/+	   Damaging	  
Probably	  
Damaging	  
INPPL1	   c.3224C>G	   p.P1075R	   -­‐/+	   Damaging	   Benign	  
	  
USP35	   c.125T>C	   p.L42P	   -­‐/+	   Damaging	  
Possibly	  
Damaging	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NCAPD2	   c.3218C>G	   p.S1073C	   -­‐/+	   Damaging	  
Possibly	  
Damaging	  
KRT79	   c.332C>T	   p.P111L	   -­‐/+	   Damaging	   Benign	  
	  DHX37	   c.504_505insGAG	   p.168_169insE	   -­‐/+	  
	   	   	  ANKLE2	   c.961G>A	   p.E321K	   -­‐/+	   Tolerated	   Benign	  




G	   p.335delE	   -­‐/+	  
	   	   	  









p.S463L;	   p.S448L;	  




	   	  
-­‐/+	  






	   	   	  




MIR3175	   c.62+3104G>C	  
	  
-­‐/+	  
	   	   	  
SYNM	  
c.2353_2355delAA
G	   p.785delK	   -­‐/+	  
	   	   	  
UNKL	  
c.1663C>A;	  
c.169C>A	   p.P57T;	  p.P555T	   -­‐/+	   Activating	  
	   	  
COX6A2	   c.203G>A	   p.R68H	   -­‐/+	   Damaging	  
Probably	  
Damaging	  
SOCS7	   c.535_536insAGC	   p.179_180insQ	   -­‐/+	  
	   	   	  COPZ2;	   mir-­‐
148	   c.112-­‐254delA	  
	  
-­‐/+	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COPZ2	   c.65G>A	   p.G22E	   -­‐/+	  







	   	   	  BAHCC1	   c.1272_1274delCTT	   p.H424_L425delinsQ	   -­‐/+	  
	   	   	  BAHCC1	   c.*6616T>C	   p.F2206L	   -­‐/+	  
	   	   	  TBCD;	  
ZNF750	  
c.1318+17390A>G;	  
c.131T>C	   p.M44T	   -­‐/+	   Damaging	  
Probably	  
Damaging	  
ZNF521	   c.2603C>T	   p.S868F	   -­‐/+	   Damaging	  
Possibly	  
Damaging	  
MBD2	   c.345_346insGGC	   p.115_116insG	   -­‐/+	  
	   	   	  
CTDP1	  
c.1510C>T;	  
c.1867C>T	   p.R623C;	  p.R504C	   -­‐/+	   Damaging	  
Probably	  
Damaging	  
ODF3L2	   c.574G>C	   p.A192P	   -­‐/+	   Damaging	  
Possibly	  
Damaging	  
S1PR5	   c.892A>G	   p.N298D	   -­‐/+	   Damaging	  
Probably	  
Damaging	  
ZNF878	   c.1111C>A	   p.Q371K	   -­‐/+	   Damaging	   Benign	  
	  ZNF490	   c.752A>C	   p.E251A	   -­‐/+	   Damaging	   Benign	  
	  
JUND	   c.752G>A	   p.S251N	   -­‐/+	   Tolerated	  
Probably	  
Damaging	  
ZNF676	   c.1511G>A	   p.R504H	   -­‐/+	   Damaging	   Benign	  
	  ZNF675	   c.1555C>T	   p.R519*	   -­‐/+	  








p.R359C;	   p.R276C;	  
p.R373C;	  p.R339C	   -­‐/+	   Damaging	   Benign	  
	  KLK5	   c.485G>T	   p.R162I	   -­‐/+	   Damaging	   Benign	  
	  NLRP5	   c.821G>A	   p.R274Q	   -­‐/+	   Activating	   Benign	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ZNF446	   c.1091G>A	   p.G364E	   -­‐/+	   Activating	   Benign	  
	  
CPXM1	   c.1030G>A	   p.G344R	   -­‐/+	   Damaging	  
Probably	  
Damaging	  
AP5S1	   c.53C>T	   p.T18M	   -­‐/+	   Damaging	   Benign	  
	  






22691delCCC	   p.4delG	   -­‐/+	  




GT	   p.654_655insPEKAKS	   -­‐/-­‐	   	  	   	  	   	  	  
	  
Patient	  2941	  
	   	   	   	   	  Gene	   NT	  change	   AA	  change	   2941	   SIFT	   Polyphen	  
ENO1	   c.641C>T;	  c.362C>T	   p.A121V;	  p.A214V	   -­‐/+	   Damaging	   Possibly	  Damaging	  





p.1040_1041insE	   -­‐/-­‐	  
	   	  APOB	   c.2722G>A	   p.E908K	   -­‐/+	   Damaging	   Probably	  Damaging	  
MYO1B	   c.*51T>C	  
	  
-­‐/+	  
	   	  MYRIP	   c.*148insT	  
	  
-­‐/+	  
	   	  ENAM	   c.2641G>A	   p.G881R	   -­‐/+	   Damaging	   Possibly	  Damaging	  
PDZD2	   c.4952G>T	   p.C1651F	   -­‐/+	   Activating	   Benign	  
NSD1	   c.1457C>A;	  c.650C>A	   p.S217Y;	  p.S486Y	   -­‐/+	   Damaging	   Possibly	  Damaging	  
PRELID1;	  MXD3	   c.*375A>T;	  c.*174T>A	  
	  
-­‐/+	  
	   	  MUC22	   c.817A>G	   p.T273A	   -­‐/-­‐	  
	   	  	  	   c.818C>A	   p.T273K	   -­‐/-­‐	  
	   	  	  	   c.837_838insGC	   p.I280fs	   -­‐/-­‐	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   c.838A>T	   p.I280F	   -­‐/-­‐	  
	   	  	  	   c.3623T>C	   p.V1208A	   -­‐/-­‐	  
	   	  	  	   c.3628G>A	   p.A1210T	   -­‐/-­‐	  
	   	  	  	   c.3629C>T	   p.A1210V	   -­‐/-­‐	  
	   	  	  	   c.3631G>A	   p.E1211K	   -­‐/-­‐	  
	   	  MAFA	   c.618_623delCCACCA	   p.207_208delHH	   -­‐/-­‐	  
	   	  C9orf43	   c.887_888insGCA	   p.296_297insQ	   -­‐/-­‐	  
	   	  MUC6	   c.5018T>G	   p.L1673R	   -­‐/+	  
	  
Benign	  
	  	   c.4847T>C	   p.V1616A	   -­‐/+	  
	  
Possibly	  Damaging	  





p.455_456delIP	   -­‐/+	  
	   	  ABCA8	   c.4036G>A	   p.V1346M	   -­‐/+	   Damaging	   Probably	  Damaging	  
CHMP6	   c.495+2T>C	  
	  
-­‐/+	  










	   	   	   	   	  Gene	   NT	  change	   AA	  change	   2941	   SIFT	   Polyphen	  
ABCA4	   c.3755A>T	   p.E1252V	   -­‐/+	   Damaging	   Benign	  
IGFN1	   c.9311C>T	   p.P3104L	   -­‐/+	   Damaging	  
	  ORMDL1	   c.428A>G	   p.H143R	   -­‐/+	   Damaging	   Probably	  Damaging	  
MAP1B	   c.4202C>T	   p.P1401L	   -­‐/+	   Activating	   Possibly	  Damaging	  
RAD50	   c.3454C>T	   p.R1152*	   -­‐/+	  
	   	  DNAH8	   c.13288G>A	   p.V4430M	   -­‐/+	   Damaging	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mir-­‐3689	  
	   	  
-­‐/+	  
	   	  SYNPO2L	   c.*1606C>G	  
	  
-­‐/+	  
	   	  BMPR1A	   c.782A>G	   p.K261R	   -­‐/+	   Damaging	   Probably	  Damaging	  
NPAT	   c.2572_2573insA	   p.T858fs	   -­‐/+	  
	   	  SELPLG	   c.460C>G;	  c.412C>G	   p.P138A;	  p.P154A	   -­‐/+	   Activating	   Benign	  
MYH6	   c.4828C>T	   p.R1610C	   -­‐/+	   Damaging	   Probably	  Damaging	  











p.388delG	   -­‐/+	  
	   	  ZKSCAN2	   c.2396G>T	   p.G799V	   -­‐/+	   Damaging	   Probably	  Damaging	  
ZKSCAN2	   c.1499G>C	   p.W500S	   -­‐/+	   Damaging	   Probably	  Damaging	  
CDH20	   c.*86A>G	  
	  
-­‐/+	  
	   	  SLC5A5	   c.643G>A	   p.G215R	   -­‐/+	   Damaging	   Probably	  Damaging	  
ACOT8	   c.622T>C	   p.W208R	   -­‐/+	   Damaging	   Probably	  Damaging	  
P2RX6	   c.1015G>A;	  c.937G>A	   p.V339I;	  p.V313I	   -­‐/+	   Activating	   Benign	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   ABBREVIATIONS	  List	  of	  abbreviations	  used	  in	  the	  text	  in	  alphabetical	  order:	  
ADE2	   Adenine	  
AIS	   Acquired	  immune	  system	  
arRP	   Autosomal	  recessive	  retinitis	  pigmentosa	  
ASC	   Apoptosis	  associated	  speckle	  protein	  containing	  CARD	  domain	  
BB	   Basal	  body	  
BBS	   Bardet-­‐Biedl	  syndrome	  
bp	   Base	  pairs	  
BWT	   Burrows-­‐Wheelers	  transform	  
BWA	   Burrows-­‐Wheelers	  transform	  based	  algorithm	  
CAPS	   Cryopyrin	  associated	  periodic	  syndromes	  
CARD	   Caspase	  activator	  and	  recruitment	  domain	  
CASP-­‐1	   Caspase-­‐1	  
CBR	   CRX	  binding	  region	  
CBS	   Corticosteroid	  binding	  region	  
CC	   Connecting	  cilium	  
CCD	   Charge-­‐coupled	  device	  
cGMP	   Cyclic	  guanosin	  monophosphate	  
cM	   Centimorgan	  
CP	   Calycal	  process	  
CRBP	   Cellular	  retinol-­‐binding	  protein	  
CRX	   Cone-­‐rod	  homeobox	  protein	  
Da	   Dalton	  
DHC1b/2	   Dynein	  heavy	  chain	  1b	  
DMEM	   Dulbecco's	  modified	  Eagles	  medium	  
DMSO	   Dimethyl-­‐sulfoxide	  
DNA	   Deoxyribonucleic	  acid	  
EBV	  	   Epstein-­‐Barr	  virus	  
ELM	   External	  limiting	  membrane	  
EM	   Electron	  microscopy	  
ER	   Endoplasmic	  reticulum	  
ERG	   Electroretinogram	  
FCS	   Fetal	  calf	  serum	  
FMF	   Familiar	  Mediterranean	  fever	  
g	   Gravitational	  force	  
GAII	   Genome	  analyzer	  II	  
GAL4-­‐BD	   GAL4	  binding	  domain	  
GATK	   Genome	  analysis	  tool	  kit	  
GDP	   Guanosin	  diphosphate	  
GO	   Gene	  ontology	  
GRK1	   G-­‐protein	  coupled	  receptor	  kinase	  1	  
	   159	  
GTP	   Guanosin	  triphosphate	  
h	   Hour	  
HEK293T	   Human	  embrionic	  kidney	  293	  Large	  T	  antigen	  
het	   Heterozygous	  
hg19	   Human	  genome	  reference	  19	  
HIDS	   Hyperimmunoglobulinemia	  syndrome	  
HIS3	   Histidine	  
homo	   Homozygous	  
HPLC	   High	  performances	  liquid	  chromatography	  
IDH3B	   Isocitrate	  dehydrogenase	  3	  beta	  
IFT	   Intraflagellar	  transport	  
IIS	   Innate	  immune	  system	  
INL	  	   Inner	  nuclear	  layer	  
Indel	   Insertion/deletion	  
IPL	   Inner	  plexyform	  layer	  
IRBP	   Inter-­‐photoreceptor	  retinoid	  binding	  protein	  
IS	   Photoreceptor	  inner	  segment	  
KAP1	   kinesin	  associated	  protein	  1	  
KO	   Knockout	  
LacZ	   Beta-­‐galactosidase	  
LC-­‐MS/MS	   Liquid	  chromatography	  and	  tandem	  mass	  spectrometry	  
LCA	   Leber	  congenital	  amaurosis	  
lncRNA	   Long	  non-­‐coding	  RNA	  
LOD	   Logarithm	  of	  odds	  	  
LPS	   Lipopolysaccharide	  
LRAT	   Lecithin:	  retinol	  acyl-­‐transferase	  
LRR	   Leucine	  rich	  domain	  
MAF	   Minor	  allele	  frequency	  
MAP	   Microtubule	  associated	  protein	  
MAPK	   Mitogen-­‐activated	  protein	  kinase	  
MAQ	   Mapping	  and	  assembly	  with	  quality	  
Mb	   Megabases	  
MEL1	   Alpha	  galactosidase	  
miRNA	   Micro	  RNA	  
mM	   Milli	  molar	  
MVK	   Mevalonate	  kinase	  
N	   Nucleus	  
NACHT	   Conserved	  n	  NAIP,	  CIITA,	  HET-­‐E,	  and	  TP-­‐1	  domain	  
NGS	   Next	  generation	  sequencing	  	  
NLRs	  	   NOD-­‐like	  receptors	  
nm	   Nanometers	  
NMD	   Non-­‐sense	  mediated	  mRNA	  decay	  
NOMID	   Neonatal-­‐onset	  mutisystem	  inflammatory	  disease	  
NPHP	   Nephronophtisis	  protein	  
NRL	   Neural	  retina	  leucine	  zipper	  
OFD1	   Oro-­‐facial	  digital	  1	  
	   160	  
ONL	   Outer	  nuclear	  layer	  
OPL	   Outer	  plexyform	  layer	  
OS	  	   Photoreceptor	  outer	  segment	  
PAGE	   Polyacrylamide	  gel	  electrophoresis	  
PAMPS	   Pathogen-­‐associated	  molecular	  patterns	  
PBLs	   Peripheral	  blood	  mononucleate	  cells	  
PCR	   Polymerase	  chain	  reaction	  
PDE	   Phospodiesterase	  
PFAPA	   Periodic	  fever	  with	  aphtous,	  stomatitis,	  pharyngitis	  and	  cervical	  adenitis	  
PPM	   Parts	  per	  million	  
PRP	   Pre-­‐mRNA	  processing	  	  
PYD	   Pyrin	  domain	  
RGB	   Red,	  green,	  blue	  
RNA	   Ribonucleic	  acid	  
RP	   Retinitis	  pigmentosa	  
RP28	   Locus	  retinitis	  pigmentosa	  28	  
RPE	   Retinal	  pigmented	  epitelium	  
RPMI	   Roswell	  Park	  Memorial	  Institute	  medium	  
SDS	   Sodium	  dodecyl	  sulfate	  
SF	   Streptavidin/FLAG	  
siRNA	   Small	  interfering	  RNA	  
SNPs	   Single	  nucleotide	  polymorphisms	  
SOAP2	   Short	  oligonucleotide	  analysis	  package	  2	  
TAP	   Tandem	  affinity	  purification	  
TBS	   Tris-­‐phosphate	  buffer	  	  
TLRs	   Toll	  like	  receptors	  
TNF	   Tumor	  necrosis	  factor	  
TPR	   Tetratricopeptide	  
TRAPS	   TNF	  receptor	  associated	  syndrome	  
UCSC	   University	  of	  California	  Santa	  Cruz	  
USH1	   Usher	  syndrome	  1	  proteins	  	  
VCF	   Variant	  call	  format	  file	  
Y2H	   Yeast	  -­‐two	  hybrid	  	  
